0001493152-20-004884.txt : 20200327 0001493152-20-004884.hdr.sgml : 20200327 20200327135439 ACCESSION NUMBER: 0001493152-20-004884 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200327 DATE AS OF CHANGE: 20200327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agape ATP Corp CENTRAL INDEX KEY: 0001713210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 364838886 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-220144 FILM NUMBER: 20750547 BUSINESS ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 BUSINESS PHONE: (603) 27325716 MAIL ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 10-K 1 form10-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

[ ]

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For The Fiscal Year Ended _______________________

[X]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from July 1, 2019 to December 31, 2019

Commission File Number 333-220144

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

Nevada

36-4838886

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

Registrant’s phone number, including area code

(60) 192230099

Securities registered pursuant to Section 12(b) of the Securities Exchange Act:

Common Stock, $0.0001 par value

(Title of Class)

The OTC Market – Pink Sheets

(Name of exchange on which registered)

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer [ ] Accelerated Filer [X] Non-accelerated Filer [ ] Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

Emerging growth Company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

The aggregate market value of the Company’s common stock held by non-affiliates computed by reference to the closing bid price of the Company’s common stock, as of the last business day of the registrant’s most recently completed second fiscal quarter:

$804,186,900.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class		Outstanding at March 25, 2020
Common Stock, $0.0001 par value		376,275,500

AGAPE ATP CORPORATION

FORM 10-K

For the Fiscal Period Ended December 31, 2019

Index

		Page #
PART I

Item 1.	Business	4
Item 1A.	Risk Factors	21
Item 1B.	Unresolved Staff Comments	27
Item 2.	Properties	27
Item 3.	Legal Proceedings	28
Item 4.	Mine Safety Disclosure	28

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	29
Item 6.	Selected Financial Data	29
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	39
Item 8.	Financial Statements and Supplementary Data	40
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	40
Item 9A.	Controls and Procedures	40
Item 9B.	Other Information	42

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	43
Item 11.	Executive Compensation	45
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	46
Item 13.	Certain Relationships and Related Transactions, and Director Independence	47
Item 14.	Principal Accounting Fees and Services	50

PART IV

Item 15.	Exhibits, Financial Statement Schedules	51

SIGNATURES		52

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Transition Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:

	●	The availability and adequacy of our cash flow to meet our requirements;

	●	Economic, competitive, demographic, business and other conditions in our local and regional markets;

	●	Changes or developments in laws, regulations or taxes in our industry;

	●	Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;

	●	Competition in our industry;

	●	The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;

	●	Changes in our business strategy, capital improvements or development plans;

	●	The availability of additional capital to support capital improvements and development; and

	●	Other risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.

This report should be read completely and with the understanding that actual future results may be materially different from what we expect. The forward looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Use of Defined Terms

Except as otherwise indicated by the context, references in this Report to:

	●	The “Company,” “we,” “us,” or “our,” “Agape” are references to Agape ATP Corporation, a Nevada corporation.

	●	“Common Stock” refers to the common stock, par value $.0001, of the Company;

	●	“U.S. dollar,” “$” and “US$” refer to the legal currency of the United States;

	●	“Securities Act” refers to the Securities Act of 1933, as amended; and

	●	“Exchange Act” refers to the Securities Exchange Act of 1934, as amended.

PART I

ITEM 1. BUSINESS

1. ORGANIZATION AND BUSINESS BACKGROUND

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

The Company and its subsidiaries provide health and wellness products and advisory services to the public. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

Details of the Company’s subsidiaries:

Subsidiary company

name

Place and date of

incorporation

Particulars of issued capital

Principal activities

Proportional of ownership

interest and

voting power

held

Agape ATP Corporation

Labuan,
March 6, 2017

100 shares of ordinary share of US$1 each

Investment holding

100

Agape ATP International Holding Limited

Hong Kong,
June 1, 2017

1,000,000 shares of ordinary share of HK$1 each

Health and wellness products and health solution advisory services

100

Business Overview

Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. As a strong advocator of “beauty from within”, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

The ATP Zeta Super Health Program consists of eight products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron and YFA-Young Formula.

At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.

As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.

Currently, all our products are acquired from unrelated third parties and rebranded by the Company. We have no expenditures or expenses relating to research and development of our products for our last two fiscal years. We leverage on the smart partnerships models that we have formed, collaborating with our customers and clients to understand the health and wellness market via a process of consultative review. We then communicate our findings and proposals to third-party suppliers to improve formulations, to bring about new products for customers who are ready to market to end-users. We refer to our approach as “the Power of 3”, which we take great pride in. In the future, we will explore sourcing from third party manufacturers located in Australia, the United States, Germany and Malaysia.

Our Products

ATP1s Survivor Select

ATP1s Survivor Select contains various essential nutrients required by the human body to maintain the normal metabolism, which includes productions of biological energy (ATP). Effective production of ATP enhances both physical as well as mental health, and helps the body to build up resistance to diseases.

It helps to:

	●	Stimulate instant bio-energy production at the cellular level to ensure sufficient supply of bio energy for body cell.
	●	Promote better metabolism at the cellular level.
	●	Promote healthy and optimal growth of bones system, teeth structure and muscle tissue of children.
	●	Improve the digestion and nutrient absorption powers of body cell.
	●	Promote cell detoxification and repair capabilities in order to enhance cell self-healing ability.

ATP2 Energized Mineral Concentrate

The ATP2 is a nutritional supplement made from the finest plant substances and also is a proprietary formulation of a super-energized colloidal concentrate developed from a dibase solution. Its formula supports and enhances nutritional biochemical activities.

It helps to:

	●	Support and enhance nutritional biochemical activities (nutrient absorption and waste metabolism).
	●	Break down or oxidised toxins and waste material to promote cellular detoxification and improve blood circulation.
	●	Increase cellular respiration and energy production to reduce fatigue and maintain energy level.
	●	Increase oxygen level in body cells to create a high oxygen environment in the body, which possibly help to prevent the growth of harmful pathogens that contribute to diseases.
	●	Provide sufficient antioxidants that act as a superior scavenger of free radicals, to strengthen the body cells resistance against oxidative damages.

ATP3 Ionized Cal-Mag

ATP3 Ionized Cal-Mag is a specialized calcium and magnesium minerals supplement that is designed to transform into ionic form completely before entering the body. This is compatible to the cellular ion channel theory, that all cellular metabolisms are dependent on ionic transmission to achieve the highest absorption rate. This product was tested for its nanoparticle by the National Measurement Institute of Australian Government, with proven content of nanosized calcium and magnesium that has better absorption and bio-availability.

It helps to:

	●	Strengthen the bone system and promote better bone development.
	●	Strengthen the teeth structure and prevent teeth damages.
	●	Provide abundant of ionic calcium and magnesium to prevent chronic diseases through better blood circulation and acid-base regulation.
	●	Promote better relaxing of nervous system and regulations of neurotransmitters which helps to enhance sleep quality.
	●	Promote better relaxing of muscle to prevent muscle soreness and cramps.

ATP4 Omega Blend

ATP4 Omega Blend is a proprietary oil blend that is rich in undamaged polyunsaturated essential fatty acid, which is fully extracted from plant-based ingredients. It provides a bio-effective balance of both essential fatty acids, Omega 3 and Omega 6 which are the important structural components of cell membranes that cannot be synthesized by humans.

It helps to:

	●	Regulate cholesterol and triglycerides levels to promote better blood circulation.
	●	Regulate inflammation, the unifying component of many diseases, and enhance cell repairing activities.
	●	Regulate hormones production and functions in the body through supplies of the balanced ratio of Omega 3 and Omega 6.
	●	Promote healthy functioning of the brain through the maintenance of healthy impulse transmission in brain cells that is crucial for memory and learning ability.

ATP5 BetaMaxx

ATP5 BetaMaxx is derived from the cell wall of premium food-grade baker’s yeast and is a medical breakthrough result of more than 50 years of intensive research and studies by scientists and physicians. This product combines the immunostimulatory properties of perfectly molecularly structured beta 1-3, 1-6-D-glucan with other immunomodulating compounds that work in perfect synergy to make ATP5 a unique and effective natural product. It is a 100% natural immune enhancer, safe and does not cause any allergic reactions.

It helps to:

	●	Strengthen the function of immune cells to build up a better immune response of body for external and internal protections
	●	Promote better cell repairing and regulate inflammatory responses in wound healing.
	●	Enhance the function of immune cell against damages caused by radiation.
	●	Helps to normalize blood sugar levels.

AGN-Vege Fruit Fiber

AGN-Vege Fruit Fiber is the special nutrition-based formula for intestines and stomach. It consists of four most essential components for gastrointestinal health effects such as fiber, probiotic the “friendly bacteria”, prebiotic fructooligosaccharides (FOS) as well as digestive enzymes.

It helps to:

	●	Promote better bowel movement and prevent low-fiber diet-induced constipation.
	●	Maintain bowel health. FOS helps increase intestinal bifidobacteria and helps maintain a good intestinal environment.
	●	Slow the absorption of sugar and lipid into the bloodstream which helps improve blood sugar and cholesterol level.
	●	Induce better satiety, which results in reduced total food intake and helps in achieving an ideal weight management.

AGP1-Iron

AGP1-Iron is the purest and most advanced Colloidal Iron that is sourced from the remains of an ancient rainforest which contains the most active plant-based element from nature. The colloidal nanosized iron provides high zeta potential promotes better absorptivity and cellular iron uptake through the ion channel.

It helps to:

	●	Promote better hemoglobin production to improve iron deficiency anemia.
	●	Iron is a component of hemoglobin in red blood cell which carries oxygen to all part of the body. Therefore, it helps to improve blood circulation and prevent some oxygen deficiency symptoms through enhancement of oxygen delivery and nutrient circulation as well as toxins excretion.
	●	Iron is a factor in red blood cell formation. It promotes hemoglobin production hence is suitable especially for women and individual who experienced accidental bleedings.

YFA-Young Formula

YFA-Young Formula is a 100% natural unique formula, a combination of amino acid, vitamins, and minerals and is the best anti-aging and youthful maintenance supplement. It stimulates the pituitary gland to release endocrine hormones such as human growth hormone (HGH) to stimulate synergies thus achieving the efficacy of anti-ageing through the promotion of cells vitality and strengthening of organ function.

It helps to:

	●	Enhance the production of bio-energy ATP and metabolism, which aids in reducing body fat accumulation and promote strong muscles building.
	●	Stimulate the production of collagen to restore skin elasticity and reduce wrinkles.
	●	Reduce pigmentation and dark spots on face caused by hormonal imbalances.
	●	HGH builds and repairs tissues and thus has an effect on hair cells at the hair root to promote healthy hair growth.
	●	Enhance memory and cardiovascular function and prevent various chronic diseases due to HGH deficiency.

BEAUNIQUE Mito+ and Mitogize

We retire ATP Regal Mitogize on October 1, 2019. In its stead, an enhanced formula, the BEAUNIQUE Mito+ was introduced in November 2019. As a strong antioxidant drink with great flavor and taste, the preeminence of BEAUNIQUE Mito+ is its ability to further protect and stimulate mitochondria (the powerhouse of cells) in cellular energy (ATP) production with the added advantage of less total sugars and calories. The new formula comprises 11 Superfood including potent mangosteen skin extract. Backed by advanced scientific research and tested on 88 nutrigenomic profile, the new formulation revealed enhanced antioxidant properties. 96.34% DPPH Radical Scavenging activity, an approximate 22% increase compare to Mitogize.

It Promotes:

	Cellular health
	●	Effective antioxidants to protect from cellular oxidative damages.

	Immune health
	●	Enhance adaptive immune response.
	●	Anti-inflammatory.
	●	Strengthen immunity against bacteria and viruses.

	Metabolic health
	●	Reduce risk of obesity.
	●	Reduce risk of vascular diseases.
	●	Reduce risk of Type II Diabetic.

	Brain health
	●	Reduce risk of neurodegenerative diseases.

	Skin health
	●	Systemic photoprotection.
	●	Reduce dark spot formation.
	●	Alleviates skin wrinkle and inflammation induced by UV-B irradiation.

ORYC-Organic Youth Care Cleansing Bar

ORYC-Organic Youth Care Cleansing Bar is a natural, organic cleansing soap for skin. It contains pure Australian-accredited natural and organic plant oils acting as a high quality and natural skin lubricant. It maintains the softness of the skin while promoting skin beauty and radiance.

It helps:

	●	With its biodynamic avocado oil and vanilla extract, remove impurities, leaving skin clear, fresh and clean.
	●	With its biodynamic, coconut, almond and olive oil, moisturize and texturize the skin to prevent skin drying.
	●	In acting as natural anti-bacterial and anti-inflammatory agents, reduce the risks of skin infections and allergies.

*References alluding to the efficacy and effects of our products are based on client testimonials.

Beauty Products

The Company’s ENERGETIQUE series aim to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of Energy Mask, Hyaluronic Acid Serum and Mousse Facial Cleanser.

ENERGY MASK SERIES

The Company’s Energetique Mask Series is formulated with triple action natural ingredients and advanced technologies. The innovative combination of award-winning patented liposome encapsulating the customized fast acting patented essence, produces micro-particle liposome which, combined with collagen peptide Tencel film, creates an effective formulation that benefits the skin at the cellular level.

There are three types of face masks in the Energetique Mask Series, each to suit a different skin requirement. They are: N°1 Med-Hydration; N°2 Med-Whitening; N°3 Med-Firming. Advanced genetic analysis and clinical trials conducted revealed the benefits and efficacies of the patented functional essence. The Energetique Mask Series has clinically shown deep penetration of liposomal essence into deep skin layers within 5 minutes of the application to deliver immediate, deep-reaching and long-lasting benefit of skin hydration, whitening, and firming.

N°1 Med-Hydration

Formulated with the patented Sea Grape (Caulerpa lentillifera) extract, the N°1 Med-Hydration enhances skin moisture and luminosity. This treatment effectively improves the moisture content of the inner skin layer and rejuvenate the skin barrier function to avoid moisture loss.

It helps:

	●	locking the skin moisture and nutrients, strengthening the skin barrier function and boosting the skin’s moisture level.
	●	to increase the skin’s natural moisturizing factor (PCA) and skin layer glycoprotein connectivity to maintain the skin’s moisture.
	●	to effectively retain water, provides moisturization, restores skin elasticity, and promotes the growth of fibroblasts for moisturization, removes dryness, regains skin’s elasticity and smoothness.
	●	immensely in delivering an instant boost of skin moisture content up to 45.7% in just 5 minutes of application and synergistically ensuring a profound and long-lasting skin moisturization and hydration.

N°2 Med-Whitening

Formulated with patented Peach Blossom Stem Cell Extract, the N°2 Med-Whitening has clinically shown its efficacy in inhibiting the melanin synthesis, down-regulating the melanin synthesis gene, boosting skin moisture level and protecting skin against UV radiation.

It helps:

	●	in suppressing melanin production and fight against UV radiation to protect skin cells and result in whitening effect.
	●	to stimulate interstitial hyperplasia cell and helps in increasing the moisturizing ceramide by 7.4 times in order to remove skin roughness and smoothing skin.
	●	to enhance the skin brightness up to 6.3% in just 5 minutes of application and synergistically rejuvenate a profound and long-lasting skin ability in anti-UV damage.

N°3 Med-Firming

Formulated with the patented Djulis (Chenopodium formosanum Koidz) Seed Extract, the native cereal plant in Taiwan and traditionally called “ruby of cereals.” The formulation is clinically proven to be effective in stimulation of collagen secretion and anti-advances glycation end-products (AGEs) reducing the glycation of skin collagen, provide protection and maintenance of the basal skin collagen production.

It helps:

	●	to suppress the skin collagen glycation process, reduces collagen loss, and enhancing collagen secretion.
	●	repairing the dead skin tissue, smooth wrinkles to restore the smoothness and health of the skin.
	●	preventing wrinkles formation and providing the essential skin moisture content.
	●	to boost skin elasticity by up to 14.4%. and improve sagging skin by 135 in just 5 minutes of application.

Unique Characteristics via Nutrigenomic

The Company’s BEAUNIQUE product series focuses on the research of diet’s impact on modifying gene expressions to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

Trim+:

Trim+ is the first product launched under this series, utilizes the advanced technology to extract the patented active ingredients in foods. Trim+ has scientifically proven to be effective in inhibiting the activities of carbohydrates digestive enzymes, which results in a reduction of the breakdown and absorption of sugars.

It helps to:

	●	Reduce total carbohydrates calories intake with the scientifically proven effect on weight management.
	●	Regulate blood sugar levels with scientifically proven efficacy.
	●	Improve cellular uptake of sugars for bioenergy ATP production.
	●	Maintain insulin hormone balance, helps prevent diabetes.
	●	Improve blood lipids composition, helps prevent cardiovascular disease.

New Products Launches

On 3rd November 2019, the Company expanded its beauty products under the ENERGETIQUE series, to include beauty essentials of the skincare routine, i.e. the ÉNERGÉTIQUE Mousse Facial Cleanser and ÉNERGÉTIQUE Hyaluronic Acid Serum. These new products have extended the ÉNERGÉTIQUE brand vision in offering a total dermal solution for a healthy skin beginning from the cellular level.

ÉNERGÉTIQUE Hyaluronic Acid (HA) Serum

Formulated with four functional hyaluronic acid and a unique peptide, this scientifically advanced and intensive quintuple action serum proven to deliver 5Rs dermal benefits. Filled in an innovative yet convenient and hygienics syringe packaging, this HA serum also ensure consumer-perceivable benefits for every skin type.

Benefits

	●	REBALANCE - Hydrate the skin surface by forming a protection layer and keep skin moisturized even after cleansing
	●	RECOVER – Repair the out-balanced lamellar layer to act as barrier to prevent skin moisture from evaporation
	●	REGENERATE - Promote the production of Type I pro-collagen and boost skin’s own production of Hyaluronic Acid up to 3 times
	●	REHYDRATE - Nano-sized particles with high capacity of water-holding allow deep penetration and bestows moisture from inside the skin. Long-lasting moisture retention up to 72 hours
	●	REMODELLING - Proven to increase skin firmness +200% (cheek, under-eye and neck). Enhance skin viscoelasticity to improves skin roughness

ÉNERGÉTIQUE Mousse Facial Cleanser

Formulated with the mildest surface-active agents available on the market, this facial cleanser was designed to deliver a distinct A to E cleansing benefits to consumers. The unique mousse like-foam delivers a comfortable and soft feeling of the skin during and after use without compromising the moisturizing level and viscoelastic properties of the skin.

Benefits

A.	All Skin Type
		a.	Hypoallergenic
		b.	Non-comedogenic

B.	Balance
		a.	pH-balanced formula with buffer capacity at pH 5.5 of the skin.

C.	Comfortable
		a.	Mild to skin and eyes without irritating or drying your skin
		b.	Comfortable and soft feeling – prolonged comfortable to skin before and after use. Accidental consuming would not be harmful to your body.

D.	Dense
		a.	Mousse-like foam very fine porous foam and smooth skin-feel during use

E.	Effortlessly
		a.	Easily remove light makeup, dirt and impurities.
		b.	Easy to rinse with no residual.

Future Plans

The World Health Organization or WHO, has since March 11, 2020 declared the corona virus or COVID-19 a pandemic. Malaysia, where our products are mainly sold at present, reported 553 cases of the COVID-19 on March 16, 2020; and the number is still rising. In view of the seriousness of the matter, the local government of Malaysia had, on the same day, imposed a nationwide lockdown effective March 18, 2020.

As the intermediary between our suppliers and our sole customer in Malaysia, the onslaught of the pandemic poses challenges to us at both sourcing and supplying our products. Our sole customer has confirmed that onward delivery of our products is via multi-level marketing or MLM to end users who are also members of the MLM group that make up consistent demand of our products. In an effort to embrace globalization, the MLM group has also embarked on e-commerce. The MLM group has synched up with a Malaysian e-commerce trading platform, which will make its debut in the next three months to commence e-marketing and e-trading of its products to members, as well as online e-recruitment of new members. The MLM group is positive that its online e-recruitment service which capitalizes on a large number of followers of well-known key products influencers will dramatically increase the number of members most expediently with minimal cost, thereby increasing demand of our products. Considering our products are health supplements, we also expect impressive demand growth at a time when everyone’s health is at risk. This should translate into sustainable growth once awareness of the importance of health is created.

Although some of the countries from which our products are sourced are experiencing lockdowns, industries involved in the provision of food, especially health products and pharmaceuticals, are normally exempted. We may experience slight delay in products delivery lead time, but barring unforeseen circumstances, the setback should be temporary.

We anticipate operating primarily in Malaysia and expanding into the Asian markets in the future, with a particular focus, at least initially, on expanding into Thailand, Indonesia and Taiwan. We will explore expansion via e-commerce. When the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the countries in which we operate to better service our customers.

We plan to hire at least five to ten salespeople for every country in which we operate. At present, we do not have any salesforce. It will also be necessary for us to acquire office space to conduct operations, have meetings with potential clients, and store acquired inventory. At present, we do not have any distinct timeline in place for expansion into these countries.

We plan to hire additional employees to support our operations in different countries. We believe that hiring fifteen to twenty employees will be sufficient in order to support our operations. We also plan to allocate funds to research new products for the ATP Zeta Super Health Program. However, such development will require intensive research, development and testing. We cannot accurately determine a definitive timeline at present, nor have we determined an appropriate budget, for these future activities. We may also evaluate potential acquisitions in the future which we feel may have some synergy with our current operations.

Marketing

Agape ATP Corporation plans to penetrate the marketplace and attract customers by building our brand image through print ads, and possibly online paid advertisements, in order to create brand awareness. We are developing a corporate website which will introduce the ATP Zeta Super Health Program. We will market our advisory services through this corporate website and utilize marketing related search engines to attract potential clients to our website. Additionally, we will further our marketing activities through social networking websites.

Competition

The health and wellness industry, with a focus on health supplements in particular in Malaysia, where Agape ATP Corporation plans to operate, is rather competitive. Our focus is on the mature group of customers, i.e. adults ranging in age from 18-65 years old. We face competition from various retail health supplement providers, pharmacies, and Multi-Level Marketing Companies which supply health supplement products, such as Bio-Life Marketing Sdn Bhd, Elken Group, Usana Group, BMS Organics, NHF Group and their respective affiliates. These competitors are generating significant traffic to their marketing websites; and have established brand recognition and financial resources.

We believe that the principal competitive factors in our type of market include the quality of health supplements, the efficacies of the health supplements, strength and depth of relationships with clients, the ability to identify the changing needs and requirements of prospective clients, and the scope of services. Through utilizing our competitive strengths, we believe that we have a competitive edge over other competitors due to the breadth of our product offerings, one stop convenience, pricing, our services, our reputation and product safety. We are confident we can develop and enlarge our market share in the Malaysian market and potentially further into the overseas market.

Customers

Agape S.E.A. Sdn Bhd, a related party, remains our sole customer as at the end of the fiscal period ended December 31, 2019. Revenue generated for the six months ended December 31, 2019, years ended June 30, 2019 and 2018 were $429,362, $1,524,596 and $487,008 respectively.

Employees

We have no employees as of the date of this annual report, with the exception of our sole officer and director, Mr. How Kok Choong. Mr. How currently devotes approximately 30 hours per week to the Company’s matters. Mr. How Kok Choong plans to devote as much time as the Board of Directors determines is necessary for him to manage the affairs of the Company. As our business and operations increase, we plan to hire full time management and administrative support personnel.

Government regulation

ITEM 1A. RISK FACTORS

Risks Related to our Business

We are exposed to concentration risk of heavy reliance on our major customer. A loss of our major customer may significantly impact on our business and results of operation.

For the six months ended December 31, 2019, we earned revenue of $429,362 from our major customer. Our major customer may terminate its business relationships with us at any time. We cannot assure you that our major customer will maintain current business relationship with us. If it chooses not to do so, our business, financial condition and operating results may suffer from a material adverse impact.

We are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation.

For the six months ended December 31, 2019, we purchased $383,479 from two of our major suppliers. Our business, financial condition and operating results depend on the continuous supply of products from our major supplier and our continuous supplier-customer relationship with it. Our heavy reliance on our major supplier for the supply of our products will have significant impact on our business and results of operation in the event of any shortage of, or delay in the supply.

Our major supplier may terminate the distribution agreement by giving notice to us, in which case our business, financial condition and operating results may suffer from a material adverse impact.

As is customary in distribution arrangements of this type, the distribution agreement with our major supplier is terminable by either party by giving notice. There is no assurance that our major supplier will not terminate the distribution agreement. In the event that it terminates the distribution agreement, we will have to source products from other suppliers and we may not be able to secure supply of products with quantity and quality required to support our business or at all. Such termination may therefore have a material adverse impact on our business, financial condition and operating results if we fail to engage any other suppliers before the termination.

We are exposed to unforeseeable events of labor disputes, strike action or natural disasters or other accidents which may affect the supply of our products from our major supplier.

There is no assurance that our major supplier will continue to supply its products in the quantities and timeframes required by us to meet the needs of our customers or comply with its supply agreement with us. Our product supply may also be disrupted by potential labor disputes, strike action or natural disasters or other accidents affecting the supplier. If our supplier does not supply products to us in a timely manner or in sufficient quantities, our business, financial condition and operating results may be materially and adversely affected. Furthermore, in the event of any delay in delivery of the products to us, our cash flow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from our customers.

Our major supplier may change its existing sales or marketing strategy by changing its export strategy, reducing its sales or production volume, changing its selling prices or appointing other distributors which may compete with us in the market where we currently operate or which we plan to expand into.

Our major supplier may change its existing sales or marketing strategy in respect of the products supplied to us by changing its export strategy, reducing its sales or production volume or changing its selling prices. Consequently, there is no assurance that our major supplier will not appoint other dealers or distributors which may compete with us in the market where we operate. Furthermore, any significant increase in the selling prices of the products which we source from our supplier will increase our costs and may adversely affect our profit margin if we are not able to pass the increased costs on to our customers.

There is no assurance that there will be no deterioration in our relationship with our major supplier which could affect our ability to secure sufficient supply of products for our business. In the event that our major supplier changes its sales or marketing strategy or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating results may be materially and adversely affected.

We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.

The market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer preference, consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products could occur as a result of change in consumer preference, perception and spending habits at any time.

Any failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related to certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing or lead to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may also result in lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes could result in a material adverse effect on our business, financial conditions or results of operations.

The success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, we may not be able to fully recover our costs and expenses incurred in our operation, and our business prospects, financial condition or results of operations may be materially and adversely affected.

We may incur losses resulting from product liability claims or product recalls.

We may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims or liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or proven to be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in personal injury or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls, and the relevant regulatory authorities in the market we operate may close down some of our related operations and take administrative actions against us. If we experience any business disruption and litigation, we may incur additional costs and have to divert our management’s attention and resources on such matters, which may adversely affect our business, financial condition and results of operations.

We operate in a heavily regulated industry.

Our business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of 1983 and Food Regulation 1985 mandate authorization from the Food and Quality Division of the Ministry of Health for our Company’s products to be sold in the country.

Various registrations, certificates and/or licenses for the conduct of our business are required under the above laws, which also contain provisions for requirements on the storage, labelling, advertising and importation of some of our products.

Based on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of our business plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates and/or licenses. Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or prosecution against us, which may adversely affect our reputation, financial condition or results of operation.

Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation.

We may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating to product or other types of liability, employees’ claims, labor disputes or contract disputes that could have a material and adverse effect on our reputation, operation and financial condition. If we become involved in material or protracted legal proceedings or other legal disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements or outcomes which adversely affect our financial condition. In addition, any litigation or legal proceedings could incur substantial legal expenses as well as significant time and attention of our management, diverting their attention from our business and operations.

If we are not successful in our innovation activities, our results may be negatively affected.

Achieving our business growth objectives depends in part on our ability to successfully develop, introduce and market new products. The success of our innovation activities in turn depends on our ability to correctly anticipate customer and consumer acceptance and trends, obtain, maintain and enforce necessary intellectual property protections and avoid infringing on the intellectual property rights of others. If we are not successful in our innovation activities, we may not be able to achieve our growth objectives, which may have a negative impact on our financial results.

Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results.

We earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including Australian Dollar, Malaysian Ringgit and the Hong Kong Dollar. Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other currencies affect our net operating revenues, operating income and the value of balance sheet items denominated in foreign currencies. We cannot assure you that fluctuations in foreign currency exchange rates, particularly the strengthening of the U.S. dollar against major currencies would not materially affect our financial results.

Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business.

Our success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise in business operations when we are developing our business. We have no “Key Man” insurance to cover the resulting losses in the event that any of our officer or directors should die or resign.

If Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely manner or at all. This would likely result in a severe damage to our business operations and would have an adverse material impact on our financial position and operating results. To continue as a viable operation, the Company may have to recruit and train replacement personnel at a higher cost.

Additionally, if Mr. How Kok Choong joins our competitors or develops similar businesses that are in competition with our Company, our business may also be negatively impacted.

Our future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing, and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring, developing, and retaining the talent required for our success.

If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.

We have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things, our evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which are more profitable than others, and on an assessment of the potential price and product mix. There can be no assurance that we will realize the sales potential and the price and product mix necessary to achieve our long-term growth objectives.

We face risks related to health epidemics, severe weather conditions and other outbreaks.

In recent years, there have been outbreaks of epidemics in various countries, including Malaysia. Recently, there was an outbreak of a novel strain of coronavirus (COVID-19), which has spread rapidly to many parts of the world, including Malaysia. In March 2020, the World Health Organization declared the COVID-19 a pandemic. The epidemic has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia for the past few weeks.

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

●

temporary closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for our products;

	●	our sole customer may require additional time to pay us or fail to pay us at all, which could significantly increase the amount of accounts receivable and require us to record additional allowances for doubtful accounts. We may have to provide significant sales incentives to our sole customer during the outbreak, which may in turn materially adversely affect our financial condition and operating results;

	●	any disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our sole customer, which may also lead to loss of our sole customer; and

	●	the global stock markets have experienced, and may continue to experience, significant decline from the COVID-19 outbreak and the marketable securities that we have invested in could be materially adversely affected, which may lead to significant impairment in the fair values of our investments and in turn materially adversely affect our financial condition and operating results.

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in the next three quarters of 2020. We may have to record downward adjustments or impairment in the fair value of investments in the first quarter of 2020, if conditions have not been significantly improved and global stock markets have not recovered from recent declines.

In general, our business could be adversely affected by the effects of epidemics, including, but not limited to, the COVID-19, avian influenza, severe acute respiratory syndrome (SARS), the influenza A virus, Ebola virus, severe weather conditions such as flood or hazardous air pollution, or other outbreaks. In response to an epidemic, severe weather conditions, or other outbreaks, government and other organizations may adopt regulations and policies that could lead to severe disruption to our daily operations, including temporary closure of our offices and other facilities. These severe conditions may cause us and/or our partners to make internal adjustments, including but not limited to, temporarily closing down business, limiting business hours, and setting restrictions on travel and/or visits with clients and partners for a prolonged period of time. Various impact arising from a severe condition may cause business disruption, resulting in material, adverse impact to our financial condition and results of operations.

Risks Related to our Industry

Our business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability insurance of our supplier may not cover our liability sufficiently or at all.

Like other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for consumption or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or degeneration, presence of microbials, illegal tampering of products by unauthorized third parties or other problems arising during the various stages of the procurement, production, transportation and storage processes. The occurrence of such problems may result in customer complaints, fines, penalties or adverse publicity causing serious damage to our reputation and brand, as well as product liability claims, other legal disputes and loss of revenues. Under certain circumstances, we may be required to recall our products. Even if a situation does not necessitate a product recall, we cannot assure you that product liability claims or other legal disputes will not be asserted against us as a result. Product liability insurance of our supplier may not cover our liability sufficiently or at all and will not cover liability that arises out of our default such as mishandling, poor storage condition and/or contamination of the products by us. As a result, a product liability or other judgment against us, or a product recall, could have a material adverse effect on our business, financial condition or results of operations.

Our business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or illnesses caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers means that food-borne illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in the future, or diseases with long incubation periods could arise that could give rise to claims or allegations on a retroactive basis. Reports in the media of instances of food-borne illnesses or health threats of our products or any of their major ingredients could adversely and significantly affect our sales, and have significant negative impact on our results of operations. This risk exists even if it were later determined that the illness or health threat in fact was not caused by our products.

In addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our products. Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If consumers were to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales and results of operation. The amount of negative news, customers complaints and claims against us may also be very costly and may divert our management’s attention from our business operation.

Increased competition and capabilities in the marketplace could hurt our business.

The market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well as numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the market where we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue to strengthen our capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively expand into other product categories, our business could be negatively affected.

Risks Related to our Common Stock

The market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:

	●	variations in our actual and perceived operating results, especially during this time when the COVID-19 pandemic poses a threat;

	●	news regarding gains or losses of customers or suppliers by us or our competitors;

	●	news regarding gains or losses of key personnel by us or our competitors;

	●	announcements of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;

	●	changes in earnings estimates or buy/sell recommendations by financial analysts;

	●	potential litigation;

	●	the imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable rules and regulations;

	●	general market conditions or other developments affecting us or our industry; and

	●	the operating and stock price performance of other companies, other industries and other events or factors beyond our control.

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of the shares.

We may never be able to pay dividends and are unlikely to do so.

To date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable. Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather than to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and future dividends are not presently being contemplated, investors are advised that return on investment in our common stock is restricted to an appreciation in the share price. The potential or likelihood of an increase in share price is uncertain.

In addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided that our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability to generate sufficient profits.

Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.

Wherever possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or other securities. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt to raise capital by selling shares of our common stock, possibly at a discount to market in the future. These actions will result in dilution of the ownership interests of existing shareholders and may further dilute common stock book value, and that dilution may be material. Such issuances may also serve to enhance existing management’s ability to maintain control of us, because the shares may be issued to parties or entities committed to supporting existing management.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Business support services are rendered from:

Our principal executive office at

1705 – 1708, Level 17, Tower 2,

Faber Towers, Jalan Desa Bahagia,

Taman Desa, 58100 Kuala Lumpur, Malaysia.

Room 2708-9, 2F,

The Metropolis Tower,

10 Metropolis Drive, Hunghom,

Kowloon, Hong Kong.

ITEM 3. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our Common Stock is currently listed on the OTC Markets – Pink Sheets under the trading symbol “ATTP.” There is no active trading market in the Company’s securities.

Holders

As of December 31, 2019, we had 376,275,500 shares of our Common Stock par value, $0.0001 issued and outstanding. There were 1,208 record holders of our Common Stock.

Transfer Agent and Registrar

Our transfer agent is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212)828-843.

Dividend Policy

Any future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors currently intends to retain all earnings for use in the business for the foreseeable future.

Equity Compensation Plan Information

Currently, there are no equity compensation plan in place.

Unregistered Sales of Equity Securities

None.

Purchases of Equity Securities by the Registrant and Affiliated Purchasers

We have not repurchased any shares of our common stock during the six months ended December 31, 2019.

ITEM 6. SELECTED FINANCIAL DATA

The following table sets forth selected financial data as of December 31, 2019 and for our last four fiscal years (from the date of incorporation of the Company), This selected financial data should be read in conjunction with the consolidated financial statements and related notes included in Item 15 of this Annual Report.

	Years ended June 30,
	2019			2018			2017
Revenue	$	1,546,057		$	487,005		$	-
Net loss	$	(519,642	)	$	(130,274	)	$	(75,362	)
Net loss per share – (basic and diluted)	$	(0.00	)	$	(0.00	)	$	(0.00	)

	As of June 30,
	2019		2018		2017
Total assets	$	4,651,755	$	5,128,531	$	2,312,748
Total liabilities	$	71,402	$	29,750	$	8,100

	Six months ended December 31,
	2019			2018			2017
				(unaudited)			(unaudited)
Revenue	$	429,362		$	685,288		$	489,499
Net loss	$	(338,931	)	$	(142,446	)	$	(178,678	)
Net loss per share – (basic and diluted)	$	(0.00	)	$	(0.00	)	$	(0.00	)

	As of December 31,
	2019		2018		2017
			(unaudited)		(unaudited)
Total assets	$	4,335,274	$	5,198,181	$	2,708,503
Total liabilities	$	83,988	$	241,847	$	144,289

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes to those financial statements appearing elsewhere in this Report.

Certain statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plan,” “potential,” “project,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking statements.

The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Overview

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016. Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a company organized in Labuan, Malaysia, which, in turn holds 100% of Agape ATP International Holding Limited, a Hong Kong Company.

Agape ATP Corporation is a company that provides health and wellness products and solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, ATPR-Mito + and ORYC-Organic Youth Care Cleansing Bar.

Currently, all our products are acquired from unrelated third parties and rebranded by us. We have no expenditures or expenses relating to research and development of our products for our last two fiscal years. We leverage on the smart partnerships model that we have formed, collaborating with our customers and clients to understand the health and wellness market via a process of consultative review. We then communicate our findings and proposals to third-party suppliers to improve formulations, to bring about new products for customers who are ready to market to end-users. We refer to our approach as “the Power of 3”, which we take great pride in. In the future, we will explore sourcing from third party manufacturers located in Australia, the United States, Germany and Malaysia.

As of December 31, 2019, June 30, 2019, and December 31, 2018, our accumulated deficit was $1,089,209, $750,278 and $373,082 respectively. Our stockholders’ equity was $4,251,286, $4,580,353 and $4,956,334, respectively. We have generated $429,362 in revenue for the six months ended December 31, 2019.

Results of Operation

For the six months ended December 31, 2019 and 2018

Revenue

The Company generated revenue of $429,362 for the six months ended December 31, 2019 as compared to $685,288 for the six months ended December 31, 2018. The revenues were mainly derived from the sale of health and wellness products. The decrease in revenue mainly due to lower demand from our related party customer, whom spend less marketing effort to promote its products during the six months ended December 31, 2019 as compared to the same period in 2018.

Cost of Revenue

Cost of revenue for the six months ended December 31, 2019 amounted to $383,479 as compared to $619,355 for the six months ended December 31, 2018. The costs were predominantly cost of goods and packing materials. The decrease in cost of revenue was in line with the decease of revenues for the six months ended December 31, 2019 as compared to the same period in 2018.

Gross Profit

Gross profit for the six months ended December 31, 2019 amounted to $45,883 as compared to $65,933 for the six months ended December 31, 2018. Gross margin for the six months ended December 31, 2019 was approximately 10.7% as compared to approximately 9.6% for the six months ended December 31, 2018. The slightly increase of gross margin was mainly due to the slight increase of our selling price of our health and wellness products.

Operating Expenses

Selling, general and administrative (“SG&A”) expenses for the six months ended December 31, 2019 amounted to $312,270 as compared to $63,068 for the six months ended December 31, 2018. The amount mainly comprised of rental of office premises, travelling, licensing and professional fees which includes legal, audit, accounting and consulting services. The increase of SG&A expenses of approximately $249,000 or 395.1% are mainly due to the increase of professional fees of approximately $200,000 as we have recently hired new professional firm located in the U.S. and Hong Kong, including legal counsel, auditor, and financial reporting consultant, to strengthen our current Securities and Exchange Commission (“SEC”) listing reporting documents and continue to stay compliance as compared to the six months ended December 31, 2018, we were using local professional firms in Malaysia. Professional fee incurred by the U.S. and Hong Kong firms are generally higher than the professional fee incurred by the Malaysia firms. The increase of SG&A was also due to the increase of approximately $32,000 of travelling expenses for our CEO for potential business developments.

Other Income (Expenses)

For the six months ended December 31, 2019, we recorded an amount of $72,544 as other expenses, net as compared to $138,346 for the six months ended December 31, 2018. During the six months ended December 31, 2019, we recorded approximately $68,000 on unrealized holding loss on marketable securities upon the adoption of ASU 2016-01 on July 1, 2019. The net other expenses of $138,346 incurred during the six months ended December 31, 2018 comprised interest income of $43,000 and net foreign currency translation losses of $83,000 and approximately $98,000 on share of results of investee company from our equity investment.

Net Loss

The Company sustained net loss of $338,931 and $142,446 for the six months ended December 31, 2019 and 2018 respectively. The losses sustained from both of the financial periods were predominantly due to reasons as discussed above.

For the years ended June 30, 2019 and 2018

Revenues

The Company generated revenue of $1,546,057 for the year ended June 30, 2019 as compared to $487,005 for the year ended June 30, 2018. The revenue is mainly derived from the sale of health and wellness products. The increase in revenue mainly due to higher demand from our related party customer as the overall national economy in Malaysia has improved. The end users of our products, who purchase the products from our related party, has more to spend and increased their demand of using our health and wellness products during the year ended June 30, 2019 as compared to the same period in 2018. As a result, our related party has purchased more products from us.

Cost of Revenue

Cost of revenue for the year ended June 30, 2019 amounted to $1,436,705 as compared to $441,409 for the year ended June 30, 2018. The cost mainly consists of cost of goods and packing materials. The increase in cost of revenue was in line with the increase of revenues for the year ended June 30, 2019 as compared to the same period in 2018.

Gross Profit

Gross profit for the year ended June 30, 2019 amounted to $109,352 as compared to $45,596 for the year ended June 30, 2018. Gross margin for the year ended June 30, 2019 was approximately 7.1% as compared to approximately 9.4% for the year ended Jun 30, 2018. The decrease of gross margin was mainly due to the increased of freight in cost of the product labels that we specifically ordered from Taiwan and sent to our manufacturing vendors in the U.S., Germany and Australia during the year ended June 30, 2019.

Operating Expenses

Selling, general and administrative (“SG&A”) expenses for the year ended June 30, 2019 amounted to $240,522 as compared to $279,682 for the year ended June 30, 2018. The amount mainly comprised of rental of office premises, travelling, licensing and professional fees which includes legal, audit, accounting and consulting services. The decrease of SG&A expenses of approximately $39,000 or 14.0% are mainly due to the decrease of professional fees as we have incurred more professional fees during the year ended June 30, 2018 throughout the initial public offerings (“IPO”) stage from July 1, 2017 until the completion of IPO in March 2018 as compared to the year ended June 30, 2019, our professional fee was mainly incurred from regularly SEC compliance and reporting fee.

Other Income (Expenses)

For the year ended June 30, 2019, we recorded an amount of $388,472 as other expense, net as compared to $109,146 of other income, net generated. During the year ended June 30, 2019, we recorded an impairment loss in investments of approximately $367,000 and approximately $124,000 equity investment loss on share from the investee company offset by approximately $86,000 of foreign currency translation gains. During the year ended June 30, 2018, we mainly derived our other income from the interest income earned through the time deposits placed with banks of approximately $139,000 offset by the share of results of investee company of approximately $30,000.

Net Loss

The Company incurred net loss of $519,642 and $130,274 for the years ended June 30, 2019 and 2018, respectively. The losses sustained from both of the financial periods were predominantly due to reasons as discussed above.

Liquidity and Capital Resources

Although some of the countries from which our products are sourced are experiencing lockdowns, industries involve in the provision of food especially health products and pharmaceuticals are normally exempted. We may experience slight delay in products delivery lead time but barring unforeseen circumstances, the setback should be temporary.

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in the next three quarters of 2020. In addition, we may have to record downward adjustments or impairment in the fair value of investments in the first quarter of 2020, if conditions have not been significantly improved and global stock markets have not recovered from recent declines.

In assessing our liquidity, we monitor and analyze our cash on-hand and our operating expenditure commitments. Our liquidity needs are to meet our working capital requirements and operating expenses obligations. To date, we have financed our operations primarily through equity financial from our sales of common stock in March 2018.

As of December 31, 2019, we had working capital of $3,452,665 consisting of cash in bank of $238,937 and time deposit of $2,505,520 as compared to working capital of $3,720,068 consisting of cash in bank of $353,214 and time deposit of $2,504,373 as of June 30, 2019. The revenues, generated from our current business operations will be sufficient to fund our operations. If we make strategic planning to further expand our business in the near future, we will likely require additional capital to further expand our business. The potential expansion may include spending on marketing expenses to expand our marketing channels or acquiring manufacturing companies to reduce our product cost. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Our inability to raise additional funds when required may have a negative impact on our business development. We believe we have sufficient cash and cash equivalents to fund our operations 12 months from the report issuance date.

The following summarizes the key components of our cash flows for the six months ended December 31, 2019 and 2018 and for the years ended June 30, 2019 and 2018:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
Net cash used in operating activities	$	(113,945	)	$	(76,591	)	$	(667,064	)	$	(347,977	)
Net cash used in investing activities		-			(1,000	)		(2,500	)		(1,362,490	)
Net cash provided by (used in) financing activities		-			(745	)		(5,318	)		2,930,267
Effect of exchange rate on cash and cash equivalents		815			(2	)		1,214			(1,293	)
Net change in cash and cash equivalents	$	(113,130	)	$	(78,338	)	$	(673,668	)	$	1,218,507

Operating activities

Net cash used in operating activities for the six months ended December 31, 2019 was $113,945 and mainly comprised of net loss of $338,931, the increase of accounts receivable – related party of $85,602 and the decrease of accounts payable (including related party) of $32,308 offset by the non-cash expense on unrealized holding loss on marketable securities of $68,391, the decrease in prepayments and deposits of $229,638, and the increase in other payables and accrued liabilities of $44,867.

Net cash used in operating activities for the six months ended December 31, 2018 was $78,338 and mainly comprised of net loss of $142,466, the increase in prepayments and deposits of $245,128 and the decrease in other payables and accrued liabilities of $11,865 offset by the non-cash expense of share of result of investee company of $98,140 and the increase in customer deposit of $217,743.

Net cash used in operating activities for the year ended June 30, 2019 was $667,064 and mainly comprised of net loss of $519,642, the increase in account receivables – related party of $433,338, and the increase of prepayments and deposits of $233,394 offset by the non-cash expense of share of result of investee company of $124,225 and impairment in cost of investments of $366,834, the increase in accounts payable – related party of $35,145 and the increase in other payables and accrued liabilities of $11,825.

Net cash used in operating activities for the year ended June 30, 2018 was $347,977 and mainly comprised of net loss of $130,274 and the increase of prepayments and deposits of $264,941 offset by the non-cash expense of share of result of investee company of $30,155 and the increase in other payables and accrued liabilities of $11,749.

Investing activities

There were no investing activities for the six months ended December 31, 2019.

Net cash used in investing activities for the six months ended December 31, 2018 was $1,000 which is due to the investment in financial assets.

Net cash used in investing activities for the year ended June 30, 2019 was $2,500 which is due to the investment in marketable and non-marketable securities.

Net cash used in investing activities for the year ended June 30, 2018 was $1,362,490, which consists of $500,000 of investment in marketable securities and $862,490 of investment in investee company.

Financing activities

There were no financing activities for the six months ended December 31, 2019.

Net cash used in financing activities for the six months ended December 31, 2018 was $745 which is due to the repayment to a related party.

Net cash used in financing activities for the year ended June 30, 2019 was $5,318 which is due to the repayment to a director.

Net cash provided by financing activities for the year ended June 30, 2018 was $2,930,267 which is mainly due to the proceed from sale of common stock of approximately $2.9 million.

Credit Facilities

We do not have any credit facilities or other access to bank credit.

Off-Balance Sheet Arrangements

As of December 31, 2019, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

Critical accounting polices

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for deferred tax assets and uncertain tax position, and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

Revenue recognition

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to the retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

The core principle underlying the revenue recognition of this ASU allows the Company to recognize revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness d products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

Sales of Health and Wellness products

- Performance obligations satisfied at a point in time

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019. Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Historically, there were no sales return as the Company’s products sold are not refundable, returnable or exchangeable.

Fair value of financial instruments

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

	●	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
	●	Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

Recent accounting pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

In July 2017, the FASB Issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815). The amendments in Part I of the Update change the reclassification analysis of certain equity-lined financial instruments (or embedded features) with down round features. The amendments in Part II of this Update re-characterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement – Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact of ASU 2018-13 will have on its consolidated financial statements.

For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign exchange risk. Substantially most of our revenues are denominated in the U.S. dollar while most of our expenses are denominated in Malaysian Ringgit and Hong Kong Dollar. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general, our exposure to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the foreign exchange rate between U.S. dollar and Malaysian Ringgit; and U.S. dollar and Hong Kong Dollar because the value of our business is effectively denominated in Malaysian Ringgit and Hong Kong Dollar, while the Common Stock is traded in U.S. dollars.

Credit risk. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements required by this item are located in PART IV of this Annual Report.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Disclosures Control and Procedures

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

	●	Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;

	●	Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and

	●	Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

As of December 31, 2019, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over financial reporting were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

Identified Material Weakness

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

Management identified the following material weakness during its assessment of internal controls over financial reporting as of December 31, 2019. (1) The Company did not have sufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP. (2) Lack of a functional internal audit department or personnel that monitors the consistencies of the preventive internal control procedures; lack of adequate policies and procedures in internal audit function to ensure that the Company’s policies and procedures have been carried out as planned. (3) We do not have adequate segregation of duties and effective risk assessment. Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2019 based on criteria established in Internal Control—Integrated Framework issued by COSO.

Management’s Remediation Initiatives

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we will prepare written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.

We plan to initiate the following series of measures to further strengthen the Company’s internal controls going forward:

1.	We intend to engage an external consulting firm to supplement our efforts to the implementation of the 2013 Committee of Sponsoring Organizations of the Treadway Commission, or COSO, framework for internal controls.

2.	We intend to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control.

3.	Once we hire additional employees, we intend to initiate a comprehensive program and development plan to provide ongoing company-wide trainings regarding internal control, with particular emphasis on our accounting staff.

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2020.

Changes in internal controls over financial reporting

There were no significant changes in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

This annual report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Our executive officer’s and director’s and their respective ages as of the date hereof are as follows:

NAME		AGE		POSITION
How Kok Choong		56		Chief Executive Officer, President, Secretary, Treasurer, Director

Set forth below is a brief description of the background and business experience of our executive officer and director for the past five years.

How Kok Choong - President, Chief Executive Officer, Secretary, Treasurer, Director

Mr. How Kok Choong earned a Master and Doctorate in Business Administrative from Newport University, USA. In 2004 Mr. How began to work as Global President of AGAPE Superior Living International Group, and continues to hold this position. AGAPE Superior Living International Group is a leading health and wellness company in nine countries. Additionally, from 2010 to present Mr. How has served as President of TH3 Holdings Sdn Bhd, a company specialized in IT, academics, online education, mobile Apps, e-Commerce and digital marketing.

In Malaysia, Mr. How received the Outstanding Asian Community Contribution Award in 2011, Malaysia Top Team 50 Enterprise Award in 2011, The Contributor Award (Medical and Health Research) in 2012, “Man of The Year” in Worldwide Excellence Award in 2015, “Man of The Year” in McMillan Global Award in 2016 and The Distinguished Asia Pacific Outstanding Entrepreneur Lifetime Achievement Award in 2019.

Mr. How’s strong academic background and business experience and numerous qualifications have led the Board of Directors to reach the conclusion that he should serve as our Chief Executive Officer and Director of the Company.

Corporate Governance

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company’s employees, officers and Directors as the Company is not required to do so.

In lieu of an Audit Committee, the Company’s Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company’s financial statements and other services provided by the Company’s independent public accountants. The Board of Directors and the Chief Executive Officer of the Company review the Company’s internal accounting controls, practices and policies with advice from third party consultants.

Committees of the Board

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter.

Audit Committee Financial Expert

Our Board of Directors has determined that we do not have a board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

In order to maintain good corporate governance and in view of the Company’s planned expansion, the Company plans to establish a full board comprising the nominating, compensation, and audit committees during the year.

Involvement in Certain Legal Proceedings

Our Directors and our Executive officers have not been involved in any of the following events during the past ten years:

1.	Bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2.	Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3.	Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities or banking activities; or
4.	Being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
5.	Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;
6.	Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;
7.	Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

	(i)	Any Federal or State securities or commodities law or regulation; or
	(ii)	Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or
	(iii)	Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;

Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Code of Ethics

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

Shareholder Proposals

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

ITEM 11. EXECUTIVE COMPENSATION

Mr. How Kok Choong, the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group had not received nor drawn any (i) Salary; (ii) Bonus; (iii) Stock compensation; (iv) Option awards, (v) Non-equity incentive plan compensation, (vi) Non-qualified deferred compensation earnings and (vii) Any other compensations in the last two fiscal years.

Summary of Compensation

Stock Option Grants

We have not granted any stock options to our executive officers since our incorporation.

Employment Agreements

We do not have an employment or consulting agreement with any officers or Directors.

Compensation Discussion and Analysis

Director Compensation

Our Board of Directors does not currently receive any consideration for their services as members of the Board of Directors. The Board of Directors reserves the right in the future to award the members of the Board of Directors cash or stock-based consideration for their services to the Company, which awards, if granted shall be in the sole determination of the Board of Directors.

Executive Compensation Philosophy

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer’s performance. This package may also include long-term stock-based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

Incentive Bonus

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company’s best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

Long-term, Stock Based Compensation

In order to attract, retain and motivate executive talent necessary to support the Company’s long-term business strategy we may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

As of December 31, 2019, the Company has 376,275,500 shares of common stock issued and outstanding, which number of issued and outstanding shares of common stock have been used throughout this report.

Name and Address of Beneficial Owner	Shares of Common Stock Beneficially Owned		Common Stock Voting Percentage Beneficially Owned			Voting Shares of Preferred Stock		Preferred Stock Voting Percentage Beneficially Owned		Total Voting Percentage Beneficially Owned
Executive Officers and Directors
How Kok Choong, President, Chief Executive Officer, Secretary, Treasurer and Director; collectively this includes HKC Holdings Sdn. Bhd.*		254,429,000		67.62	%		none		n/a		67.62	%
5% Shareholders
-		-		-			-		-		-

*HKC Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director.

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE

On June 1, 2016, Mr. How Kok Choong was appointed as CEO, President, Secretary, Treasurer and a member of our Board of Directors. Additionally, on June 1, 2016, the Company issued 100,000 shares of restricted common stock, each with a par value of $0.0001 per share, to Mr. How Kok Choong for initial working capital of $10.

On April 5, 2017, the Company acquired Agape ATP Corporation, a company incorporated in Labuan, Malaysia.

On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to Mr. How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.

*HKC Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director. As such, HKC Holdings Sdn Bhd is regarded a related party.

With regards to all of the above transactions we claim an exemption from registration afforded by Section 4a(2) and/or Regulation S of the Securities Act of 1933, as amended (“Regulation S”) due to the fact that all sales of stock were made to non-U.S. persons (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.

Related Party Transactions

The Company’s related party list and relationship are as follows:

Related parties		Relationships

Agape S.E.A. Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd

Agape Superior Living Pty Ltd		Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

Agape Superior Living Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd

Agape ATP (Asia) Limited		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

Related parties

Relationships

Greenpro Capital Corp.

Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan.

Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:

	For the six months ended				As of
	December 31, 2019		December 31, 2018		December 31, 2019		December 31, 2018
			(Unaudited)				(Unaudited)
	Revenue				Accounts Receivable, Trade

Agape S.E.A. Sdn Bhd	$	429,362	$	685,288	$	520,786	$	-

	Professional fee				Accounts Payable, Non-trade

Greenpro Capital Corp.	$	-	$	4,500	$	-	$	-

	Expenses paid on behalf				Amount due from a related party

Agape ATP (Asia) Limited	$	-	$	-	$	2,217	$	-

Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:

	Years ended				As of
	June 30, 2019		June 30, 2018		June 30, 2019
	Revenue				Accounts Receivable, Trade
Agape S.E.A. Sdn Bhd	$	1,524,596	$	487,005	$	433,338
Agape Superior Living Pty Ltd		21,461		-		-
Total	$	1,546,057	$	487,005	$	433,338

Professional fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

12,000

214,883

Company Secretarial fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

3,282

292

License fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,509

Incorporation fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,419

Expenses paid on behalf

Amount due from

A related party

Agape Superior Living Sdn Bhd

745

Expenses paid on behalf

Amount due from

A related party

Agape ATP (Asia) limited

2,210

Sundry purchases

Accounts Payable,

Non-trade

Agape Superior Living Pty Ltd

35,145

In addition, as of December 31, 2019, June 30, 2019 and December 31, 2018, our Director, Mr. How Kok Choong, advanced $3,952, $3,938 and $3,921, respectively to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

* How Kok Choong has acted as the sole promoter of the Company since inception. He has not been provided any form of compensation as of the date of this registration statement.

Review, Approval and Ratification of Related Party Transactions

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. Until formal policies and procedures are put in place, our Directors will continue to approve any related party transaction.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Total Asia Associates PLT was our independent auditor for the quarter ended September 30, 2019 and for the years ended June 30, 2019 and 2018 and incurred audit fees in the total of $2,500, $23,000, and $25,000, respectively. Friedman LLP is our independent auditor for the six months ended December 31, 2019 and incurred audit fees in the total of $80,000.

Below is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal years.

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018

Audit fees	$	82,500	$	6,000	$	23,000	$	25,000

The category of “Audit fees” includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory filings with the SEC, such as the issuance of comfort letters and consents.

The category of “Audit-related fees” includes employee benefit plan audits, internal control reviews and accounting consultation.

All of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) Financial Statements

The following are filed as part of this report:

Financial Statements

The following financial statements of AGAPE ATP Corporation. and Report of Independent Registered Public Accounting Firm are presented in the “F” pages of this Report:

	Page

Index	F-1

Reports of Independent Registered Public Accounting Firms	F-2 - F-3

Financial Statements

Consolidated Balance Sheets	F- 4

Consolidated Statements of Operations and Comprehensive Loss	F-5

Consolidated Statements of Changes in Stockholders’ Equity	F-6

Consolidated Statements of Cash Flows	F-7

Notes to Consolidated Financial Statements	F-8 – F-27

(b) Exhibits

The following exhibits are filed or “furnished” herewith:

3.1	Articles of Incorporation**

3.2	Bylaws**

31.1	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial officer*

32.1	Section 1350 Certification of principal executive officer and principal financial officer*

* Filed herewith.

** As filed in the Registrant’s Registration Statement on Form S-1 Amendment No.8 (File No. 333-220144) on October 26, 2017.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AGAPE ATP CORPORATION.
	(Name of Registrant)

Date: March 27, 2020

	By:	*/s/ How Kok Choong*
	Title:	Chief Executive Officer, President, Secretary, Treasurer, Director
		Principal Executive Officer Principal Financial Officer Principal Accounting Officer

INDEX TO FINANCIAL STATEMENTS

	Page
Financial Statements

Reports of Independent Registered Public Accounting Firm	F-2 - F-3

Consolidated Balance Sheets	F-4

Consolidated Statements of Operations and Comprehensive Loss	F-5

Consolidated Statements of Changes in Stockholders’ Equity	F-6

Consolidated Statements of Cash Flows	F-7

Notes to Consolidated Financial Statements	F-8 - F-27

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and

Stockholders of Agape ATP Corporation

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheet of Agape ATP Corporation (the “Company”) as of December 31, 2019, and the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows for the six-month period ended December 31, 2019, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for the six-month period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provide a reasonable basis for our opinion.

/s/ Friedman LLP

We have served as the Company’s auditor since 2019

New York, New York

March 27, 2020

F-2

TOTAL ASIA ASSOCIATES PLT

(AF002128 & LLP0016837-LCA)

A Firm registered with US PCAOB and Malaysian MIA

Block C-3-1, Megan Avenue 1, 189, Off Jalan Tun Razak,

50400, Kuala Lumpur.

Tel: (603) 2733 9989

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of Agape ATP Corporation

1705 - 1708, Level 17,

Tower 2, Faber Towers,

Jalan Desa Bahagia, Taman Desa,
58100 Kuala Lumpur, Malaysia

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Agape ATP Corporation (the ‘Company’) as of June 30, 2019 and 2018, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows each of the year ended 2019 and 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2019 and 2018, and the results of its operations and its cash flows each of the years ended 2019 and 2018, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

*/s/ TOTAL ASIA ASSOCIATES PLT*
TOTAL ASIA ASSOCIATES PLT

We have served as the Company’s auditor since 2018.

Kuala Lumpur, Malaysia

September 10, 2019

F-3

AGAPE ATP CORPORATION

CONSOLIDATED BALANCE SHEETS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	December 31,			June 30,			December 31,
	2019			2019			2018
							(Unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	2,744,457		$	2,857,587		$	3,452,917
Accounts receivable – related party		520,786			433,338			-
Amount due from a related party		2,217			2,210			-
Prepayments and deposits		269,193			498,335			510,069
Total Current Assets		3,536,653			3,791,470			3,962,986

OTHER ASSETS
Investment in investee company		-			-			734,195
Investment in marketable securities		66,484			134,166			501,000
Investment in non-marketable securities		732,137			726,119			-
Total other assets		798,621			860,285			1,235,195

TOTAL ASSETS	$	4,335,274		$	4,651,755		$	5,198,181

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$	2,790		$	-		$	-
Accounts payable – related party		-			35,145			-
Customer deposits		-			-			217,743
Income tax payable		-			-			12,299
Other payables and accrued liabilities		77,246			32,319			7,884
Amount due to a director		3,952			3,938			3,921
Total Current Liabilities		83,988			71,402			241,847

TOTAL LIABILITIES		83,988			71,402			241,847

STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding		-			-			-
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 issued and outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018		37,628			37,628			37,628
Additional paid in capital		5,293,082			5,293,082			5,293,082
Accumulated deficit		(1,089,209	)		(750,278	)		(373,082	)
Accumulated other comprehensive loss		9,785			(79	)		(1,294	)
TOTAL STOCKHOLDERS’ EQUITY		4,251,286			4,580,353			4,956,334

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	4,335,274		$	4,651,755		$	5,198,181

The accompanying notes are an integral part of these consolidated financial statements.

F-4

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	For the six months ended						For the years ended
	December 31,						June 30,
	2019			2018			2019			2018
				(Unaudited)

REVENUE – RELATED PARTY	$	429,362		$	685,288		$	1,546,057		$	487,005

COST OF REVENUE		(383,479	)		(619,355	)		(1,436,705	)		(441,409	)

GROSS PROFIT		45,883			65,933			109,352			45,596

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES		(312,270	)		(63,068	)		(240,522	)		(279,682	)

INCOME (LOSS) FROM OPERATIONS		(266,387	)		2,865			(131,170	)		(234,086	)

OTHER INCOME/(EXPENSES)
Other Income/(Expenses), Net		(4,153	)		(40,206	)		86,078			139,301
Loss from equity investment		-			(98,140	)		(124,225	)		(30,155	)
Unrealized holding loss on marketable securities		(68,391	)		-			-			-
Gain on deemed disposal of shares in Investee Company		-			-			16,509			-
Impairment loss in equity investment		-			-			(366,834	)		-
TOTAL OTHER INCOME/(EXPENSES), NET		(72,544	)		(138,346	)		(388,472	)		109,146

NET LOSS BEFORE INCOME TAXES		(338,931	)		(135,481	)		(519,642	)		(124,940	)

PROVISION FOR INCOME TAXES		-			(6,965	)		-			(5,334	)

NET LOSS		(338,931	)		(142,446	)		(519,642	)		(130,274	)

OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation adjustment		9,864			(1	)		1,214			(1,293	)

COMPREHENSIVE LOSS	$	(329,067	)	$	(142,447	)	$	(518,428	)	$	(131,567	)

NET LOSS PER SHARE
Basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
Basic and diluted		376,275,500			376,275,500			376,275,500			373,017,955

The accompanying notes are an integral part of these consolidated financial statements.

F-5

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Currency expressed in United States Dollars (“US$”), except for number of shares)

	COMMON STOCK				ADDITIONAL					ACCUMULATED OTHER			TOTAL
	Number of shares		Par value		PAID IN CAPITAL		ACCUMULATED DEFICIT			COMPREHENSIVE INCOME (LOSS)			STOCKHOLDERS’ EQUITY
Balance as of June 30, 2017		371,350,000	$	37,135	$	2,367,875	$	(100,362	)	$	-		$	2,304,648
Net loss		-		-		-		(130,274	)		-			(130,274	)
IPO completed on March 9, 2018 at $1.00 per share		2,925,500		293		2,925,207		-			-			2,925,500
Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share		2,000,000		200		-		-			-			200
Foreign currency translation adjustment		-		-		-		-			(1,293	)		(1,293	)
Balance as of June 30, 2018		376,275,500	$	37,628	$	5,293,082	$	(230,636	)	$	(1,293	)	$	5,098,781
Net loss		-		-		-		(142,446	)		-			(142,446	)
Foreign currency translation adjustment		-		-		-		-			(1	)		(1	)
Balance as of December 31, 2018 (unaudited)		376,275,500	$	37,628	$	5,293,082	$	(373,082	)	$	(1,294	)	$	4,956,334
Net loss		-		-		-		(377,196	)		-			(377,196	)
Foreign currency translation adjustment		-		-		-		-			1,215			1,215
Balance as of June 30, 2019		376,275,500	$	37,628	$	5,293,082	$	(750,278	)	$	(79	)	$	4,580,353
Net loss		-		-		-		(338,931	)		-			(338,931	)
Foreign currency translation adjustment		-		-		-		-			9,864			9,864
Balance as of December 31, 2019		376,275,500	$	37,628	$	5,293,082	$	(1,089,209	)	$	9,785		$	4,251,286

The accompanying notes are an integral part of these consolidated financial statements.

F-6

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Currency expressed in United States Dollars (“US$”)

	For the six months ended December 31,						For the years ended June 30,
	2019			2018			2019			2018
				(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(338,931	)	$	(142,446	)	$	(519,642	)	$	(130,274	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Loss from equity investment		-			98,140			124,225			30,155
Unrealized holding loss on marketable securities		68,391			-			-			-
Gain on deemed disposal of shares in Investee Company		-			-			(16,509	)		-
Impairment in cost of investment		-			-			366,834			-
Deferred tax expenses		-			-			-			5,334
Changes in operating assets and liabilities:
Accounts receivable – related party		(85,602	)		-			(433,338	)		-
Amount due from a related party		-			-			(2,210	)		-
Prepayments and deposits		229,638			(245,128	)		(233,394	)		(264,941	)
Accounts payable		2,778			-			-			-
Accounts payable – related party		(35,086	)		-			35,145			-
Customer deposits		-			217,743			-			-
Income taxes payable		-			6,965			-			-
Other payables and accrued liabilities		44,867			(11,865	)		11,825			11,749
Net cash used in operating activities		(113,945	)		(76,591	)		(667,064	)		(347,977	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in Investee Company		-			-			-			(862,490	)
Investment in marketable securities		-			(1,000	)		(1,000	)		(500,000	)
Investment in non-marketable securities		-			-			(1,500	)		-
Net cash used in investing activities		-			(1,000	)		(2,500	)		(1,362,490	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in share capital		-			-			-			493
Proceeds from sale of common stock		-			-			-			2,925,207
Amount due to a related party		-			(745	)		-			745
Amount due to a director		-			-			(5,318	)		3,822
Net cash (used in) provided by financing activities		-			(745	)		(5,318	)		2,930,267

EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS		815			(2	)		1,214			(1,293	)

(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(113,130	)		(78,338	)		(673,668	)		1,218,507

CASH AND CASH EQUIVALENTS, beginning of period		2,857,587			3,531,255			3,531,255			2,312,748

CASH AND CASH EQUIVALENTS, end of period	$	2,744,457		$	3,452,917		$	2,857,587		$	3,531,255

SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid	$	-		$	-		$	-		$	-
Interest paid	$	-		$	-		$	-		$	-

SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES
Amount transferred from investment in investee company to investment in non-marketable securities	$	-		$	-		$	724,619		$	-

The accompanying notes are an integral part of these consolidated financial statements.

F-7

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

1. ORGANIZATION AND BUSINESS BACKGROUND

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

Details of the Company’s subsidiaries:

Subsidiary company

name

Place and

date of

incorporation

Particulars of issued capital

Principal activities

Proportional of ownership

interest and

voting power

held

Agape ATP Corporation

Labuan,
March 6, 2017

100 shares of ordinary share of US$1 each

Investment holding

100

Agape ATP International Holding Limited

Hong Kong,
June 1, 2017

1,000,000 shares of ordinary share of HK$1 each

Health and wellness products and health solution advisory services

100

Business Overview

F-8

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

Basis of presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

Change of year end

As of December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements consist of a six-month transition period ended December 31, 2019 and 2018 (unaudited), and the fiscal years ended June 30, 2019 and 2018.

Basis of consolidation

The consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

F-9

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Use of estimates

Cash and cash equivalents

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

Accounts receivable – related party

Accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2019, June 30, 2019 and December 31, 2018, all of the Company’s accounts receivable balance are due from a related party, as a result, no valuation allowance was made.

Prepayments and deposits

Prepayments and deposits are cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Entities in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the Board of Directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Dividends received from the equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence.

F-10

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Investment in marketable equity securities

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

Investment in non-marketable equity securities

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

F-11

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Revenue recognition

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

The core principle underlying the revenue recognition of this ASU allows the Company to recognize- revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

F-12

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Sales of Health and Wellness products

- Performance obligations satisfied at a point in time

Disaggregated information of revenues by products are as follows:

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018
			(Unaudited)

Survivor Select	$	-	$	204,138	$	203,815	$	104,656
Energized Mineral Concentrate		100,270		222,789		361,092		66,573
Ionized Cal-Mag		-		-		55,731		43,124
Omega Blend		68,927		97,170		165,999		68,561
BetaMaxx		67,789		87,793		211,280		126,191
Iron		-		2,813		2,809		20,270
Young Formula		-		-		117,480		57,630
Organic Youth Care Cleansing Bar		17,206		-		17,751		-
Energetique Hyaluronic Acid Serum		175,170		-		-		-
Trim+		-		-		198,862		-
Lipomask		-		70,585		211,238		-
Total revenues	$	429,362	$	685,288	$	1,546,057	$	487,005

Cost of revenue

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers

Selling, general and administrative expenses

Selling, general and administrative expenses are primarily comprised of rental of office premises, travelling, licensing and professional fees.

F-13

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Income taxes

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax.

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Comprehensive income (loss)

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

Earnings (loss) per share

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average common share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

F-14

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Foreign currencies translation and transaction

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the six months ended December 31,				As of and for the year ended June 30,
	2019		2018		2019		2018

Period-end MYR : US$1 exchange rate		4.09		4.14		4.13		4.03
Period-average MYR : US$1 exchange rate		4.16		4.13		4.13		4.21
Period-end HKD : US$1 exchange rate		7.79		7.83		7.81		-
Period-average HKD : US$1 exchange rate		7.83		7.84		7.84		-
Period-end AUD : US$1 exchange rate		1.43		-		1.42		-
Period-average AUD : US$1 exchange rate		1.46		-		1.42		-

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

F-15

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Fair value of financial instruments

	●	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
	●	Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

Operating leases

A lease for which substantially all the benefits and risks incidental to ownership remain with the lessor is classified by the lessee as an operating lease. All leases of the Company are currently classified as operating leases. The Company records the total expenses on a straight-line basis over the lease term.

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. The Company adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019

Recent accounting pronouncements

F-16

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.

F-17

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation, such as reclassifying $366,834 impairment in cost of investments from selling, general and administrative expenses to other income (expenses) for the year ended June 30, 2019, reclassifying accounts receivable – related party of $78,272 as of June 30, 2019 to be net against other payables and accrued liabilities, and reclassifying cash inflows of $78,272 from changes in other payables and accrued liabilities to accounts receivable – related party for the year ended June 30, 2019. These reclassifications have no effect on the reported revenues, net loss or total assets.

3. INVESTMENT IN MARKETABLE SECURITIES

	(i)	On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.

	(ii)	On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
								(Unaudited)
Cost of investment	$	134,166		$	501,000		$	501,000
Less: Impairment in cost of investment		-			(366,834	)		-
Less: Unrealized holding loss		(68,391	)		-			-
Exchange rate effect		709			-			-
Investment in marketable securities	$	66,484		$	134,166		$	501,000

F-18

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

4. INVESTMENT IN NON-MARKETABLE SECURITIES

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.

Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.

On March 2, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company.

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

Unreserved Sdn Bhd	As of December 31, 2019		As of June 30, 2019			As of December 31, 2018
							(Unaudited)
Cost of investment	$	-	$	832,335		$	832,335
Less: loss of equity of investee company		-		(124,225	)		(98,140	)
Add: gain on deemed disposal of shares in investee company		-		16,509			-
Investment in investee company	$	-	$	724,619		$	734,195
Reclassify to investment in non-marketable securities		-		(724,619	)		-
Investment in investee company	$	-	$	-		$	-

Investment in non-marketable securities	$	730,637	$	724,619		$	-

Phoenix Plus Corporation
Cost of investment	$	1,500	$	1,500		$	1,500

Total investment in non-marketable securities	$	732,137	$	726,119		$	-

F-19

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

5. CASH AND CASH EQUIVALENTS

As of December 31, 2019, June 30, 2019 and December 31, 2018, the Company recorded $2,744,457, $2,857,587, and $3,452,917 (unaudited), respectively, of cash and cash equivalents, which consists $238,937, $353,214, and $990,323 (unaudited), respectively, of cash in bank and $2,505,520, $2,504,373 and $2,462,594 (unaudited), respectively, of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum.

6. ACCOUNTS RECEIVABLE – RELATED PARTY

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accounts receivable – related party	$	520,786	$	433,338	$	-
Allowance for doubtful accounts		-		-		-
Total accounts receivables – related party	$	520,786	$	433,338	$	-

7. PREPAYMENTS AND DEPOSITS

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Prepaid expenses	$	2,641	$	21,081	$	2,702
Deposits to supplier		266,552		477,254		507,367
Total prepaid expenses and deposits	$	269,193	$	498,335	$	510,069

8. RELATED PARTY TRANSACTIONS

The Company’s related party list and relationship are as follows:

Related parties		Relationships

Agape S.E.A. Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd

Agape Superior Living Pty Ltd		Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

F-20

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Agape Superior Living Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd

Agape ATP (Asia) Limited		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

Greenpro Capital Corp.		Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:

	For the six months ended				As of
	December 31, 2019		December 31, 2018		December 31, 2019		December 31, 2018
			(Unaudited)				(Unaudited)
	Revenue				Accounts Receivable, Trade

Agape S.E.A. Sdn Bhd	$	429,362	$	685,288	$	520,786	$	-

	Professional fee				Accounts Payable, Non-trade

Greenpro Capital Corp.	$	-	$	4,500	$	-	$	-

	Expenses paid on behalf				Amount due from a related party

Agape ATP (Asia) Limited	$	-	$	-	$	2,217	$	-

F-21

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:

	Years ended				As of
	June 30, 2019		June 30, 2018		June 30, 2019
	Revenue				Accounts Receivable, Trade
Agape S.E.A. Sdn Bhd	$	1,524,596	$	487,005	$	433,338
Agape Superior Living Pty Ltd		21,461		-		-
Total	$	1,546,057	$	487,005	$	433,338

Professional fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

12,000

214,883

Company Secretarial fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

3,282

292

License fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,509

Incorporation fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,419

Expenses paid on behalf

Amount due from

A related party

Agape Superior Living Sdn Bhd

745

Expenses paid on behalf

Amount due from

A related party

Agape ATP (Asia) limited

2,210

Sundry purchases

Accounts Payable,

Non-trade

Agape Superior Living Pty Ltd

35,145

F-22

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

9. STOCKHOLDERS’ EQUITY

Preferred stock

As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 200,000,000 preferred shares authorized but none were issued and outstanding.

Common stock

As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 376,275,500 of common stocks issued and outstanding.

There were no stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018.

10. OTHER PAYABLES AND ACCRUED LIABILITIES

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accrued professional fees	$	58,594	$	20,000	$	7,884
Others		18,652		12,319		-
Total payables and accrued liabilities	$	77,246	$	32,319	$	7,884

11. INCOME TAXES

The United States and foreign components of income (loss) before income taxes were comprised of the following:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
Tax jurisdictions from:
- Local	$	(279,476	)	$	(33,977	)	$	(76,309	)	$	(261,918	)
- Foreign - Labuan		(4,174	)		(45,576	)		(2,777	)		134,806
- Foreign – Hong Kong		(55,281	)		(55,928	)		(440,556	)		2,172
Loss before income tax	$	(338,931	)	$	(135,481	)	$	(519,642	)	$	(124,940	)

F-23

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

The provision for income taxes consisted of the following:

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018
			(Unaudited)
Current:
- Local	$	-	$	-	$	-	$	-
- Foreign		-		6,965		-		5,334

Deferred:
- Local		-		-		-		-
- Foreign		-		-		-		-

Income tax expense	$	-	$	6.965	$	-	$	5,334

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

United States of America

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of December 31, 2019, June 30, 2019 and December 31, 2018, the operations in the United States of America incurred $717,901, $438,426, and $395,095 (unaudited), respectively, of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2037 and ending in 2039, if unutilized. The tax valuation allowance as of December 31, 2019, June 30, 2019 and December 31, 2018 are $150,759, $92,069 and $82,970 (unaudited), respectively.

Labuan

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit. Due to Agape ATP Corporation is a holding company, it did not generate any income nor incurred any income tax. In addition, its related expenses incurred cannot be carried forward to offset any future operation income.

Hong Kong

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.

F-24

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
U.S. statutory rate		21.0	%		21.0	%		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%		(21.0	)%		(21.0	)%
Permanent difference ⁽¹⁾		0.0	%		(5.1	)%		0.0	%		(4.3	)%
Effective tax rate		0.0	%		(5.1	)%		0.0	%		(4.3	)%

⁽¹⁾This was related to disallowed expenditure incurred in the ordinary course of business.

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
							(Unaudited)
Deferred tax assets:
Net operating loss carry forwards in U.S.	$	150,759		$	92,069		$	82,970
Less: valuation allowance		(150,759	)		(92,069	)		(82,970	)
Deferred tax asset	$	-		$	-		$	-

12. AMOUNT DUE TO A DIRECTOR

As of December 31, 2019, June 30, 2019 and December 31, 2018, a director of the Company advanced $3,952, $3,938 and $3,921 (unaudited), respectively, to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

13. CONCENTRATIONS OF RISKS

(a) Major customers

For the six months ended December 31, 2019 and 2018, one customer accounted for 100% of the Company’s total revenues. For the years ended June 30, 2019 and 2018, one customer accounted for approximately 99% and 100% of the Company’s total revenues, respectively.

As of December 31, 2019, and June 30, 2019, one customer accounted for 100% of the total balance of accounts receivable.

F-25

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(b) Major vendors

For the six months ended December 31, 2019, two vendors accounted for approximately 59% and 41% of the Company’s total purchases, respectively. For the six months ended December 31, 2018, one vendor accounted for approximately 89% of the Company’s total purchases. For the year ended June 30, 2019, two vendors accounted for approximately 71% and 26% of the Company’s total purchases. For the year ended June 30, 2018, one vendor accounted for 100% of the Company’s total purchases.

As of December 31, 2019 and June 30, 2019, one vendor accounted for 100% of the total balance of accounts payable.

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.

(d) Exchange rate risk

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

14. COMMITMENTS AND CONTINGENCIES

Lease commitments

The Company has entered into an operating lease agreement for an office in Hong Kong. The Company’s commitment for minimum lease payments under these operating leases as of December 31, 2019 for the next two years is as follow:

Twelve months ending December 31,	Minimum lease payment
2020	$	17,973
Thereafter		-
Total minimum payments required	$	17,973

Rent expense for the six months ended December 31, 2019 and 2018 was $26,828 and $8,932 (Unaudited), respectively. Rent expense for the years ended June 30, 2019 and 2018 was $35,706 and $0, respectively

F-26

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

Purchase commitments

The total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2019 for the next five years and thereafter is as follows:

Twelve months ending December 31,	Minimum purchase
2020	$	693,900
2021		693,900
2022		693,900
2023		693,900
2024		693,900
Thereafter		2,081,700
Total minimum purchase commitments required	$	5,551,200

As of the date of this report, the Company’s vendor is not able to meet the Company’s minimum purchase commitment of the health and wellness products due to the manufacturing process was being delayed by its vendor.

Contingencies

From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

15. SUBSEQUENT EVENT

In December 2019, a novel strain of coronavirus (COVID-19) surfaced. The spread of COVID-19 around the world in the first quarter of 2020 has caused significant volatility in Malaysia. There is significant uncertainty around the breadth and duration of business disruptions related to COVID-19, as well as its impact on the Malaysia economies and, as such, the Company is unable to determine if it will have a material impact to its operations.

F-27

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION

I, HOW KOK CHOONG, certify that:

1. I have reviewed this transition report on Form 10-K of Agape ATP Corporation (the “Company”) for the period ended December 31, 2019;

2. Based on my knowledge, this transition report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 27, 2020	By:	/s/ How Kok Choong
		HOW KOK CHOONG
		Chief Executive Officer, President, Director, Secretary, Treasurer
		(Principal Executive Officer and Principal Financial Officer)

EX-32.1 3 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Transition Report of Agape ATP Corporation (the “Company”) on Form 10-K for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 27, 2020	By:	/s/ How Kok Choong
		HOW KOK CHOONG
		Chief Executive Officer, President, Director
		(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

GRAPHIC 4 image_001.jpg begin 644 image_001.jpg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end GRAPHIC 5 image_002.jpg begin 644 image_002.jpg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end GRAPHIC 6 image_003.jpg begin 644 image_003.jpg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end GRAPHIC 7 image_004.jpg begin 644 image_004.jpg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end GRAPHIC 8 image_005.jpg begin 644 image_005.jpg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image_006.jpg begin 644 image_006.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HI M&=44L[!5')). *R[K7[*W3,;^<_94_QH U:*Y*;Q)>2']VD40SZ;C^=49M3O MIS\]W+]$.T?I0!W>0*B:ZMT^]/&/JXKS\_.V7)8^K')HP!V% '=G4K%7V->6 MX;&<&5+'ES2)@8^5R*N1:WJ$0 %P6'HX!_7K0!VU%W MUVPG3+3"(XR1+\N/QZ4 :5%(K!E#*00>012T %%%% !2.P1&9C@ 9)I:KZ@Y MCTVZD R5ACR=97"CT% $^A:E-',MM(S/$V%7/\ M">WX5U%K2MDQKI!7.73@(R*?FQ MS[5NVLXN;2&X"E1*BO@]1D9IH1-1113 *YOQVK'PG=NIP8RC9[_> _K725SW MCC_D3=1_W5_]#6D]A/8\LM==M)&2&_!CDQQ,IQ^HZ?RKH[22?:&M[N&YC]). M#_WT./TKS2[R'4^U-M[J6VDWP2O&WJIQ7FK&N.DEO)?31'][8S8_ MO1D./\?TJU%J=HW#2&,GM(I3^=><6?BO5[>,.X6:/H&=,?J,5HK\1C;A?M-@ M6![QO_0C^M;1QE*3M>WR-E7@ST*.[MI/N7$3?1Q5M2",@@BN @^(/AVXP+B" M2(]]\.?Y9J_#XG\(R\BYA0^Z,O\ 2ME5@^J+YX]SM0*D ([5RD.N>&G \O5( MAD]IR*T_.T]%#&_=5QG)G/3\Z?M8=U]Z'S+N;0!IP!Q7.G5]$1=S:U&!G&3= M#_&D&N>'R>-:B8^UUG^M/VD>Z^\.9=SI,&CH,D@?C7.S:WX?@!::_7CJ2[-2 M1ZYX>D*F*5)"WW?D//YBH>(I)7.USH#-$O66,?5A3#=0YX+,?]E2:X MF[^)>B64IABL[F24$K@(J@$>N345Q\0[@\6^GQKGIO,HPWD0ZU-= M3N?/=ONP,/=R!_C5.]O8;2,R7MY% @[;@N?Q//Y5P-SK/B_5OEMHI88S_P \ MH]@_[Z/^-06W@>_NW\_5+S8S?VFC66D6[):QX8 MCYI&Y9OJ:]$M?^/2'_<7^5=5.,DKS>I<.;>1+1116A85A>,E#>$=1!_YY@_J M*W:Q/%X+>$]2 &3Y)/Y$4GL)['@-Z/N?C3X58V#;(P8P#YAV@_-D8YZCC^M) M=\QI]:DM([M+87%F) ZL0YC;)(XQD?G7C0?OOYG!'=G5:1&D=H%6,H#\VP_P MY ./PS5V32M/N1^^LX7]]@S67H#R/9L92QD\P[MW7/'6MY"%7). .237H4VI M16AUQLXW,YO"&B2_\N>T^JR,/ZU"WP_TF3[DMRGT<'^E9J>-9+=;UEL&NH[: M4EY$E 5$;&WW/.1QP,5ICQ=<11AY]$U*)<9+"WWC'UR/SKK>!;^ROP,?:4GN M+!\/;./)6]FZ\;E!Q71SZ)Y]N(O/*@)MSM_^O2:7=G488KV"X22TECRJB/!W M9]<_ABM8'BN.I@:$I>_'7YFJA!JZ.*D^'4#K.9PSW$X^0(0N #COTI8?!6DQL& M/VAR.FZ3I^6*Z/KBEIQPE".T$5[.'8P8?!OA^%]ZZ;&6]79F_F:UH+&TMN8+ M:&,CNB &K ZT5NH16R&H16R&FHGZ5*U12, .35%%&Y^ZU=K;?\>L/^X/Y5Q- MP248].*[:V_X]8?]Q?Y4#1+1110,*R/%(SX6U/\ Z]W_ )5KUD^)PS>%]2"@ MD_9VZ>F.:3V$]CP"X4M",#)SVI;-;1(EEGDG61G*JT) V 8Y/YT\%E4%6VL# MD'.,5()=Z,+JT$T0?F:$;2#]1P:\:"7.WU_ X5:]SH-(1TCE\R7S2S[A)_>! M48/Y8J76()KZUCL89EC69PL_.&,7\6W^51:5-#-&S6^X1@@ ,.1@ 8_(5H2V M5M=A?/B#XZ$]:]"C-)IW_4Z;7CH<_P"(?#EW++NTFV5HI;46\D:L%P%(*XR? M;%7I]$FOM2O);_[?]G6.)(%MI,9ROS\=\'^=;<5G$BJL9= /[KFKB0,!A9Y! MSGDYKJ6,JI*H6R21[@\ID M';(Y%7@>*RYW)W>YNDDK(<*D!J)34@JDP)UZ4$TQ7&,#GZ4,2>@Q]:8QXIK2 M*,@DO_H! MK0JKJ:++I5Y&XRK0.I'J"IH ^>43M>7[.+O?1ZZG$DB[HTSRQRO*06+\D #/ ]*W(V M![USL&JZ?;0N6'.[(5"6QQZT?\)*TI"V]L%R<;F-=-.C)17,[G337NHZV('T MJTORCYB!^-K\5F0SA(QL10!Z8IQU#8RAE8@^@S1>W0.5FH/,/WG _W14B! M1U.?1G^U"QT0=0,Y%'F+ZBN234[W M +QX]>1_C3XKVXD \R>(%_XP<@4U4\AV.J\].FX4T7"'^(8KF#OY4U-MA8[#S%;H:BFD"H3FJ"W<<* .X!J"XO/-90C X M^;'\JT=TA^S98N&RC#VKOJ\K2[:>X"*X<=,CN:]4IIW0-6"BBBF(*KW_ /R# MKK_KD_\ (U8J*Y@2YM98),[)4*-@X.",4 ?-]U>[)S#"N9.YQ3XM+NKA!//+ MF//(4Y(^OI3$B\FX:3^-^I]*T;>57D(6;R"3\H8G'?O7#[6',X=3DYE>Q)%D:*T3=G&2F.ON14\".1(78%^/FR"/S'6LMI)'DE(+=> MH7. /6M4W;4[**]T<^^"22XMYXV4<[%;)QW(^G?TH345N-NS:DGMQGZU)!*( MI69YX0[ @JW(SZ].P[=*SI+ P.MS:EW5>60\_B*3?8Z$C176YHI"DP,>#\RG MC_(JZFI2A/.D#[ <=*PKJ:.[MA,H998OE;(QD$XQ[&MB&W\C2D#+AG^8@\D4 M-DR1+]OE91(0-A_BSC-*NKL\>Y5RH."">A_"J:^3<*%D)5CQMZ 5/#;QPRG9 MOVCG=G(.?_U5E?N8EM+WIO_TK.U2YVVS0Q) MF65P%"\D<]?\XI]K;ZD(6MYSMB() =QGW_SFG;2XR:V:5;E(60E7*ABV,#)Z M_7I6P(FL+5=Y ?JY5<[ACI7--(84BA\N4.6";G!'/K4G'5%POND(=7^TWC0P+(64X^;H*FL+B=[=EEQYF2HP>B],_C@U9 M2RA42WT0"JR@[C6'9:S8F]$ N%:61L!$RP [#/3/^-:TY.;.B%YZ)'0V>4O[ M=>Q<5Z[7D5BI;486.?ED&,UZ[71(PK_$%%%%28A0>E%!H ^/^!#I5K6!_Q,+D^DS_ ,S5>U$X@EEMVD#QE2VT\%>> MH[]J\6M']^>?+XS4MHPMO(\ F1 M_*KNG7LDS2M+)DA552 !U]*IQ@R:A. J_,^.O'/3CI_.NRBXNFFMCOH2]U6 M)Q:AXR@P(]HR2 /F_K6G:.B$Q/,0?+V,CH0#[!MN/Y]:N/%%A(XE0 ?>( !/ MXUS>H2-#=RQ'.=Q8NZDE\\ #M]:V=HZK4W5WH;>I3/.8Q;QQ((QNVLPQG^6? M>K$(M#"L%Q-# V,(C2WM7FAGN8UB"E@QD& M=O6JFFZNMG92RW4H6%>IS_+UKB=2O3J-]-*N];=B-JL>6 Z%JP]I?9'9@LOG MBI66B[G6Z9J^ERMM-]$SISDBKEWXCTRTMRKO(SL"5 C8\"O.''ENLL8P4Y&T MEVMQ;ZQ!&^Y,8=F/&.XS^-06& MF3PS21ME%% 'SUJZN+NZ\Q#'()6W(>JG/(J)[=T,MQ$7B58U9&3@'H#R/QK0\2<^ M(-5'K=2_^AFL6SN+B*4B"3:"I9E/(. 3T_"O+KM*=GU.&=N;4NVUQ)<+.\K ML%49P!GKU]ZATQ#%]ST<)&\8O?3:^\C.>U4KE8WO&DAG57+%3$V2KGMQG MC\/RJ['L*@YY_G62(Y_[7D>.-V0/R!QGBI]O[.RD]&=[H\R;70CFMQ$68S,T MJ?*4!*CIT'^)SWID-F3OC,DJ3-\S;CP /?&!^-=%&D8+ *Z@C&W ./PI18Q M;7&_;K71S0G\+.;5;G'ZWHM_)"9XXFDBC&2J8)'U ]JY6.9I9"78!0 M.]>W06Z-;LA3&\$$KP>:\>USPUJ6FZI-"4>6(O\ NI?^>@/?Z^M9QHT2HK9V9P0,$=; M'+:5X0O7BN!<(+>"1 I);++Z'\\58_L86^H?8[:(R2 ??(Y/K6LNKW3(85(V MNVO%BD7$OF+D=^HK MUX5Y=IE '@WB(?\5%J9[& M[F_]#-8MM!&TS^8\BC<$7R\9RV1S[5KZ\6/B#4\@C_39\ _]=&JA;)(M\TD9 MC^5-Q67A6YZ9[=J\^K&\UIU..:O(DTVSD9'88*NO&#Z'D?6J*+)!=SF4%26Z M$^E;NGNZR>5]D-LB@LHW%MQ.,G/?H*JWFG/>3WTBEC,@5U^4 $8/'')_&HA3 M2A9'?@IJ'*GM(XSQTJ#PR (S(1\S-C M\J9J1/\ :5P,MC=G&>*X,5\/S/65G4L5EC?:>3@]R:LVMW<0;0&)7=T;FH4! M*@ DL3QCFK#0R1;=Z$ \5YO-):HV:B]&=)I^IQW!\L95O[I_I5J6UMC^^E57 MG0$HS#[M86D6X:[\T$8C]/6MG4&6.)+C<,$X?V->Q@ZTW"\M3SJ]"*GH+9E- MK/,W4\*!T%7?L-K,ZR^2AQW9>:KZ3%'>PHHHK0 HHH/2@#PCQ.3_P ) M1JBGI]I?'YUEDH5:.1MJ2C:6QG:>H/TXK3\3AT\6:LCC_EY9A]#S5.W\W.(B M5D8?*>F>>F?P-<,U>31RRW+NG82&. 7*3!(V,FQLJHSE>O>IM,D3^U;F)9&9 MR,NK)C'X]QS52PM/*D,DD!CDW.OS#[PR"#^N*N6MPXU6"WUFZM"0!O++_6K&K B[,\7*OC<1V.*G^P6<5P;AT4 MRL) M-:M$8CO<9R#T;/;VI^CZ7'?2&990UJO0J>?I6TLMO C);6J*1T8C)K@A3E:\ MG9/N=-2M"^BNRMH\.RW=]AR6].U6=5B$NBWRD8Q$2#[CFKNF74DT!9NS'@@5 M:N+>/4+2>V<;!*A0LO;(KU<+2BJ<>5G)4JMR=T9'AN6,>'++:>#'S]>_ZU=E MD)&0,#U)K/TK2I-%L5L'DWM&20V.H)SQ4=[!=WUN]K]H$!8)DNVEBE^7 M8XR<^OTK*N]=%M87.G(&$D[KN([1\[A^)Q^M<<:;]M&3>QTX2K.4U36[*DE\ MMUJ16T*LN[,;$8./>NTT2T@MV6Y" SNH!/4YKB/"6E2ZOK+11/LCC4R,Q[ ' MI^=>G6,)MH(6$:?+AWB. !CZ$#/U)KF[+4'*A8IF7'\/I^ M=<4VE-J1RS:4K,?IZ7%O?NLI=P$^1B M.!"!P2??&*JO4C*-NYMRW5C7\*[6\,2"$C/GOOP>^:THV^;']:XKPQ--!";WV.B,[:6-W35Q$YV%? MGY!^E75/)]*K6 Q"5]#5V-,GG@5WX=?NXI$R>I4U:9+>VAG;^^%/TKF_$L(O M-*#PW1A8."&4G!QFN@U1[>>/R64L%Y!'8UQOB&V8Z3(""L*,&)#;68\\>WUK M:I=)V9+C=:;G,HXGE:6[NO.D0?>ZC\/?BLK7(XPUI=K(K/,A,B C*$'@'\,? MK79^'];L#IS6K*JR@]7/7\:DN=#LM3P'A3']Y5&3^(KB]JHN[U?Y'KX;#1P] M3GE=->C*_@$P6%G)?3*<74RQ(-V-H7DGW&2*ZU+EK@)&D00X57?/W@!@?3@U MBZ;X72P91#(S1 Y"MVK7N;VUTQ&RP:;'"#K^/I656M4FTHNT3S,?.#J.;9T& MB#?KEK$IY!+G'8 ?_J'XUWM.:UX)N;"Z!@01.P) M$1<8;!ZJ?Z&O;ZKWEC;7\/E7,*R)G(SU!]0>H/N*SJ4HU%:1$X1FK,^??-N; M"Y N86#*"N&A:W]@9O.*^7,PP69>WIFO2=3\+3(";>..]A)/[F0 ,H]B> M#^./QKEKGPKI\C_-'<6,A_A8%1^3?TKSIX*M'^&[^IDJ=2'PN_J002Q2@&.1 M6^AJCJ5NSW&8]F[C[XX/%6Y/!4XYMKR-_9P5_P :JR>'=;@Y\AW'JCAOZYKA MQ$,1RVY'^8_:S7Q1^XH_9)SN(M(B03M(;!]C6C;S7\*[1;[@,?\ +0?C5=;; M5HC\]M6X/O&:XG.:?O1_,%B$NYMVE[>B)B+(O\PQAU!Z< M_K5EY]2=4VVB+G[REP<=>_Y?K6%#J.HP*55!C.>4J<:GJS<#/'Z56U31[>[LFCD'#&LX/KLQP([H_P"[ M%C^0J1='U^ZX9) OK+)C^M7+%RJ+EA3;^12Q#^RF88\,6MO(2P1?J:M1W%C9 MKA-TA'8=/UK<@\'7.2US>QID=$4M_/%:-AX0T^ [A!+>OUR_W?Z#\ZSAA,34 M>JMZFT\5BJBMLC0P$:;YIOF?X&,:.O--W8B(L:! M5 "@8 ':G445WFP4444 %%%% !1110 4C*KJ58 J1@@C((I:* ,^31-/D)(M MQ&QYS$2G///''>FG18/X9IU^C _S%:5% &:VD@9V3M[;ES_A0-+;_GN/^^/_ M *]:5% &=_9C?\]__'/_ *]*--.>9N/]S_Z]:%% %,:='WD<_3%._L^#ON/_ M *K5% %5-.M8W+"(%O5B6_GTJU110 4444 %%%% !1110 4444 %%%% !11 E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$! end GRAPHIC 10 image_007.jpg begin 644 image_007.jpg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end GRAPHIC 11 image_008.jpg begin 644 image_008.jpg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end GRAPHIC 12 image_009.jpg begin 644 image_009.jpg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end GRAPHIC 13 image_010.jpg begin 644 image_010.jpg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image_011.jpg begin 644 image_011.jpg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end GRAPHIC 15 image_012.jpg begin 644 image_012.jpg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end GRAPHIC 16 image_013.jpg begin 644 image_013.jpg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end GRAPHIC 17 image_014.jpg begin 644 image_014.jpg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image_015.jpg begin 644 image_015.jpg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end GRAPHIC 19 image_016.jpg begin 644 image_016.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HS12&@ S17RCXR M\6ZO'XUUB+[?]NO^_S?XT["NS[%HKX['BW4 M?^?NZ/\ VV;/\Z7_ (2S43_R]7!_[;-_C3L*[/L2BOCS_A+-2[75P?\ MLW^ M-*/%.H_\_5Q_W^?_ !HY0N?86:,U\?\ _"4:D?\ EZN/^_S?XT?\))J1X^UW M'T,S?XTA2"BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ I*6B@#XT\;C_BN=;SG_C^F_P#0C6)T M]Q[UM^-_^1YUL_\ 3]-R?]XUB ^OZFFP0X$'O3L]@:CZ&I!_G% "@<\FG@GL M?P--'I^E/4^],0]2#Z?2I%.._P"M1#KFI4_"@1(N3C-6H.''/?UJLI]_\:GA M.)%&,.=;]KZ;K_O&L-23POYFMKQU_R/ M.M^OVZ;_ -"-8@X'_P!:FP1)@]V_.E!QUI ?P_E3O\XI /IV>W4_RJ/ Z?A M3U%,1( >Y_2GKQR33%/^14J^O\NAIB)%YZ5/#_K4SQSTJNH%30#,R>F:I"9] M0?#4?\4/9?5OYUUM?\ .:0$HX__ %<&G#BHU/-2#'_ZS0 X$]>GUI_U /T- M,'KG\?\ "GCCV_&F)DBGWS[U(O\ G%0@<]ZE4?4_C3$2J23QTJ>'_7ITZ^M0 M+^!_D*GA_P!?'SW]<4T)GU%\._\ D2[+_@7\ZZJN6^'G_(F67_ OYUU-3+B000'MGFG)$N>G2JFHW&U=BT 4[H072RV\\2202@JZ.,A@> MH(KYB^(WA(>$/$S00 FQN!YML?[JYY4^X-?3$.7;/I7DOQLM9]6O]+M;&(32 MVT;O* 0"@8@#.3WP:3 \4!)[?E4J-FM$>%]9[V7_ )$0'^=2#PQK&>;/\?,3 M_&BX^5F=]3C]33@=O7CV[FM2ST^X2,Y 8J#TQ^-;&I^&'\/R0R3 M31302[ED&T9&!D\?R-:*%UE3RZ'J-M;O/) M;D11C+,&4[1G'8^]5H1FXC!.<&J0FCZE^'O_ ")EE_P+^==17,?#[_D3;+_@ M7\ZZ>I>XX["T444AA1110 4444 %%%% !1110 4444 %%%-=PBY- $5U<""( MM_$> *SX4/+,068Y)]ZM[!*4/X&F S<%Y(J5.1NI !G##%1NI7 M[A_"@"5GIJ9SFJXDYY_$5;3IF@!9'$49)ZU@W#F:7'K5V_N-QV@\"J<*$_-Z MT 5]0O[?1M)NM0N#MAMXS(Q]<=J^;+O7;CQ(OB/4[DG=-)"50_P+N.!^5=A\ M:_%YGNH_#EG+B&([[H@_>;LO'I7GFC_\@#6>O6#K_O&E(<=RE@48I:#THL,L M6YFA4/&KJP;(.TX/'\^]7;V^U"]:-;QI<#@#R\$_A5_3[;6]03_1IX2RKPK M+QZ9QBH+C2M6A'EW#HC(/XP ",Y^5L?-SZ52DTK&,Z,6^:VJ,-XPKXP0.V1C M(INT5),)%E*RD[U.#FF5.AJK]38T, 6.M?\ 7JO;_IHM00']_'QW]*GT3_CQ MUG_KT7_T8M00_P#'Q'CU'2JB*>Q]3?#[_D3K+_@7\ZZBN7^'W_(FV7_ OYUU M%)[B6P4444AA1110 4444 %%%% !1110 4444 %59'\Q\#H*=!WH&-=0PP:JR*T7(^9?Y5;)J)CB@17C197R1TJ6YE$ M41'>@JT0+IT/45G74QD/M3 K$F63VJY;1>9*J#IU/M5=%$8R?K6Q8P>5#N8? M,_)^E 'QYXZX\;ZUV_TZ7&?]XU#H_'A[6>HY@X/^\:E\>$CQQK8[?;IO_0C4 M>B0W *E7X_$F MKPQE!>L01CX/AV0D6\\,2[V9W*%BR>4-N!V)?.?KZ42W.B#6K M1D-N;'[+AU*$[7\KGM_?_7- '*%B22QRQY)/K29XKJ;/^Q[BULXA]E6_98M[ M2#" ;V+Y]]NVFSR: TUK+!Y:0J!')&RG=GSB23_P#'- %31XI(K/65D1E/V1 M3@_]=%JK!_KT^HYK:9K9Y]>-D\;6WV8>5L'1?.7 /2L2$DSQYY.150)GL?4_ MP^_Y$VR_X%_.NGKF/A[_ ,B99?\ OYUT])[B6PM%%%(845C:+JDM_>:I;S! M*Z3PUXQUOPM#]#5LGM7G'A#XG:-XJC2UN<66HGK#*WRR'_ M &6[_2NS666V^[F2+^[W'TH&:)-, W-4<K=(#XQ\>D?\)QK?(_ MX_IO_0C4.C?\B_K(SW@_]"-3>._^1XULX_Y?INW^T:AT?_D :R>.L'_H1HEL M..Y5I55F8*BEF/0#DDU.EA>2P+-';R/&V[#*,YQU_*I8;/4+>YCEB@D$J287 M;R0XYQ]1CI0,KBUN& VV\Q!&1A#R*:+>8KN\B3!&<[3BMI=8UTNA'+I$'#%! MPAQSZ8/%(E[K5K;M&L.V*-P""H."XX'XB@#$DB>-BLB,C=PPP:3O6E=6^JZE M<^?+:R-(S&/AJ_P#HQ:K18\^/ZU4"9['U/\/?^1+LO^!?SKJ: MY;X>?\B78_\ OYUU-)[B6P4444AE#3]+CT^:[E1F=[F8RL3VR>GT&3^=7Z* M* "BBB@ HHHH ***CFFC@A>65PD:*69F. .M '&_$[QBGA#PK--%(!?W.8; M9<\AB.6_#_"OE2UM+S5+B4P1O/+@R/R,GWKIOB1XOD\9>*YKE"?L5OF&U3_9 M'4_B>?RK$NO]!MDL$.)?$L&J0_;(0,"0G$J?1N_T/%-NM-5(A3L/H?7\*S6)H%L?8EI(E];IJ&ESQRJZ[@5.5D%6DU..YC9>8Y4^_&W M4?XBOE[P/\0]2\$W@5&-QIKM^^M6/'U7T->[VVNZ?XGLHM5TJXR#T8#YD/=6 M%,#>E?<^:GM83+(J#OU/H*S;&Y\_*R+MECQO7^H]JZ33H/+A\QA\S\_A0!<5 M0J@ 8 '%.HI*0'QCX]_Y'?6O^OZ;I_O&D\/6L]YHVL0VT32RGR2%09) 8T>/ M#_Q7.M9_Y_IN1_O&N=61E)V,5)XRO!H8XNS.QM[7Q-:1QQP6UTBQ[MH"=,]1 M^-*EOXFBD+QVMPK%_,)6, ENF:Y$3S\9FD^@4,%TGXL:=F%T=#Y'BE9"_P!GNMQ8/G9_$._U]Z<\7BF19 ]M?\B78_\ OYU MU5C) MX>LY0+J^&9R#RD7I^->G:YK-KH&BW>J7CA8+:,NW/)] /I M-;DNF_;(;:&VD!&XQ6R9QO(^\['MD_H!6.\;Q-MD4J?>D-H0#D =2<592*2S MN0TJ8="'4'H<$=*B@6-Y@CD 'U_^M5^\@EL0F-MS9RC*DG)4=Q]:&".KO$T& MY\$*+7[/)?M@@D;9DESR23U'7GTK@M6-O]O*VY!54178# 9\#VLUEX-ZC^Z??/;M7;CH*\\^#'AN]\.> H5OV837DANA"W_ M "R5@,+^0S^->B4@"BBB@#XO\>C/CC6_^OZ;_P!"-J/^$XUO\ MZ_IN_P#M&N;(YXSD=J;$AX_''M3U_P XZ5&&!ZTX$>H-(9.G^>*F4D<'I5=, MGDFIP..OYTQ$@-2K^7\S4"MC@U*K#L?RIB)UX]*EBXFC^HJ!7L/P_G7F$(^PZ<9L?Z1= I'ZK'_$WX]!^-16T;ZE?R37@^M3S0W&HB2^2,>7]U8UZJHZ #T'\Z!H@M;B:UD5XG*E2#CJ.#FN@ ML[RSU0QV]XR0HH=W!'^MD/.<]NWT KGD1F<)CYF..>.:EOK*XLGVSH1GE6'1 MAZ_I2!-DFHZ=]FF*PN)5."J#)90>5SVSCGC-)9:K]GC:TN@SP$Y'\11N_!_E M2VFNSVB-&QW?(RQMW0G@D>IP,9["I)=+6\MA+9GS)40&9U^[([<[5]PO4].# M0/T,FXE032>06$3< =,CZ51D;)X[U--N1RC A@<$5%!"]W<)#'C5]UQR?3CUKLO@]X'_P"$N\5+ M1+-GI(_\*?U/L/>N*,4FJ:C;:=IT32980VZ _\CQK7_7]-U_W MC7-G_()Y%='X]/\ Q7&MC_I^FX/^\:YP_C^--@A?K_*G+SR<8]*BSD\5(,C^ M+'X4@)T/_P"OK4H_SZ&H$/KCZU,#_G-,1(*>ISQ@5%N[5(A;Z?A3$6%Z=/RJ M6(_OT^HY%5U8XYY^G6IX3F=#[CD52W$SZI^'/_(E6/\ P+^==97)?#VF92X#;7&.A#?T.1[5HQVW$L0_VU'4 M?[0X^E8:K5FWGFM)EFMY7BE3E70X(I-#3+N^TO8AO;R)8UZ@YW G/NQ.!R> ME--[]B#Q%-HW#=LR..^!V]^!4SSV.LC;<>78WQZ3 8AF/^V!]T^XX^ ME5))9M/D>SU*U).=^#_$<84DC[R^F*"B.ZTS]R+BR?SH=N6 Y*X S^'.*I6U MZ;5F#;GA=2K1ARH((]OPJU/:SVUO(]M-YML^ Y7N<9QCKQ_2LAVIHEFU="'5 M_P!]&L46R(/*0,<]P?Y >@)JC+ML;1EC!$]T,G/5(NH'U;K],>M1:>@S+/*3 M]FB7,BYQYA[)^)_( UK>$_#UYXX\86^FH3F=]\\H'^KC'WC^ X'U%(&>J_ + MP*)9'\6W\/"$QV"MZ]&D_H/QKZ!'2JNFZ=;:3IMMI]E$([:VC$4:#LHXJW3$ M%%%% !1110!\6^/2#XYUL<'_ $Z;K_O&N:.*Z3QZ<>.=;Z_\?TW?_:-HQ3@>_ZBH]Q[_I3@?_ -8I 3*<>E2#%1*<"G@DTQ$J^M2*:@#?3\#4 MBG_/>FA%A#SG/XU+$1YZ=.M5U;WJ2-LSICU%-;B9]7_#,Y\"V/U;^==?7'?# M Y\!V/\ O/\ ^A5V-3+Y[5>S7A7Q>\1GQ!KD?A.RE;[):?OM09.[=DX]/T)]J 2N>0>)=?NO$_B&[U M>[)WW#Y5,_<0?=4?0?UK,4&NDE\$ZE,)9-+ADNHXAN=3C>!VX_BR.>/2N?$; M1N4=2K*<%2,$'WHN4XM#D!%*QP*7@"H9&H)&.MM47[.++48SG2DJLBY"MQ@@C^%L'_#-9M\+>YN( MC9Y9YN6C5=H#$] *+34I;%V"A9()!MEA?[D@]QZ^AZU8=K&SC:\L9MTDHV11 M-]^#/WB3W] ?>@J]RK?R+$JV,+!HX22[#H\G<_0=!_\ 7KZ<^"O@4>&?# U2 M[B*ZGJ2AVW#!CCZJOU[FO&_@]X(_X2WQ6MQ=Q%M+T\B6;/1W_A3\^3["OK10 M , 8'I02*.E%%% !1110 4444 ?%7CXC_A.M<]?MTW_H1KF\]ZZ/QX?^*ZUS M_K^F_P#0C7.'KS_]>@2%S[_K2CCUIG3_ IPY[4#)1^=2 U IYQ4H-,1*#[T MH.#FHP?_ -=.!/H:: F4Y[FIHC^]7'KVJLK8-31G]XGUIHEGUA\+#GP#8G_: M?_T*NTKB?A0<_#ZQ_P!Y_P#T(UVU2]REL%%%%(8444UV"@LQP ,DGM0!ROQ# M\7Q>#?"MQ?Y#74G[JUC/\4A'!^@ZFOG#P[J$%S(ZRR%]1GF,C-*W,KMG./7_ M /7S4WQ3\8R>+?%TQC9Q861,-NAXS_>8CW/Z8KB1U&.O;%)JXU*S/I;2]/AT M+3""H+_?F94Y8_3]*S-?\&Z1XM@:X7%O?8_UZ#G.,X<=#U'O7GWA+XDWND;+ M75=UY9= Y_UD8^O<>U>K6=S9:E9F_P!&N(Y R%4&>$8\].Q]'=2\-W9@OX2JG[DJ\HX]0?Z=:P6.3UKZ.GEM=5M)-/UBU4AV*[) ,-T M^;VZ]>*\I\8?#NYT;S+W2]]S8=63J\0]_4>]7&?1F,Z5M8['",:B=JM2VMK/?7<-I;1M)/,XCC1>K,3@5%7N'P!\$_:;R3Q7?1?NH"8K,, M/O/_ !/^'0>^:0'L'@#PC!X+\*6NF1@&OX#H/I74T#I10 4444 M %%%% !1110!\4>/>?'>N?\ 7_-_Z$:YLYSUKH_'I_XKO7?^O^;_ -"-(>+/AOK/A=FG"F\T_M<1*?E_WAV^O2OHB"[CD/)P:U;2$3'#J M&1N"&&01Z$=Z8'QN, 9K8TW4-4\/3?;M)N2R# D &5?@$@KZ9.,U[!\0/A)8 MWTLE[X;5+:[QN>U_Y9R'_9_NG]/I7ADRZAH6H26\T4EO<1G#Q2+U_P#K4F-. MVQ[)X>\8Z5XMA%O,!;:CMP8R>3[H>_T[5M2W,MA*YGYMCG&/X%& .>Y//%?/ M=W<0,\5Q:*89LDL%/0^H/OS7H/A/XD"81Z?K[_-P(KHCKZ!O?WK*4.J.F%5- MV9/XO\!6NJ1MJ>A;([@\O"IPLGT]#7DDT4EO*\4R-'(APRL,$&OH2]NK?2=+ M:5#F-1\A7G<3TKR#Q'!%<1RW\TF+EFRS;2 Y[C_/O3@WU)K06Z*'A3PY=>*_ M$EGH]J#NF?\ >.!_JT'WF/X5]I:/I5KHFCVNF6,>RVMHQ&B^P[_6O,_@;X'_ M + \.G6[V/%_J*@J&',<78?CU_*O6ATK0YP'2BBB@ HHHH **** "@T4AXH M^)_'O_(^:]_V$)N/^!&N:9Y!YE[-A48$L=W3V_^O6'_P ( MY9CAY'$IVE$#C!![ENWK0Y(KE9RW6@&O6_!OPXT'6[*Z>]>[:6*;9A'"@#]< MUTW_ IKPP1D+?\ /3]]_P#6J'-7+5&3U/ /:G ^U>_#X->&2,A;\C_KN/\ M"E'P9\-6558$HP(.3S MU&>/_K5*GAZU#HK.XE+X4!@5;C/7M_\ 7_&K4D9GT4 <'K M^@7FGN+O37+6X)+QXR5_Q%1:3XDE@VI(P)Q@@_TKT C-4/K79^ O#'_ GOC:*,ACI&G[9K@YR'/9?Q/Z U MYI;P2W=Q';P1M)+*P1$7JQ/ %?8WPY\&Q>#/"5O88#74O[VZD'\3D=/H.E39 M#YFT=:BJB*J@!0, #H!3J!THIB"BBB@ HHHH **** "D-+10!\H^*-5LK?QA MJ\#Z?_ %_:L5=7L/)91.@&!F,YPW/7/;_Z]97CSCQ[K_\ MU_S?^A&N>I6+YV>X^!O&6@:=87B7FJ)"S3[D20'@8]>__P!:NN'Q(\+J !KE MO@=.#Q^E?,.:*CV:N:*O)*Q]/#XC^&%!"ZY;\^Q_PH/Q'\,$8_MV#L>_^%?. ME@-)\N+[:TH8A_,V#..FW'ZUHX\+$D;KO=_XZ?Z^M'LD'MWV/>?^%C^%_P#H M.V_Z_P"%5[SX@>%Y;2X"ZW!YC1L 5!SG%?-K *Y"MN&>#ZT9I^R0?6)':)J] MCL)%SL.S!;));GT[?_6]ZD76+ $_OP%:0GRU)PPQW/\ GK7$CU[TX?>%7RHR MAKC+K3+S3)=ERA _AD7[IKTVF21)*I61%9 M3V89%%QW/+GO)HQY4OW3T/K2&WBNH'AF198Y!AU89!'H:[&_\*PS"0P' ;_E MF>GX&L&WT*^6Z^R^4ZAC@.1P!ZYJK@06)!_(USGV*Y_P"?:;_O MV: *]**G^Q7/_/M-_P!^S1]BN?\ GVF_[]F@""E%3_8[G_GVF_[]FC['<_\ M/M-_W[-,"&E%2_8[G_GVF_[]FE^R7/\ S[3?]^S0(B!IRGYA3_LEU_S[3?\ M?LTX6ER/^7:;_OV:$!]8?!,Y^&-A_P!=9?\ T,UZ'7GWP6AFM_AEIZSQ/&Q> M5@'&#@L<5Z#2&%%%% !1110 4444 %%%% !24M% !1110 4444 %%%% !111 M0 4444 %(:6B@",PQL,?_?(J2B@"/[/#_SQC_[Y%)]GA_YY1_\ ?(J6B@!H7: .P[4ZB $B@#_V0$! end GRAPHIC 20 image_017.jpg begin 644 image_017.jpg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end GRAPHIC 21 audit_01.jpg begin 644 audit_01.jpg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end GRAPHIC 22 audit_02.jpg begin 644 audit_02.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBLS6=8 M_LJ.!(;62\O;F3R[>VC95+D DDEC@* "2?YD@4 :=%8%IXHB4W,6M0#1[BWV M,RW$Z,C(Y*JRN#@@D$XP<^F M* ->BL_4M6AT_3HKU1Y\4LT$2&-A@^;(J!@>X^8'Z4S6=9CT: RNB28AFFV> M:%=A&A8A0?O=/PH TZ*Q[3Q3HEWIDU^NIV@@MPIN&\Y2(21P&/XX]^U)+XL\ M/P6,%[)K-DMM.6$4AE&'*\,!ZD=QVH V:*Q-(\6:+K.C#5+:^B%NL"SR[W , M*D'[_IT(_ TNL:U=V.H65C8:8;^XNHY9<>>L014* \D'/,@H VJ*Y?3O&UI= M7-Q!?6YTY[6.1KHSRKMB9'"E=P.#GS,]TJO GG#,@894CZCD>M:-S<1VEM+<3%A' M$A=RJEC@#)P!DGZ"@"6BN2_X3RU;14OQ9R12RW,MO%;WS*H3KYF=A(*\$%2.M '945BZUK= MUIU_8V-CIIOKF[65POGK$%5-N220?[PIECXKTZXA@%Y*EC=S7#VJVTT@W-*C M!652/OIIY\3:$+ M""^.KV0M9Y/*BE,RA7?G*@^HP<^F* -6BL?1_$NG:OHUGJ*W$4(NBL8C>5*-!BO5LGU>R6Y:0PB(S+NWYQM(['/&/6@#6HJI%J=C/\ 9_*N MX7^T[O)VN#YFW[V/7'>H=6U"[L8XELM,FO[B5L*B,$10.26<\*/3N30!HT5R MT'CBUGGTNV^P7JW-[.UO*K1_);.I=6#/]TG=&P&TG.,]*T(]<:;5H;*.SN"10!LT5SUYX@U%=X!(]:FT_5M/U43'3[R&Y$+F.0Q.&"L.H..] %RBL.'Q/;2>(]1T5 MH98Y[.-75VQMGR@9@I]5#+D>X-)8^+M&NXM.62^M[>[OK:.XCM))1Y@#KN Q MZXS]<4 ;M%4TU73Y%1EOKG-5;GQ!:6EUIPD_X\]0 M&(+Q6!CWXW*I/;F0#6HKG+/QII$MG;75]0:P1XRM"GB &WF671EE=HV('GHBY+(?3/RGT M./44 =+17,W7C.VM(KN-[2_N;6YG<*2(;:,N20,G)Z* 26.!Q^% &S17-ZGXL:POKI(],FN+.P\O M[==+(JB#< W"GEL*0QQV/&3Q4!\;Q12FXN=/FAT=I)88M0,BD.\88M\@.X ^ M6^#WP.!D4 =717)CQL;:-O[5TF>PF>%9K6)YDP0ROC: MDC@$Y) _4$5!JVHWMD88]/TF;4)Y-Q(618T11W9VXR20 .IY[ FFTUJQ)I[& MG17,1>-[*XET6.&SO6;5&P"T1"PWU6&"YT:ZA ML)[G[)#>,RY:3G!,?W@A((#?0XPK^+X])U@6)T^>94$1ED5U! D M8JNQ"U=P7'4LPR0!Z>XH WJ M*PM*\07-YJG]G:AI$^G7#P&YA#R+('C#!3G;]U@67(/KP3@XI7/BV]T[5#;: MCHOD6RP37,EPEVLGEPQC)VT#<#A2"1NST!R":4>,+F246$.AS/K2R.DMD;A (U55;?YG0J1)'CC M.6Z#!H ZNBJ6D:G#K&E07\"NB2@Y1Q\R,"0RG'<$$<>E7: "BBB@ HHHH ** M** "BBB@ HHK.US6(=#TTWDP#9=8T4N%W,QP.3T'<^P-.,7)V6XFU%79HT5F M0Z[933QVZ7-L;C.)HA."8R%)(]\8_K3XM=TF>TFNXM1MGMX<>9()!A<],_7M MZU3IR707/'N:%%8\7B?2G2>22\@BACD\M)'D&),(C$CZ;P*LKKFE,L[+J-JR MVX!E(E!" ],_R^M#IS71B52+ZE^BLXZ]I*VB71U&V$#E@LAD&"1U ]QZ5#/K M]O#?1VZH9$D\HK,K KB3S,'Z#RS^="IS?0'.*ZFO15.SU;3]0E>.SO8)W0!F M6-PQ /0\=J0ZOIHO)+,WUN+B,9>,R %1C)S^'/TI#D9P0.#R*V*AN+NVM%#7 M-Q%"&. 9'"Y_.A*^P7L&=4U>Y^WZJU@MSY]J%AAW/&D$4PE898 LS'V M&![DTKWP/J#ZB;^WF@=Q=74@A^U36P*3;#G?'SN!CP1@@AC78?VQIG_01L_^ M_P"O^-']L:9_T$;/_O\ K_C52-7+K$? M+E60KGYF .TCO5?5M!UO7XHFO?[/MIHX;J$+#*\BD2P[%.2B]">>.E=#_;&F M?]!&S_[_ *_XT?VQIG_01L_^_P"O^-')+L'-'N<5=>!M6U"".6YGL(KJTBMH M;=+5I(DE2%BWSL,,F2>-N=F,\YK2T;PA/IVI6=\WV>-UDN9;A%FEF)>18U!W MR?,QQ'R3CKTKH_[8TS_H(V?_ '_7_&C^V-,_Z"-G_P!_U_QHY)=@YH]SAH_# M=^M_X8TJXV'[-;"+4&@1VBEMX2K19=@ &,BCY>3AF[UK3KF\4/ M:VL,Z-&)'1BSF/!!4C@!&SSW%:7]L:9_T$;/_O\ K_C1_;&F?]!&S_[_ *_X MTYS>H>#IHI6.@M:V4:68@B0@YW^<)&.<'!(!^?E@3GDBLL>#O$T5O M/;)<64UM>7GVJ]BDO)@TJ^4B"(RE68KE"6/&X8&%&179L[HB<[>3C],'\:C_ +8TS_H(V?\ MW_7_ !H_MC3/^@C9_P#?]?\ &CDEV#FCW.:F\(WBM!=Q?8;BZMM2NKR**Y#> M4R3%N"0"58 CG![^N13'@K5(](N-,0:,8K^-UGZTF:*ST MZ_CLDE1X-1=@K;@@# A6Y&T]N]4[#P3=QK&D\MK;P^5>Q"WM=Q2V6<1@+$6' M0;&8YQRYP .*ZK^V-,_Z"-G_ -_U_P :/[8TS_H(V?\ W_7_ !HY)=@YH]SB MY?"'B.>*R8W&E6TVFVJVEN;964S)N0L2Q4^4<1KMVAL$MS4FG>#=9TN5+R*7 M3KB[\^Y++=-)(OESK'N^8Y8LIB R?O G[N>.P_MC3/\ H(V?_?\ 7_&C^V-, M_P"@C9_]_P!?\:.278.:/> -:EM?L<6HVY@DCC>5C(Z%IPV^1G51^\W-G!8_+G[IP*[O^V-,_Z"-G M_P!_U_QH_MC3/^@C9_\ ?]?\:.278.:/6XAAN&ATZ"1& MC.)'5[@C(Y!D)PV,87TYKH/$=OKEU91P:)+;0L[_ +]Y9&C;9CHC!6P2>^.! MG'."+G]L:9_T$;/_ +_K_C1_;&F?]!&S_P"_Z_XTYDC0KJ33]"A\F MSLSI]X)WA@=G38%=<*Q4$D[@3D>M;*Z;9+<"X6UB$P)+ M#!' )8]S1[-^[J.^X=/2LX>%]9L-2?4M/;39YW:[0Q7>\((YI?,4@@$Y' *X MP?48KJ/[8TS_ *"-G_W_ %_QH_MC3/\ H(V?_?\ 7_&CDEV#FCW.*TSP%J>E M6":)%PE54?+@F, $GY0<8.!GI-"L[S1++3]+>))E/ MGO-/&2%0ERRCDVLD,5Q+; M7-NWV669C=7";)(D1<+$I".,Q@J6P1GD''/=_P!L:9_T$;/_ +_K_C1_;&F? M]!&S_P"_Z_XTYQ5U\.;B9[C9?1H&N/)A(R#'I[9\R <=UWPWJ=U?ZC+IATXPZG8K8SB[5LPJN_#(%!##$C?*<<@< MU6O/ ;WNE3Z9-<@VTVI17+LKLCF%84C(W#D.=N?3FNJ_MC3/^@C9_P#?]?\ M&C^V-,_Z"-G_ -_U_P :.278.:/(=&U,B$_V?;S1$ MD?.2X0 @^VUOSJSXATZ75_#FI:;"Z)+=6TD*,^=H+*0"<=JE_MC3/^@C9_\ M?]?\:/[8TS_H(V?_ '_7_&CDEV#FCW.>U;PWJMU=:K!:368T_5_+^U/*6\V' M"JC; !ALHHQDC!R>1Q56;P9J5Y;#1;FXM%T:*>XGBECW&X;S!( K C:,&5N0 M3G:.!DUU?]L:9_T$;/\ [_K_ (T?VQIG_01L_P#O^O\ C1R2[!S1[G)7?A'6 M=9$4VJR:6+BRBB2UCB#O%*RR)(QD# $ ^6H"C.,DY-;OAO1KC3#J-S=K:Q7% M_<>.HYJ?Q!8:Y<6 MEI9Z-+;+;CY;HS3O%(Z !5=4;&>1$5"+;ON9LNC7-Q::"GEVEJ=.NDF>&%B8PBQN@5#@ M?WAU Z&JT>G>(9?$YOK^/39[.*4_95%PX-NF"-P3R\&0@\DMP"0,I%FXD9 MS-8.@ S;G'3(W#E?F)SGI4G_ A5W9>(8-5L-8N)0DMSN6Z4^/P[K]OJK> M((WTU]5FDD$ULSR" 1,D:@*^W=N'DH22N#EA@<&NF_MC3/\ H(V?_?\ 7_&C M^V-,_P"@C9_]_P!?\:.278.:/Y=HJE_;&F?\ 01L_^_Z_XT?VQIG_ $$;/_O^O^-')+L'-'N7:I:I M9R7UHD4;JK+/#*2WHDBL1^2T?VQIG_01L_\ O^O^-']L:9_T$;/_ +_K_C34 M9IW2_ 3<6K-F->>&)KVP>T-RD8DN[F9G4'(659%'XC>,_0U#!X8NTQ=-]F2] MB:(H#/+,CA"3AB_*CYC@ <'!YZ5O_P!L:9_T$;/_ +_K_C1_;&F?]!&S_P"_ MZ_XUJJM5*UOP,_9TKWO^)DV.@WB:M_:%V;,,TLTI2$'"EXXT&"1R?D.3QG/X M57?PU?QV=@EK/;QS6MDEL2,C<0R$X.#MSM.&P2">E;W]L:9_T$;/_O\ K_C1 M_;&F?]!&S_[_ *_XT>TJWO;\ ]G3M:_XF+I7ANZL[V"XN)89-EU+<'YFWX![.E:U_Q,70],U)(-+N)TM8_LEFL,<: M!D+!@F[?Q\N OW1GGN*2Y\-WUQ9W>F^;9+9R32SI,8BTA9R6VLIXX+$;@[; .2L@D 'U M^<9^E7_[8TS_ *"-G_W_ %_QH_MC3/\ H(V?_?\ 7_&DYU7I;\!J%-:W_$NT M4R*6.:-9(I%DC;D,AR#^-/K V"J6I:/INL1QQZE90721GN,=\TTVG=":35F5_P#A"?"__0!T M_P#[\+1_PA/A?_H Z?\ ]^%K-L_%5X\<=XUG-=#593_9-C JJYMT7)E=W( W M#YL$C 91US5F+QQ82Z??78M;M?L,*23Q.H#JS2/&4QG[RM&P/;T)K3VU7^9_ M>_\ ,GV4/Y5]Q9_X0GPO_P! '3_^_"T?\(3X7_Z .G_]^%JWH^KG5_M;K93P M0P7$D"2RE<3%'9&*@$D#*GKBN?M/%[1:E-%?EV474T($<:A$07(A1F).>"R@ M^QSVH]M5_F?WO_,/90_E7W&K_P (3X7_ .@#I_\ WX6C_A"?"_\ T =/_P"_ M"UDZG\2M)TV=XG@E[N7$<$$;2R.?X549)_(4 M>VJ_S/[W_F'LH?RK[C'_ .$)\+_] '3_ /OPM'_"$^%_^@#I_P#WX6L6T^)V MEW8VQV5R\[F+RH(I(I6<2-L'W'(4@D95B",Y]:MIX[BVL\^CZA;Q(\\+2/Y9 M GB1W:/AR3\J-AON\=:/;5?YG][_ ,P]E#^5?<7_ /A"?"__ $ =/_[\+1_P MA/A?_H Z?_WX6J \>0EX+VJ_P S^]_YA[*'\J^X MN_\ "$^%_P#H Z?_ -^%H_X0GPO_ - '3_\ OPM8VI?$_1K&_:SBBEN76W2Y M+B6*)2C+N 4R.NYL%?E'/S58G^(>FPP7-TMK<-90QP,MR61%E:95:-!N8$$A M\DL !@Y-'MJO\S^]_P"8>RA_*ON-'_A"?"__ $ =/_[\+1_PA/A?_H Z?_WX M6L>#XC6FHPRQ:9I]W=7T2R-/# 8Y!"J@'?O#;7!W+@*23R,<&NET"\FU#PYI M=[<%3-<6D4LA48!9D!.!VY-'MJO\S^]_YA[*'\J^XI?\(3X7_P"@#I__ 'X6 MC_A"?"__ $ =/_[\+6]11[:K_,_O?^8>RA_*ON,'_A"?"_\ T =/_P"_"T?\ M(3X7_P"@#I__ 'X6MZBCVU7^9_>_\P]E#^5?<8/_ A/A?\ Z .G_P#?A:/^ M$)\+_P#0!T__ +\+6]11[:K_ #/[W_F'LH?RK[C!_P"$)\+_ /0!T_\ [\+1 M_P (3X7_ .@#I_\ WX6MZBCVU7^9_>_\P]E#^5?<8/\ PA/A?_H Z?\ ]^%H M_P"$)\+_ /0!T_\ [\+6]11[:K_,_O?^8>RA_*ON,'_A"?"__0!T_P#[\+1_ MPA/A?_H Z?\ ]^%K>HH]M5_F?WO_ ##V4/Y5]Q@_\(3X7_Z .G_]^%H_X0GP MO_T =/\ ^_"UO44>VJ_S/[W_ )A[*'\J^XP?^$)\+_\ 0!T__OPM'_"$^%_^ M@#I__?A:WJ*/;5?YG][_ ,P]E#^5?<8/_"$^%_\ H Z?_P!^%H_X0GPO_P! M'3_^_"UO44>VJ_S/[W_F'LH?RK[C!_X0GPO_ - '3_\ OPM'_"$^%_\ H Z? M_P!^%K>HH]M5_F?WO_,/90_E7W&#_P (3X7_ .@#I_\ WX6C_A"?"_\ T =/ M_P"_"UO44>VJ_P S^]_YA[*'\J^XP?\ A"?"_P#T =/_ ._"T?\ "$^%_P#H M Z?_ -^%K;$L9E,0=3( &*9Y /0X].#^5*SHA4.ZKN.U_\ MP]E#^5?<8?\ PA/A?_H Z?\ ]^%H_P"$)\+_ /0!T_\ [\+6X[I&A=V55')9 MC@"G4>VJ_P S^]_YA[*'\J^XP?\ A"?"_P#T =/_ ._"T?\ "$^%_P#H Z?_ M -^%K>IK.B;=[*NX[1DXR?2CVU7^9_>_\P]E#^5?<8?_ A/A?\ Z .G_P#? MA:/^$)\+_P#0!T__ +\+6]48N(&:-1-&6DR4 89;'7'KBCVU7^9_>_\ ,/90 M_E7W&+_PA/A?_H Z?_WX6C_A"?"__0!T_P#[\+6W'+',F^*173)&Y3D9!P?U M%*[I&NYV55R!EC@<\4>VJ_S/[W_F'LH?RK[C#_X0GPO_ - '3_\ OPM'_"$^ M%_\ H Z?_P!^%K>JOVJ_S/[W_F'LH?RK M[C)_X0GPO_T =/\ ^_"T?\(3X7_Z .G_ /?A:W00PR#D=*6CVU7^9_>_\P]E M#^5?<8/_ A/A?\ Z .G_P#?A:/^$)\+_P#0!T__ +\+6O<7MK:@FXN(H@H# M'>X& 3@'\^*C?5=/C2)WO;=5FSY9,@^?'7'KUH]M5_F?WO\ S#V4/Y5]QF?\ M(3X7_P"@#I__ 'X6C_A"?"__ $ =/_[\+6TD\,A4)*C%@2N&!R!U(I[,%&6( M ]31[:K_ #/[W_F'LH?RK[C"_P"$)\+_ /0!T_\ [\+1_P (3X7_ .@#I_\ MWX6MN.6.4$QR*X&.5.>H!'Z$'\:)9HH0#+(B!C@;FQDT>VJ_S/[W_F'LH?RK M[C$_X0GPO_T =/\ ^_"T?\(3X7_Z .G_ /?A:W(Y$EC62-@Z,,AE.0:=1[:K M_,_O?^8>RA_*ON,'_A"?"_\ T =/_P"_"T?\(3X7_P"@#I__ 'X6MZFNZ1KN M=E5<@98X'/ H]M5_F?WO_,/90_E7W&'_ ,(3X7_Z .G_ /?A:/\ A"?"_P#T M =/_ ._"UNAU+E PW@ E<\@'.#^A_*D,B*&+, %&6R>@]Z/;5?YG][_S#V4/ MY5]QA_\ "$^%_P#H Z?_ -^%J.;P?X2MX6FFT338XU&6=H5 ]ZZ$$,H92"" M,@CO4-W;)=VYC9F7N&4X(/K_ /6H]M5_F?WO_,/90_E7W&&/"/A)I3&NAZ<6 M"A^(%Q@]*J)H/@MM5.F/H=C#>;2Z1RVX7S5'5D/1AZXY'>I+?3KG3-\*PF$C M)BG@!:,9Z_)U4>PX]J\^\6/K,MUI>HQ31QSV-\CJ5;",Q.TG_9R"CVU M7^9_>_\ ,/90_E7W'JEMXM^$MTEP\6G6Q6WB\Z3-@1A<@>GJPK2O=1^&5AI^ MEWDVFV975!NM(TLMTD@Z9V@9'/%><:IX7\4:9X(U75=6AT9+":R0H;.%$DRS MH5SA1QCKS5>RSX1U[P-XJU%3=:5 P+=ZC'')&J7(2XYN2':0-(2"2V]V)QC.X@@CBNKHH MJZ?80Z;;-! 7*--+,=YR=TCL[?AECCVK*/@[2V>\9_/<7<4\4JE^,3/O;''! MST]*WZ* .<;P78(+3[)=7MDUO:K:%K>123I.L\$@#1. ML?E_+D$8*Y!!!!S5'_A7^F+'(D-[J<(N4*7QCN.;T%B2920>3N;E=IPQ'3&. MLHH YR3P;8B]2Y@N+R)8KC[5#:+*! DVTKN"XSSG)&<9R<9)K7%C]HT86&I$ M77F6_DW)(P)?2KJ"V>3SWFN;N+S'^7SI8Y$.>/N_O#Q]*Z.B@#DK7P):K: MVSW%_J!U"".)8+H3@O;; 1MC)7&T[F!W [@>SNVO!/ M+(&>65A\Q?C!!^4X &-JXQBNBHH Y6#P!I5DJ'3KB]L95,@:6!UW2*[;MC;E M((' 7C( !JW<>$--N8;N-FN5-Q)#*)%E^>)XE"HR$YY&T=6ZN4O<7%R)(V7&$6-AM ! W9&U3UZ[ MO6I)]"E:PDM8)4C7SWDB&3A%*%0!ZS,S1.@) +MUZ?WV9L(IQM!D9 MN.#DD$*>1T[U"?"^"RL?^!9KJZ* .<_L"^^T6T@ MO J1J0(U;B++,=JG&2,%5ZCA1QV%JWT%89-/(D9$M;8[E?Q#*/P],5+;Z'<6^DS6@G5BYC;!9L M/A5W@GKABK9//WN];M% '/?V!<1CSD:"2Y"VX!+19 M7U-;ZXE*,=[-'!*R@,?+ &1C<,1Y.>YZ5M44 8VE:++IX99)Q,LL963/4'<2 M OHN"1C\>I-5+?P[?QK^_P!2:'7TY[ M:4^2DL90/Y1;!18=FT9QQN ;I5>?PK-=6[17#P/PXRQ9M[&-T,AST8[QD?[/ M6NIHH YX:#=I\J7**-DB12!FW6^6?EQGN.#T=% '/?V!??;I)AJ;K$SR%4&?D!!V8]U9F/OQZ5$GA MJ9I!)*\(V%#%$&9EB(=68C/][:3TZL:Z:B@#ET\,W?GLQNDA#E%E>%VWS* ^ M6;/1B2IX]#S2W'AV_GT\PR7,5P[0A9!*S*KOA]S''3YG! ]NW%=/10!B:;I% MW8ZE/P9>N/?FJ>C>#-:N9/M_B/4HS=;1LB@0,%.)!VP1^/ KOJ* .:U7P M=IVJWD<\^GZ;+LC\H&:U5V50I"@$] &YI+WPM]LTW^S7CTUK%-YBMI+-6C4X M&P[>G'S?7=7344 8\^C->V36-Z+2:R)*BV: &/8"I4$'T /YCTJA)X46ZTVV MTV]@TRXL(/+V6SV@*(03NVCMD$ >G-=/10!7L+?[)806VR-/*0)MB&%&/3VJ &Q110!__9 end EX-101.INS 23 aatp-20191231.xml XBRL INSTANCE FILE 0001713210 2018-06-30 0001713210 2017-06-30 0001713210 country:US 2019-06-30 0001713210 AATP:LabuanMember 2018-07-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2018-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001713210 us-gaap:RetainedEarningsMember 2018-06-30 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 2019-07-01 2019-12-31 0001713210 2019-06-30 0001713210 2017-07-01 2018-06-30 0001713210 us-gaap:CommonStockMember 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-06-30 0001713210 AATP:PeriodEndMYRMember 2019-06-30 0001713210 AATP:PeriodEndMYRMember 2018-06-30 0001713210 AATP:PeriodAverageMYRMember 2019-06-30 0001713210 AATP:PeriodAverageMYRMember 2018-06-30 0001713210 AATP:PeriodEndHKDMember 2019-06-30 0001713210 AATP:PeriodEndHKDMember 2018-06-30 0001713210 AATP:PeriodAverageHKDMember 2019-06-30 0001713210 AATP:PeriodAverageHKDMember 2018-06-30 0001713210 AATP:MYRCurrencyMember 2018-07-01 2019-06-30 0001713210 AATP:MYRCurrencyMember 2017-07-01 2018-06-30 0001713210 AATP:HKDCurrencyMember 2018-07-01 2019-06-30 0001713210 AATP:HKDCurrencyMember 2017-07-01 2018-06-30 0001713210 country:HK 2018-07-01 2019-06-30 0001713210 country:HK 2017-07-01 2018-06-30 0001713210 AATP:LabuanMember 2017-07-01 2018-06-30 0001713210 us-gaap:AccountsPayableMember 2018-07-01 2019-06-30 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 AATP:GreenproCapitalCorpMember 2019-06-30 0001713210 us-gaap:CommonStockMember 2017-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0001713210 us-gaap:RetainedEarningsMember 2017-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001713210 us-gaap:CommonStockMember 2017-07-01 2018-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2018-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 2018-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0001713210 us-gaap:RetainedEarningsMember 2017-07-01 2018-06-30 0001713210 2018-03-09 0001713210 2018-04-16 0001713210 AATP:PeriodendAUDMember 2019-06-30 0001713210 AATP:PeriodendAUDMember 2018-06-30 0001713210 AATP:PeriodAverageAUDMember 2019-06-30 0001713210 AATP:PeriodAverageAUDMember 2018-06-30 0001713210 AATP:AUDCurrencyMember 2018-07-01 2019-06-30 0001713210 AATP:AUDCurrencyMember 2017-07-01 2018-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:PhoenixPlusCorpMember us-gaap:CommonStockMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-06-30 0001713210 AATP:AgapeSEASdnBhdMember 2018-07-01 2019-06-30 0001713210 AATP:AgapeSEASdnBhdMember 2017-07-01 2018-06-30 0001713210 AATP:AgapeSEASdnBhdMember 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2018-07-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2017-07-01 2018-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2019-06-30 0001713210 AATP:GreenproCapitalCorporationMember 2018-07-01 2019-06-30 0001713210 AATP:GreenproCapitalCorporationMember 2017-07-01 2018-06-30 0001713210 AATP:GreenproCapitalCorporationMember 2019-06-30 0001713210 AATP:AgapeSuperiorLivingSdnBhdMember 2018-07-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingSdnBhdMember 2017-07-01 2018-06-30 0001713210 AATP:AgapeSuperiorLivingSdnBhdMember 2019-06-30 0001713210 AATP:AgapeATPAsiaLimitedMember 2018-07-01 2019-06-30 0001713210 AATP:AgapeATPAsiaLimitedMember 2017-07-01 2018-06-30 0001713210 AATP:AgapeATPAsiaLimitedMember 2019-06-30 0001713210 2018-12-31 0001713210 2020-03-25 0001713210 2019-12-31 0001713210 2018-07-01 2018-12-31 0001713210 2018-07-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2018-07-01 2018-12-31 0001713210 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-07-01 2019-12-31 0001713210 us-gaap:CommonStockMember 2018-12-31 0001713210 us-gaap:CommonStockMember 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2018-07-01 2018-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-07-01 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2018-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001713210 2019-01-01 2019-06-30 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2019-12-31 0001713210 AATP:SubsidiaryCompanyMember 2019-07-01 2019-12-31 0001713210 AATP:SubsidiaryCompanyMember 2019-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2019-07-01 2019-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2019-12-31 0001713210 srt:RestatementAdjustmentMember AATP:OtherPayablesAndAccruedLiabilitiesMember 2019-06-30 0001713210 srt:RestatementAdjustmentMember 2018-07-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2019-07-01 2019-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2019-07-01 2019-12-31 0001713210 AATP:IonizedCalMagMember 2019-07-01 2019-12-31 0001713210 AATP:OmegaBlendMember 2019-07-01 2019-12-31 0001713210 AATP:BetaMaxxMember 2019-07-01 2019-12-31 0001713210 AATP:IronMember 2019-07-01 2019-12-31 0001713210 AATP:YoungFormulaMember 2019-07-01 2019-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2019-07-01 2019-12-31 0001713210 AATP:EnergetiqueHyaluronicAcidSerumMember 2019-07-01 2019-12-31 0001713210 AATP:TrimPlusMember 2019-07-01 2019-12-31 0001713210 AATP:LipomaskMember 2019-07-01 2019-12-31 0001713210 AATP:SurvivorSelectMember 2018-07-01 2018-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2018-07-01 2018-12-31 0001713210 AATP:IonizedCalMagMember 2018-07-01 2018-12-31 0001713210 AATP:OmegaBlendMember 2018-07-01 2018-12-31 0001713210 AATP:BetaMaxxMember 2018-07-01 2018-12-31 0001713210 AATP:IronMember 2018-07-01 2018-12-31 0001713210 AATP:YoungFormulaMember 2018-07-01 2018-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2018-07-01 2018-12-31 0001713210 AATP:EnergetiqueHyaluronicAcidSerumMember 2018-07-01 2018-12-31 0001713210 AATP:TrimPlusMember 2018-07-01 2018-12-31 0001713210 AATP:LipomaskMember 2018-07-01 2018-12-31 0001713210 AATP:SurvivorSelectMember 2018-07-01 2019-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2018-07-01 2019-06-30 0001713210 AATP:IonizedCalMagMember 2018-07-01 2019-06-30 0001713210 AATP:OmegaBlendMember 2018-07-01 2019-06-30 0001713210 AATP:BetaMaxxMember 2018-07-01 2019-06-30 0001713210 AATP:IronMember 2018-07-01 2019-06-30 0001713210 AATP:YoungFormulaMember 2018-07-01 2019-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2018-07-01 2019-06-30 0001713210 AATP:EnergetiqueHyaluronicAcidSerumMember 2018-07-01 2019-06-30 0001713210 AATP:TrimPlusMember 2018-07-01 2019-06-30 0001713210 AATP:LipomaskMember 2018-07-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2017-07-01 2018-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2017-07-01 2018-06-30 0001713210 AATP:IonizedCalMagMember 2017-07-01 2018-06-30 0001713210 AATP:OmegaBlendMember 2017-07-01 2018-06-30 0001713210 AATP:BetaMaxxMember 2017-07-01 2018-06-30 0001713210 AATP:IronMember 2017-07-01 2018-06-30 0001713210 AATP:YoungFormulaMember 2017-07-01 2018-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2017-07-01 2018-06-30 0001713210 AATP:EnergetiqueHyaluronicAcidSerumMember 2017-07-01 2018-06-30 0001713210 AATP:TrimPlusMember 2017-07-01 2018-06-30 0001713210 AATP:LipomaskMember 2017-07-01 2018-06-30 0001713210 AATP:PeriodEndMYRMember 2019-12-31 0001713210 AATP:PeriodEndMYRMember 2018-12-31 0001713210 AATP:PeriodAverageMYRMember 2019-12-31 0001713210 AATP:PeriodAverageMYRMember 2018-12-31 0001713210 AATP:PeriodEndHKDMember 2019-12-31 0001713210 AATP:PeriodEndHKDMember 2018-12-31 0001713210 AATP:PeriodAverageHKDMember 2019-12-31 0001713210 AATP:PeriodAverageHKDMember 2018-12-31 0001713210 AATP:PeriodendAUDMember 2019-12-31 0001713210 AATP:PeriodendAUDMember 2018-12-31 0001713210 AATP:PeriodAverageAUDMember 2019-12-31 0001713210 AATP:PeriodAverageAUDMember 2018-12-31 0001713210 AATP:MYRCurrencyMember 2019-07-01 2019-12-31 0001713210 AATP:MYRCurrencyMember 2018-07-01 2018-12-31 0001713210 AATP:HKDCurrencyMember 2019-07-01 2019-12-31 0001713210 AATP:HKDCurrencyMember 2018-07-01 2018-12-31 0001713210 AATP:AUDCurrencyMember 2019-07-01 2019-12-31 0001713210 AATP:AUDCurrencyMember 2018-07-01 2018-12-31 0001713210 AATP:GreenproCapitalCorpMember 2019-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-12-31 0001713210 AATP:GreenproCapitalCorpMember 2019-07-01 2019-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-07-01 2019-06-30 0001713210 AATP:GreenproCapitalCorpMember 2017-07-01 2018-06-30 0001713210 srt:DirectorMember 2019-12-31 0001713210 srt:DirectorMember AATP:MYRCurrencyMember 2019-12-31 0001713210 srt:MaximumMember 2019-12-31 0001713210 srt:MinimumMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-12-31 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2018-12-31 0001713210 AATP:PhoenixPlusCorpMember 2019-12-31 0001713210 AATP:PhoenixPlusCorpMember 2018-12-31 0001713210 AATP:AgapeSEASdnBhdMember 2019-07-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2019-07-01 2019-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2019-07-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingSdnBhdMember 2019-07-01 2019-12-31 0001713210 AATP:GreenproCapitalCorpMember 2019-07-01 2019-12-31 0001713210 AATP:AgapeSEASdnBhdMember 2018-07-01 2018-12-31 0001713210 AATP:AgapeSEASdnBhdMember 2019-12-31 0001713210 AATP:AgapeSEASdnBhdMember 2018-12-31 0001713210 AATP:GreenproCapitalCorporationMember 2019-07-01 2019-12-31 0001713210 AATP:GreenproCapitalCorporationMember 2018-07-01 2018-12-31 0001713210 AATP:GreenproCapitalCorporationMember 2019-12-31 0001713210 AATP:GreenproCapitalCorporationMember 2018-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2018-07-01 2018-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2019-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2018-12-31 0001713210 country:US 2019-12-31 0001713210 country:US 2018-12-31 0001713210 country:US 2019-07-01 2019-12-31 0001713210 country:US AATP:IfUnutilizedMember 2019-07-01 2019-12-31 0001713210 AATP:LabuanMember 2019-07-01 2019-12-31 0001713210 country:HK 2019-07-01 2019-12-31 0001713210 AATP:LabuanMember 2018-07-01 2018-12-31 0001713210 country:HK 2018-07-01 2018-12-31 0001713210 AATP:OneCustomersMember 2019-07-01 2019-12-31 0001713210 AATP:OneCustomersMember 2018-07-01 2018-12-31 0001713210 AATP:OneCustomersMember 2018-07-01 2019-06-30 0001713210 AATP:OneCustomersMember 2017-07-01 2018-06-30 0001713210 AATP:OneCustomersMember us-gaap:AccountsReceivableMember 2019-07-01 2019-12-31 0001713210 AATP:OneCustomersMember us-gaap:AccountsReceivableMember 2018-07-01 2019-06-30 0001713210 AATP:TwoVendorMember 2019-07-01 2019-12-31 0001713210 us-gaap:AccountsPayableMember 2019-07-01 2019-12-31 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2018-07-01 2018-12-31 0001713210 AATP:TwoVendorMember 2018-07-01 2019-06-30 0001713210 AATP:OneVendorMember 2017-07-01 2018-06-30 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2019-07-01 2019-12-31 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2018-07-01 2019-06-30 0001713210 2019-06-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:MYR Agape ATP Corp 0001713210 10-K 2019-12-31 false --12-31 Accelerated Filer FY 2019 376275500

0.0001

200000000

1000000000

2500000

376275500

2500000

376275500

2500000

10. OTHER PAYABLES AND ACCRUED LIABILITIES   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Accrued professional fees</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">58,594</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">20,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">7,884</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Others</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">18,652</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">12,319</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total payables and accrued liabilities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">77,246</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">32,319</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">7,884</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

12. AMOUNT DUE TO A DIRECTOR   As of December 31, 2019, June 30, 2019 and December 31, 2018, a director of the Company advanced $3,952, $3,938 and $3,921 (unaudited), respectively, to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

8. RELATED PARTY TRANSACTIONS   The Company’s related party list and relationship are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 33%">Related parties</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 66%; text-align: justify">Relationships</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape S.E.A. Sdn Bhd</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape Superior Living Pty Ltd</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</td></tr> </table>      <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 33%">Agape Superior Living Sdn Bhd</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 66%; text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape ATP (Asia) Limited</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Greenpro Capital Corp.</td> <td style="text-align: justify"> </td> <td> Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan.   Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018. </td></tr> </table>   Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">As of</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Revenue</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Receivable, Trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Agape S.E.A. Sdn Bhd</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">429,362</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">685,288</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">520,786</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">          -</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Professional fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">4,500</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Amount due from a related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Agape ATP (Asia) Limited</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,217</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>    Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Years ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Revenue</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Receivable, Trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%">Agape S.E.A. Sdn Bhd</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">1,524,596</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">487,005</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">433,338</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">21,461</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,546,057</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">487,005</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">433,338</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Professional fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">12,000</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">214,883</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Company Secretarial fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">3,282</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">292</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">           -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">License fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">1,509</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Incorporation fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">1,419</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Amount due from A related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape Superior Living Sdn Bhd</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">745</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">        -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Amount due from A related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape ATP (Asia) limited</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">2,210</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">2,210</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Sundry purchases</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape Superior Living Pty Ltd</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">35,145</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">35,145</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> </table>

15. SUBSEQUENT EVENT   In December 2019, a novel strain of coronavirus (COVID-19) surfaced. The spread of COVID-19 around the world in the first quarter of 2020 has caused significant volatility in Malaysia. There is significant uncertainty around the breadth and duration of business disruptions related to COVID-19, as well as its impact on the Malaysia economies and, as such, the Company is unable to determine if it will have a material impact to its operations.

Basis of presentation   The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

Basis of consolidation   The consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.   Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

Use of estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for deferred tax assets and uncertain tax position, and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

Revenue recognition   On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.   The core principle underlying the revenue recognition of this ASU allows the Company to recognize- revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.   The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.   The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.   Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.   The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.   Sales of Health and Wellness products   - Performance obligations satisfied at a point in time   On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019. Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Historically, there were no sales return as the Company’s products sold are not refundable, returnable or exchangeable.   Disaggregated information of revenues by products are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%">Survivor Select</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">204,138</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">203,815</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">104,656</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Energized Mineral Concentrate</td> <td> </td> <td> </td> <td style="text-align: right">100,270</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">222,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">361,092</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">66,573</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Ionized Cal-Mag</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">55,731</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">43,124</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Omega Blend</td> <td> </td> <td> </td> <td style="text-align: right">68,927</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">97,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,999</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">68,561</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>BetaMaxx</td> <td> </td> <td> </td> <td style="text-align: right">67,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">87,793</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">211,280</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">126,191</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Iron</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,813</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,809</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">20,270</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Young Formula</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">117,480</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">57,630</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Organic Youth Care Cleansing Bar</td> <td> </td> <td> </td> <td style="text-align: right">17,206</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">17,751</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Energetique Hyaluronic Acid Serum</td> <td> </td> <td> </td> <td style="text-align: right">175,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Trim+</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">198,862</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Lipomask</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">70,585</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">211,238</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total revenues</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">429,362</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">685,288</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,546,057</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">487,005</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Cost of revenue   Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers

Cash and cash equivalents   Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

Income taxes   The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.   Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.   An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax.   The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Earnings (loss) per share   The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average common share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

Related parties   Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Fair value of financial instruments   The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.   The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</td></tr> </table>   Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

The United States and foreign components of income (loss) before income taxes were comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-indent: -10pt">Tax jurisdictions from:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 24%; padding-left: 10pt">- Local</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(279,476</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(33,977</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(76,309</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(261,918</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">- Foreign - Labuan</td> <td> </td> <td> </td> <td style="text-align: right">(4,174</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(45,576</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(2,777</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">134,806</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign – Hong Kong</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(55,281</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(55,928</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(440,556</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,172</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Loss before income tax</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(338,931</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(135,481</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(519,642</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(124,940</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>

The provision for income taxes consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Current:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">- Local</td> <td> </td> <td>$</td> <td style="text-align: right">          -</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> $</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%; padding-left: 10pt">- Foreign</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">6,965</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">5,334</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deferred:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">- Local</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">- Foreign</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Income tax expense</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">6.965</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">5,334</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred tax assets:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 43%">Net operating loss carry forwards in U.S.</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">150,759</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">92,069</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">82,970</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Less: valuation allowance</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(150,759</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(92,069</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(82,970</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Deferred tax asset</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Accrued professional fees</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">58,594</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">20,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">7,884</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Others</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">18,652</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">12,319</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total payables and accrued liabilities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">77,246</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">32,319</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">7,884</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> As of and for the six months ended December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">As of and for the year ended June 30,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify">Period-end MYR : US$1 exchange rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.09</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.14</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.13</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.03</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average MYR : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">4.16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.21</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.79</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.81</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.43</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.46</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> </table>

724619

734195

45883

45596

65933

109352

5334

6965

-338931

-130274

-142446

-519642

-142446

-377196

-338931

-377196

-0.00

0.00

-0.00

0.00

376275500

373017955

376275500

5098781

2304648

37628

5293082

-230636

4580353

37628

5293082

-750278

37135

2367875

-100362

-1293

-79

4956334

4251286

37628

5293082

-373082

-1089209

-1294

9785

3938

3921

3952

383479

441409

619355

1436705

5. CASH AND CASH EQUIVALENTS   As of December 31, 2019, June 30, 2019 and December 31, 2018, the Company recorded $2,744,457, $2,857,587, and $3,452,917 (unaudited), respectively, of cash and cash equivalents, which consists $238,937, $353,214, and $990,323 (unaudited), respectively, of cash in bank and $2,505,520, $2,504,373 and $2,462,594 (unaudited), respectively, of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum.

7. PREPAYMENTS AND DEPOSITS   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Prepaid expenses</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">2,641</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">21,081</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">2,702</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Deposits to supplier</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">266,552</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">477,254</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">507,367</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total prepaid expenses and deposits</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">269,193</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">498,335</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">510,069</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Cost of investment</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">134,166</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">501,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">501,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Less: Impairment in cost of investment</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(366,834</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: Unrealized holding loss</td> <td> </td> <td> </td> <td style="text-align: right">(68,391</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Exchange rate effect</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">709</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Investment in marketable securities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">134,166</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">501,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Investment in marketable equity securities   Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.   On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

Selling, general and administrative expenses   Selling, general and administrative expenses are primarily comprised of rental of office premises, travelling, licensing and professional fees.

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Prepaid expenses</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">2,641</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">21,081</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">2,702</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Deposits to supplier</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">266,552</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">477,254</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">507,367</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total prepaid expenses and deposits</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">269,193</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">498,335</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">510,069</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Details of the Company’s subsidiaries:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Subsidiary company name</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Place and date of incorporation</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Particulars of issued capital</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Principal activities</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Proportional of ownership interest and voting power held</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 5%">1. </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 30%">Agape ATP Corporation</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: center">Labuan, March 6, 2017</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 16%; text-align: center">100 shares of ordinary share of US$1 each</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: center">Investment holding</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: right">100</td> <td style="vertical-align: top; width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top">2. </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top">Agape ATP International Holding Limited </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">Hong Kong, June 1, 2017 </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">1,000,000 shares of ordinary share of HK$1 each </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">Health and wellness products and health solution advisory services</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: right">100</td> <td style="vertical-align: top">%</td></tr> </table>

0.03

1.00

0.0001

2790

312270

279682

63068

240522

Foreign currencies translation and transaction   Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.   The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency.   In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.   Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> As of and for the six months ended December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">As of and for the year ended June 30,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify">Period-end MYR : US$1 exchange rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.09</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.14</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.13</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.03</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average MYR : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">4.16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.21</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.79</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.81</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.43</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.46</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> </table>

134166

501000

66484

501000

Accounts receivable – related party   Accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2019, June 30, 2019 and December 31, 2018, all of the Company’s accounts receivable balance are due from a related party, as a result, no valuation allowance was made.

3. INVESTMENT IN MARKETABLE SECURITIES   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 14px"> </td> <td style="width: 34px; text-align: justify">(i)</td> <td style="text-align: justify">On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify">(ii)</td> <td style="text-align: justify">On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Cost of investment</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">134,166</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">501,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">501,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Less: Impairment in cost of investment</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(366,834</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: Unrealized holding loss</td> <td> </td> <td> </td> <td style="text-align: right">(68,391</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Exchange rate effect</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">709</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Investment in marketable securities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">66,484</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">134,166</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">501,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> true true false

-338931

-124940

-135481

-519642

9864

-1293

-1

1214

3531255

2312748

2857587

3452917

2744457

376275500

371350000

376275500

1. ORGANIZATION AND BUSINESS BACKGROUND   Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.   Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.   Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.   The Company and its subsidiaries provide health and wellness products and advisory services to the public. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.   Details of the Company’s subsidiaries:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Subsidiary company name</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> Place and date of incorporation</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Particulars of issued capital</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Principal activities</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Proportional of ownership interest and voting power held</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 5%">1. </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 30%">Agape ATP Corporation</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: center">Labuan, March 6, 2017</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 16%; text-align: center">100 shares of ordinary share of US$1 each</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: center">Investment holding</td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; width: 14%; text-align: right">100</td> <td style="vertical-align: top; width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top">2. </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top">Agape ATP International Holding Limited </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">Hong Kong, June 1, 2017 </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">1,000,000 shares of ordinary share of HK$1 each </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: center">Health and wellness products and health solution advisory services</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: top; text-align: right">100</td> <td style="vertical-align: top">%</td></tr> </table>   Business Overview   Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.   At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. As a strong advocator of “beauty from within”, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.   The ATP Zeta Super Health Program consists of eight products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron and YFA-Young Formula.   At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.   As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.

-329067

-131567

-142447

-518428

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.   Basis of presentation   The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).   Change of year end   As of December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements consist of a six-month transition period ended December 31, 2019 and 2018 (unaudited), and the fiscal years ended June 30, 2019 and 2018.   Basis of consolidation   The consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.   Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.   Use of estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for deferred tax assets and uncertain tax position, and impairment of investment in non-marketable securities. Actual results could differ from these estimates.   Cash and cash equivalents   Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.   Accounts receivable – related party   Accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2019, June 30, 2019 and December 31, 2018, all of the Company’s accounts receivable balance are due from a related party, as a result, no valuation allowance was made.   Prepayments and deposits   Prepayments and deposits are cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.   Investment in investee company   The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Entities in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the Board of Directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Dividends received from the equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence.    Investment in marketable equity securities   Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.   On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.   Investment in non-marketable equity securities   Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.   On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.   At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.    Revenue recognition   On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.   The core principle underlying the revenue recognition of this ASU allows the Company to recognize- revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.   The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.   The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.   Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.   The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.   Sales of Health and Wellness products   - Performance obligations satisfied at a point in time   On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019. Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Historically, there were no sales return as the Company’s products sold are not refundable, returnable or exchangeable.   Disaggregated information of revenues by products are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%">Survivor Select</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">204,138</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">203,815</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">104,656</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Energized Mineral Concentrate</td> <td> </td> <td> </td> <td style="text-align: right">100,270</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">222,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">361,092</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">66,573</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Ionized Cal-Mag</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">55,731</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">43,124</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Omega Blend</td> <td> </td> <td> </td> <td style="text-align: right">68,927</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">97,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,999</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">68,561</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>BetaMaxx</td> <td> </td> <td> </td> <td style="text-align: right">67,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">87,793</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">211,280</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">126,191</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Iron</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,813</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,809</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">20,270</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Young Formula</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">117,480</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">57,630</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Organic Youth Care Cleansing Bar</td> <td> </td> <td> </td> <td style="text-align: right">17,206</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">17,751</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Energetique Hyaluronic Acid Serum</td> <td> </td> <td> </td> <td style="text-align: right">175,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Trim+</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">198,862</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Lipomask</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">70,585</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">211,238</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total revenues</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">429,362</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">685,288</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,546,057</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">487,005</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Cost of revenue   Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers   Selling, general and administrative expenses   Selling, general and administrative expenses are primarily comprised of rental of office premises, travelling, licensing and professional fees.    Income taxes   The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.   Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.   An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax.   The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.   Comprehensive income (loss)   Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.   Earnings (loss) per share   The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average common share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.    Foreign currencies translation and transaction   Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.   The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency.   In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.   Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> As of and for the six months ended December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">As of and for the year ended June 30,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify">Period-end MYR : US$1 exchange rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.09</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.14</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.13</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">4.03</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average MYR : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">4.16</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">4.21</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.79</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.81</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average HKD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">7.83</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7.84</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Period-end AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.43</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Period-average AUD : US$1 exchange rate</td> <td> </td> <td> </td> <td style="text-align: right">1.46</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> </table>   Related parties   Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.    Fair value of financial instruments   The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.   The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</td></tr> </table>   Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.   Operating leases   A lease for which substantially all the benefits and risks incidental to ownership remain with the lessor is classified by the lessee as an operating lease. All leases of the Company are currently classified as operating leases. The Company records the total expenses on a straight-line basis over the lease term.   Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. The Company adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019   Recent accounting pronouncements   The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:   In July 2017, the FASB Issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815). The amendments in Part I of the Update change the reclassification analysis of certain equity-lined financial instruments (or embedded features) with down round features. The amendments in Part II of this Update re-characterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020.   Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.   In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement – Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.   In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact of ASU 2018-13 will have on its consolidated financial statements.   In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.    In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.   Reclassification   Certain prior year amounts have been reclassified to conform to the current year presentation, such as reclassifying $366,834 impairment in cost of investments from selling, general and administrative expenses to other income (expenses) for the year ended June 30, 2019, reclassifying accounts receivable – related party of $78,272 as of June 30, 2019 to be net against other payables and accrued liabilities, and reclassifying cash inflows of $78,272 from changes in other payables and accrued liabilities to accounts receivable – related party for the year ended June 30, 2019. These reclassifications have no effect on the reported revenues, net loss or total assets.

Recent accounting pronouncements   The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:   In July 2017, the FASB Issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815). The amendments in Part I of the Update change the reclassification analysis of certain equity-lined financial instruments (or embedded features) with down round features. The amendments in Part II of this Update re-characterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020.   Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.   In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement – Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.   In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact of ASU 2018-13 will have on its consolidated financial statements.   In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.    In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.

Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">As of</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Revenue</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Receivable, Trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Agape S.E.A. Sdn Bhd</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">429,362</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">685,288</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">520,786</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">          -</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Professional fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">4,500</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Amount due from a related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Agape ATP (Asia) Limited</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,217</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>    Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Years ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Revenue</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Accounts Receivable, Trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%">Agape S.E.A. Sdn Bhd</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">1,524,596</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">487,005</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">433,338</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Agape Superior Living Pty Ltd</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">21,461</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,546,057</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">487,005</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">433,338</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Professional fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">12,000</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">214,883</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Company Secretarial fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">3,282</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">292</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">           -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">License fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">1,509</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Incorporation fee</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Greenpro Capital Corp.</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">1,419</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">          -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Amount due from A related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape Superior Living Sdn Bhd</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">745</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">        -</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Expenses paid on behalf</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Amount due from A related party</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape ATP (Asia) limited</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">2,210</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">2,210</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Sundry purchases</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Accounts Payable, Non-trade</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 47%; padding-bottom: 2.5pt">Agape Superior Living Pty Ltd</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">35,145</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right">-</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right">35,145</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td></tr> </table>

11. INCOME TAXES   The United States and foreign components of income (loss) before income taxes were comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-indent: -10pt">Tax jurisdictions from:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 24%; padding-left: 10pt">- Local</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(279,476</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(33,977</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(76,309</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">(261,918</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">- Foreign - Labuan</td> <td> </td> <td> </td> <td style="text-align: right">(4,174</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(45,576</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(2,777</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">134,806</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">- Foreign – Hong Kong</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(55,281</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(55,928</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(440,556</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,172</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Loss before income tax</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(338,931</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(135,481</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(519,642</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(124,940</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>    The provision for income taxes consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Current:</td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">- Local</td> <td> </td> <td>$</td> <td style="text-align: right">          -</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> $</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%; padding-left: 10pt">- Foreign</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">6,965</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">5,334</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Deferred:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">- Local</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">- Foreign</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-indent: -10pt">Income tax expense</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">6.965</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">5,334</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:   United States of America   Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of December 31, 2019, June 30, 2019 and December 31, 2018, the operations in the United States of America incurred $717,901, $438,426, and $395,095 (unaudited), respectively, of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2037 and ending in 2039, if unutilized. The tax valuation allowance as of December 31, 2019, June 30, 2019 and December 31, 2018 are $150,759, $92,069 and $82,970 (unaudited), respectively.   Labuan   Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit. Due to Agape ATP Corporation is a holding company, it did not generate any income nor incurred any income tax. In addition, its related expenses incurred cannot be carried forward to offset any future operation income.   Hong Kong   Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.    The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%">U.S. statutory rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Valuation allowance</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Permanent difference (1)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.0</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(5.1</td> <td style="padding-bottom: 1.5pt">)%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.0</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(4.3</td> <td style="padding-bottom: 1.5pt">)%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Effective tax rate</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">0.0</td> <td style="padding-bottom: 2.5pt">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.1</td> <td style="padding-bottom: 2.5pt">)%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">0.0</td> <td style="padding-bottom: 2.5pt">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(4.3</td> <td style="padding-bottom: 2.5pt">)%</td></tr> </table>   (1) This was related to disallowed expenditure incurred in the ordinary course of business.   The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Deferred tax assets:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 43%">Net operating loss carry forwards in U.S.</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">150,759</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">92,069</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">82,970</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Less: valuation allowance</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(150,759</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(92,069</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(82,970</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Deferred tax asset</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

13. CONCENTRATIONS OF RISKS   (a) Major customers   For the six months ended December 31, 2019 and 2018, one customer accounted for 100% of the Company’s total revenues. For the years ended June 30, 2019 and 2018, one customer accounted for approximately 99% and 100% of the Company’s total revenues, respectively.   As of December 31, 2019, and June 30, 2019, one customer accounted for 100% of the total balance of accounts receivable.    (b) Major vendors   For the six months ended December 31, 2019, two vendors accounted for approximately 59% and 41% of the Company’s total purchases, respectively. For the six months ended December 31, 2018, one vendor accounted for approximately 89% of the Company’s total purchases. For the year ended June 30, 2019, two vendors accounted for approximately 71% and 26% of the Company’s total purchases. For the year ended June 30, 2018, one vendor accounted for 100% of the Company’s total purchases.   As of December 31, 2019 and June 30, 2019, one vendor accounted for 100% of the total balance of accounts payable.   (c) Credit risk   Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.   (d) Exchange rate risk   The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

9864

-1293

-1

1215

9864

1215

Investment in non-marketable equity securities   Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.   On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.   At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount. 4. INVESTMENT IN NON-MARKETABLE SECURITIES   The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.   Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.   On March 2, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company.   On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Unreserved Sdn Bhd</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Cost of investment</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">832,335</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">832,335</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Less: loss of equity of investee company</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(124,225</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(98,140</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Add: gain on deemed disposal of shares in investee company</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">16,509</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Investment in investee company</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">724,619</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">734,195</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Reclassify to investment in non-marketable securities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(724,619</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Investment in investee company</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Investment in non-marketable securities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">730,637</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">724,619</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Phoenix Plus Corporation</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Cost of investment</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total investment in non-marketable securities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">732,137</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">726,119</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid">Unreserved Sdn Bhd</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Cost of investment</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">832,335</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">832,335</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Less: loss of equity of investee company</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">(124,225</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(98,140</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Add: gain on deemed disposal of shares in investee company</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">16,509</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Investment in investee company</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">724,619</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">734,195</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Reclassify to investment in non-marketable securities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(724,619</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Investment in investee company</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Investment in non-marketable securities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">730,637</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">724,619</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Phoenix Plus Corporation</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Cost of investment</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,500</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total investment in non-marketable securities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">732,137</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">726,119</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table> Yes Yes false 726119 724619 732137 730637

2857587

3452917

2744457

498335

510069

269193

2210

2217

3791470

3962986

3536653

4651755

5198181

4335274

32319

7884

77246

71402

241847

83988

71402

241847

83988

37628

5293082

-79

-1294

9785

-750278

-373082

-1089209

4651755

5198181

4335274

-229638

264941

245128

233394

2210

2778

44867

11749

-11865

11825

-113945

-347977

-76591

-667064

815

-1293

-2

1214

-113130

1218507

-78338

-673668

6. ACCOUNTS RECEIVABLE – RELATED PARTY   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Accounts receivable – related party</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">520,786</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">433,338</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">             -</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Allowance for doubtful accounts</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total accounts receivables – related party</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">520,786</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">433,338</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Investment in investee company   The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Entities in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the Board of Directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Dividends received from the equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence.

9. STOCKHOLDERS’ EQUITY   Preferred stock   As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 200,000,000 preferred shares authorized but none were issued and outstanding.   Common stock   As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 376,275,500 of common stocks issued and outstanding.   There were no stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018.

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> As of December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%">Accounts receivable – related party</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">520,786</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">433,338</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">             -</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Allowance for doubtful accounts</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total accounts receivables – related party</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">520,786</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">433,338</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

0.05

1.00

0.20

0.200

0.1786

Agape ATP Corporation Agape ATP International Holding Limited Labuan, March 6, 2017 Hong Kong, June 1, 2017 100 shares of ordinary share of US$1 each 1,000,000 shares of ordinary share of HK$1 each Investment holding Health and wellness products and health solution advisory services

Greater than 50%

4.13

4.03

4.13

4.21

7.81

7.84

1.42

4.09

4.14

4.16

4.13

7.79

7.83

7.84

1.43

1.46

500000

1000

501000

1500

832335

1500

134166

501000

863592

3500000

730637

832335

1500

83333

33333

300000000

15000000

-124225 -98140

16509

-724619

353214

990323

238937

2504373

2462594

2505520

0.0325

0.0295

21081

2702

2641

477254 507367 266552 Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited. Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd Greenpro Capital Corp., through its wholly owned subsidiaries (collectively "Greenpro"), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

20000

7884

58594

12319

18652

438426

717901

395095

2037 2039

0.000

-0.043

-0.051

0.000

0.03

0.210

0.165

-279476

-261918

-33977

-76309

-2777

-440556

2172

134806

-4174

-55281

-45576

-55928

5334

6965

92069

82970

150759

92069

82970

150759

82970

0.26

1.00

0.99

1.00

0.59

0.41

0.89

0.71

1.00

433338

520786

429362

487005

1524596

487005

21461

685288

1546057

100270

68927

67789

17206

175170

204138

222789

97170

87793

2813

70585

203815

361092

55731

165999

211280

2809

117480

17751

198862

211238

104656

66573

43124

68561

126191

20270

57630

429362

685288

The Company’s related party list and relationship are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 33%">Related parties</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 66%; text-align: justify">Relationships</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape S.E.A. Sdn Bhd</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape Superior Living Pty Ltd</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</td></tr> </table>      <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 33%">Agape Superior Living Sdn Bhd</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 66%; text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Agape ATP (Asia) Limited</td> <td style="text-align: justify"> </td> <td style="text-align: justify">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td>Greenpro Capital Corp.</td> <td style="text-align: justify"> </td> <td> Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan.   Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018. </td></tr> </table>

35145

745

2210

366834 No No 804186900

433338

520786

78272

520786

734195

860285

1235195

798621

35145

12299

-266387

-234086

2865

-131170

-4153 139301 -40206 86078

-68391

68391

16509

-366834

-72544

109146

-138346

-388472

2925500

293

2925207

2925500

200

2000000

5334

-35086

35145

78272

6965

-862490

-1362490

-1000

-2500

493

2925207

745

-745

3822 -5318

2930267

-745

-5318

724619

14. COMMITMENTS AND CONTINGENCIES   Lease commitments   The Company has entered into an operating lease agreement for an office in Hong Kong. The Company’s commitment for minimum lease payments under these operating leases as of December 31, 2019 for the next two years is as follow:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Twelve months ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Minimum lease payment</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 69%">2020</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 28%; text-align: right">17,973</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Thereafter</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total minimum payments required</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">17,973</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Rent expense for the six months ended December 31, 2019 and 2018 was $26,828 and $8,932 (Unaudited), respectively. Rent expense for the years ended June 30, 2019 and 2018 was $35,706 and $0, respectively    Purchase commitments   The total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2019 for the next five years and thereafter is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Twelve months ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Minimum purchase</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%">2020</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 21%; text-align: right">693,900</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2021</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>2022</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2023</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>2024</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Thereafter</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,081,700</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total minimum purchase commitments required</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">5,551,200</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   As of the date of this report, the Company’s vendor is not able to meet the Company’s minimum purchase commitment of the health and wellness products due to the manufacturing process was being delayed by its vendor.   Contingencies   From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

709

433338

520786

12000

214883

4500

35145

2210

2217

3282 292 1509 1419

-0.210

0.000

-0.043

-0.051

0.000

P2Y

26828

8932

35706

17973

693900

2081700

5551200

-366834 -30155 -98140 -124225 Change of year end   As of December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements consist of a six-month transition period ended December 31, 2019 and 2018 (unaudited), and the fiscal years ended June 30, 2019 and 2018. Prepayments and deposits   Prepayments and deposits are cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.

Comprehensive income (loss)   Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

Operating leases   A lease for which substantially all the benefits and risks incidental to ownership remain with the lessor is classified by the lessee as an operating lease. All leases of the Company are currently classified as operating leases. The Company records the total expenses on a straight-line basis over the lease term.   Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. The Company adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019

Reclassification   Certain prior year amounts have been reclassified to conform to the current year presentation, such as reclassifying $366,834 impairment in cost of investments from selling, general and administrative expenses to other income (expenses) for the year ended June 30, 2019, reclassifying accounts receivable – related party of $78,272 as of June 30, 2019 to be net against other payables and accrued liabilities, and reclassifying cash inflows of $78,272 from changes in other payables and accrued liabilities to accounts receivable – related party for the year ended June 30, 2019. These reclassifications have no effect on the reported revenues, net loss or total assets.

Disaggregated information of revenues by products are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%">Survivor Select</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">204,138</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">203,815</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">104,656</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Energized Mineral Concentrate</td> <td> </td> <td> </td> <td style="text-align: right">100,270</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">222,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">361,092</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">66,573</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Ionized Cal-Mag</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">55,731</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">43,124</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Omega Blend</td> <td> </td> <td> </td> <td style="text-align: right">68,927</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">97,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,999</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">68,561</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>BetaMaxx</td> <td> </td> <td> </td> <td style="text-align: right">67,789</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">87,793</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">211,280</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">126,191</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Iron</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,813</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,809</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">20,270</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Young Formula</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">117,480</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">57,630</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Organic Youth Care Cleansing Bar</td> <td> </td> <td> </td> <td style="text-align: right">17,206</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">17,751</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Energetique Hyaluronic Acid Serum</td> <td> </td> <td> </td> <td style="text-align: right">175,170</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Trim+</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">198,862</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Lipomask</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">70,585</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">211,238</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total revenues</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">429,362</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">685,288</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,546,057</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">487,005</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the six months ended</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the years ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2018</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%">U.S. statutory rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">21.0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Valuation allowance</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td> <td> </td> <td> </td> <td style="text-align: right">(21.0</td> <td>)%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Permanent difference (1)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.0</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(5.1</td> <td style="padding-bottom: 1.5pt">)%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">0.0</td> <td style="padding-bottom: 1.5pt">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(4.3</td> <td style="padding-bottom: 1.5pt">)%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Effective tax rate</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">0.0</td> <td style="padding-bottom: 2.5pt">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(5.1</td> <td style="padding-bottom: 2.5pt">)%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">0.0</td> <td style="padding-bottom: 2.5pt">%</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">(4.3</td> <td style="padding-bottom: 2.5pt">)%</td></tr> </table>

The Company has entered into an operating lease agreement for an office in Hong Kong. The Company’s commitment for minimum lease payments under these operating leases as of December 31, 2019 for the next two years is as follow:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Twelve months ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Minimum lease payment</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 69%">2020</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 28%; text-align: right">17,973</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Thereafter</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total minimum payments required</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">17,973</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Purchase commitments   The total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2019 for the next five years and thereafter is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Twelve months ending December 31,</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Minimum purchase</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 76%">2020</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 21%; text-align: right">693,900</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2021</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>2022</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>2023</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>2024</td> <td> </td> <td> </td> <td style="text-align: right">693,900</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Thereafter</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">2,081,700</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total minimum purchase commitments required</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">5,551,200</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

85602

433338

500000

1000

1500 217743 217743 This was related to disallowed expenditure incurred in the ordinary course of business.

EX-101.SCH 24 aatp-20191231.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Organization and Business Background link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Investment in Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Investment In Non-Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accounts Receivables - Related Party link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Prepayments and Deposits link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Other Payables and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Amount Due to a Director link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Concentrations of Risks link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Organization and Business Background (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Investment in Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Investment In Non-Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Accounts Receivables - Related Party (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Prepayments and Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Other Payables and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Organization and Business Background (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Dis-aggregated Information of Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Investment in Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Investment in Non-Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Cash and Cash Equivalents (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Accounts Receivables - Related Party - Schedule of Accounts Receivables - Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Related Party Transactions - Schedule of Related Parties Relationships (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Amount Due to a Director (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Concentrations of Risks (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Commitments and Contingencies - Schedule of Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Commitments and Contingencies - Schedule of Purchase Commitments (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 25 aatp-20191231_cal.xml XBRL CALCULATION FILE EX-101.DEF 26 aatp-20191231_def.xml XBRL DEFINITION FILE EX-101.LAB 27 aatp-20191231_lab.xml XBRL LABEL FILE Geographical [Axis] United States of America [Member] Labuan [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Legal Entity [Axis] Greenpro Capital Corp. [Member] Variable Rate [Axis] Period-end MYR [Member] Period-average MYR [Member] Period-end HKD [Member] Period-average HKD [Member] Award Type [Axis] MYR Currency [Member] HKD Currency [Member] Hong Kong [Member] Extinguishment of Debt [Axis] Accounts Payable [Member] Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] Period-end AUD [Member] Period-average AUD [Member] AUD Currency [Member] Phoenix Plus Corporation [Member] Title of Individual [Axis] Directors of Unreserved Investments [Member] Related Party [Axis] Agape S.E.A. Sdn Bhd [Member] Agape Superior Living Pty Ltd [Member] Greenpro Capital Corporation [Member] Agape Superior Living Sdn Bhd [Member] Agape ATP (Asia) Limited [Member] Consolidated Entities [Axis] Agape ATP International Holding Limited [Member] Subsidiary Company [Member] Subsidiary Company One [Member] Restatement [Axis] Reclassification [Member] Balance Sheet Location [Axis] Other Payables and Accrued Liabilities [Member] Product and Service [Axis] Survivor Select [Member] Energized Mineral Concentrate [Member] Ionized Cal-Mag [Member] Omega Blend [Member] BetaMaxx [Member] Iron [Member] Young Formula [Member] Organic Youth Care Cleansing Bar [Member] Energetique Hyaluronic Acid Serum [Member] Trim+ [Member] Lipomask [Member] Director [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Mr. How Kok Choong [Member] Greenpro Capital Corp [Member] Scenario [Axis] If Unutilized [Member] Customer [Axis] One Customer [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Two Vendor [Member] One Vendor [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filer Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable - related party Amount due from a related party Prepayments and deposits Total Current Assets OTHER ASSETS Investment in investee company Investment in marketable securities Investment in non-marketable securities Total other assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable Accounts payable - related party Customer deposits Income tax payable Other payables and accrued liabilities Amount due to a director Total Current Liabilities TOTAL LIABILITIES STOCKHOLDERS' EQUITY Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 issued and outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018 Additional paid in capital Accumulated deficit Accumulated other comprehensive loss TOTAL STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE - RELATED PARTY COST OF REVENUE GROSS PROFIT SELLING, GENERAL AND ADMINISTRATIVE EXPENSES INCOME (LOSS) FROM OPERATIONS OTHER INCOME/(EXPENSES) Other Income/(Expenses), Net Loss from equity investment Unrealized holding loss on marketable securities Gain on deemed disposal of shares in Investee Company Impairment loss in equity investment TOTAL OTHER INCOME/(EXPENSES), NET NET LOSS BEFORE INCOME TAXES PROVISION FOR INCOME TAXES NET LOSS OTHER COMPREHENSIVE INCOME (LOSS) Foreign currency translation adjustment COMPREHENSIVE LOSS NET LOSS PER SHARE Basic and diluted WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Net loss IPO completed on March 9, 2018 at $1.00 per share IPO completed on March 9, 2018 at $1.00 per share, shares Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share, shares Foreign currency translation adjustment Balance Balance, shares Statement of Stockholders' Equity [Abstract] Shares issued, price per share Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Loss from equity investment Unrealized holding loss on marketable securities Gain on deemed disposal of shares in Investee Company Impairment in cost of investment Deferred tax expenses Changes in operating assets and liabilities: Accounts receivable - related party Amount due from a related party Prepayments and deposits Accounts payable Accounts payable - related party Customer deposits Income taxes payable Other payables and accrued liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Investment in Investee Company Investment in marketable securities Investment in non-marketable securities Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Increase in share capital Proceeds from sale of common stock Amount due to a related party Amount due to a director Net cash (used in) provided by financing activities EX-101.PRE 28 aatp-20191231_pre.xml XBRL PRESENTATION FILE XML 29 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 R13.htm IDEA: XBRL DOCUMENT

Accounts Receivables - Related Party

6 Months Ended

Dec. 31, 2019

Receivables [Abstract]

Accounts Receivables - Related Party

6. ACCOUNTS RECEIVABLE – RELATED PARTY

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accounts receivable – related party	$	520,786	$	433,338	$	-
Allowance for doubtful accounts		-		-		-
Total accounts receivables – related party	$	520,786	$	433,338	$	-

XML 31 R17.htm IDEA: XBRL DOCUMENT

Other Payables and Accrued Liabilities

6 Months Ended

Dec. 31, 2019

Other Liabilities Disclosure [Abstract]

Other Payables and Accrued Liabilities

10. OTHER PAYABLES AND ACCRUED LIABILITIES

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accrued professional fees	$	58,594	$	20,000	$	7,884
Others		18,652		12,319		-
Total payables and accrued liabilities	$	77,246	$	32,319	$	7,884

XML 32 R38.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Period-end MYR [Member]
Foreign Currency Exchange Rate, Translation	4.09	4.13	4.14	4.03
Period-average MYR [Member]
Foreign Currency Exchange Rate, Translation	4.16	4.13	4.13	4.21
Period-end HKD [Member]
Foreign Currency Exchange Rate, Translation	7.79	7.81	7.83
Period-average HKD [Member]
Foreign Currency Exchange Rate, Translation	7.83	7.84	7.84
Period-end AUD [Member]
Foreign Currency Exchange Rate, Translation	1.43	1.42
Period-average AUD [Member]
Foreign Currency Exchange Rate, Translation	1.46	1.42

XML 33 R34.htm IDEA: XBRL DOCUMENT

Organization and Business Background (Details Narrative)	Dec. 31, 2019
Agape ATP International Holding Limited [Member]
Ownership percentage	100.00%

XML 34 R30.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Tables)

6 Months Ended

Dec. 31, 2019

The Company’s related party list and relationship are as follows:

Related parties		Relationships

Agape S.E.A. Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd

Agape Superior Living Pty Ltd		Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

Agape Superior Living Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd

Agape ATP (Asia) Limited		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

Greenpro Capital Corp.		Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

Schedule of Related Party Transactions

Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:

	For the six months ended				As of
	December 31, 2019		December 31, 2018		December 31, 2019		December 31, 2018
			(Unaudited)				(Unaudited)
	Revenue				Accounts Receivable, Trade

Agape S.E.A. Sdn Bhd	$	429,362	$	685,288	$	520,786	$	-

	Professional fee				Accounts Payable, Non-trade

Greenpro Capital Corp.	$	-	$	4,500	$	-	$	-

	Expenses paid on behalf				Amount due from a related party

Agape ATP (Asia) Limited	$	-	$	-	$	2,217	$	-

Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:

	Years ended				As of
	June 30, 2019		June 30, 2018		June 30, 2019
	Revenue				Accounts Receivable, Trade
Agape S.E.A. Sdn Bhd	$	1,524,596	$	487,005	$	433,338
Agape Superior Living Pty Ltd		21,461		-		-
Total	$	1,546,057	$	487,005	$	433,338

Professional fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

12,000

214,883

Company Secretarial fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

3,282

292

License fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,509

Incorporation fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,419

Expenses paid on behalf

Amount due from

A related party

Agape Superior Living Sdn Bhd

745

Expenses paid on behalf

Amount due from

A related party

Agape ATP (Asia) limited

2,210

Sundry purchases

Accounts Payable,

Non-trade

Agape Superior Living Pty Ltd

35,145

XML 35 R51.htm IDEA: XBRL DOCUMENT

Income Taxes (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
Income Taxes (Details Narrative) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Valuation allowance	$ 150,759	$ 82,970	$ 92,069
Tax percentage	0.00%	(5.10%)	0.00%	(4.30%)
Statutory income tax rate	21.00%	21.00%	21.00%	21.00%
United States of America [Member]
Cumulative net operating loss	$ 717,901	$ 395,095	$ 438,426
Operating loss carryforwards expire year	2037
Valuation allowance	$ 150,759	$ 82,970	$ 92,069
United States of America [Member] \| If Unutilized [Member]
Operating loss carryforwards expire year	2039
Labuan [Member]
Tax percentage	3.00%
Hong Kong [Member]
Statutory income tax rate	16.50%

XML 36 R55.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 150,759	$ 92,069	$ 82,970
Less: valuation allowance	(150,759)	(92,069)	(82,970)
Deferred tax asset

XML 37 R59.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Lease Commitments (Details)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2020	$ 17,973
Thereafter
Total minimum payments required	$ 17,973

XML 39 R48.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue	$ 429,362	$ 685,288	$ 1,546,057	$ 487,005
Accounts Receivable, Trade	520,786		433,338
Agape S.E.A. Sdn Bhd [Member]
Revenue	429,362	685,288	1,524,596	487,005
Accounts Receivable, Trade	520,786		433,338
Greenpro Capital Corporation [Member]
Professional fee		4,500	12,000	214,883
Accounts Payable, Non-trade
Company Secretarial fee			3,282	292
License fee			1,509
Incorporation fee				1,419
Agape ATP (Asia) Limited [Member]
Expenses paid on behalf			2,210
Amount due from a related party	$ 2,217		2,210
Agape Superior Living Pty Ltd [Member]
Revenue			21,461
Accounts Receivable, Trade
Accounts Payable, Non-trade			35,145
Sundry Purchases			35,145
Agape Superior Living Sdn Bhd [Member]
Expenses paid on behalf				$ 745
Amount due from a related party

XML 40 R44.htm IDEA: XBRL DOCUMENT

Cash and Cash Equivalents (Details Narrative) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Cash and cash equivalents	$ 2,744,457	$ 2,857,587	$ 3,452,917
Cash on hand	238,937	353,214	990,323
Time deposits	$ 2,505,520	$ 2,504,373	$ 2,462,594
Minimum [Member]
Percentage of Interest rate for time deposits	2.95%
Maximum [Member]
Percentage of Interest rate for time deposits	3.25%

XML 41 R40.htm IDEA: XBRL DOCUMENT

Investment in Marketable Securities (Details Narrative) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018	Oct. 16, 2018	May 17, 2018	Apr. 16, 2018	Mar. 09, 2018
Purchased price per shares						$ 0.0001	$ 1.00
Greenpro Capital Corp. [Member]
Investment in securities, shares				33,333	83,333
Investment amount	$ 134,166	$ 501,000	$ 501,000	$ 1,000	$ 500,000
Purchased price per shares				$ 0.03	$ 6

XML 42 R21.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

6 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

14. COMMITMENTS AND CONTINGENCIES

Lease commitments

Twelve months ending December 31,	Minimum lease payment
2020	$	17,973
Thereafter		-
Total minimum payments required	$	17,973

Purchase commitments

The total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2019 for the next five years and thereafter is as follows:

Twelve months ending December 31,	Minimum purchase
2020	$	693,900
2021		693,900
2022		693,900
2023		693,900
2024		693,900
Thereafter		2,081,700
Total minimum purchase commitments required	$	5,551,200

Contingencies

XML 43 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of Dis-aggregated Information of Revenues

Disaggregated information of revenues by products are as follows:

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018
			(Unaudited)

Survivor Select	$	-	$	204,138	$	203,815	$	104,656
Energized Mineral Concentrate		100,270		222,789		361,092		66,573
Ionized Cal-Mag		-		-		55,731		43,124
Omega Blend		68,927		97,170		165,999		68,561
BetaMaxx		67,789		87,793		211,280		126,191
Iron		-		2,813		2,809		20,270
Young Formula		-		-		117,480		57,630
Organic Youth Care Cleansing Bar		17,206		-		17,751		-
Energetique Hyaluronic Acid Serum		175,170		-		-		-
Trim+		-		-		198,862		-
Lipomask		-		70,585		211,238		-
Total revenues	$	429,362	$	685,288	$	1,546,057	$	487,005

Schedule of Translation Exchange Rates

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

	As of and for the six months ended December 31,				As of and for the year ended June 30,
	2019		2018		2019		2018

Period-end MYR : US$1 exchange rate		4.09		4.14		4.13		4.03
Period-average MYR : US$1 exchange rate		4.16		4.13		4.13		4.21
Period-end HKD : US$1 exchange rate		7.79		7.83		7.81		-
Period-average HKD : US$1 exchange rate		7.83		7.84		7.84		-
Period-end AUD : US$1 exchange rate		1.43		-		1.42		-
Period-average AUD : US$1 exchange rate		1.46		-		1.42		-

XML 44 R7.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended		12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (338,931)	$ (142,446)	$ (519,642)	$ (130,274)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Loss from equity investment		98,140	124,225	30,155
Unrealized holding loss on marketable securities	68,391
Gain on deemed disposal of shares in Investee Company			(16,509)
Impairment in cost of investment			366,834
Deferred tax expenses				5,334
Changes in operating assets and liabilities:
Accounts receivable - related party	(85,602)		(433,338)
Amount due from a related party			(2,210)
Prepayments and deposits	229,638	(245,128)	(233,394)	(264,941)
Accounts payable	2,778
Accounts payable - related party	(35,086)		35,145
Customer deposits		217,743
Income taxes payable		6,965
Other payables and accrued liabilities	44,867	(11,865)	11,825	11,749
Net cash used in operating activities	(113,945)	(76,591)	(667,064)	(347,977)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in Investee Company				(862,490)
Investment in marketable securities		(1,000)	(1,000)	(500,000)
Investment in non-marketable securities			(1,500)
Net cash used in investing activities		(1,000)	(2,500)	(1,362,490)
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in share capital				493
Proceeds from sale of common stock				2,925,207
Amount due to a related party		(745)		745
Amount due to a director			(5,318)	3,822
Net cash (used in) provided by financing activities		(745)	(5,318)	2,930,267
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS	815	(2)	1,214	(1,293)
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(113,130)	(78,338)	(673,668)	1,218,507
CASH AND CASH EQUIVALENTS, beginning of period	2,857,587	3,531,255	3,531,255	2,312,748
CASH AND CASH EQUIVALENTS, end of period	2,744,457	3,452,917	2,857,587	3,531,255
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid
Interest paid
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES
Amount transferred from investment in investee company to investment in non-marketable securities			$ 724,619

XML 45 R29.htm IDEA: XBRL DOCUMENT

Prepayments and Deposits (Tables)

6 Months Ended

Dec. 31, 2019

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepaid Expenses and Deposits

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Prepaid expenses	$	2,641	$	21,081	$	2,702
Deposits to supplier		266,552		477,254		507,367
Total prepaid expenses and deposits	$	269,193	$	498,335	$	510,069

XML 46 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	200,000,000	200,000,000	200,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000	1,000,000,000
Common stock, shares issued	376,275,500	376,275,500	376,275,500
Common stock, shares outstanding	376,275,500	376,275,500	376,275,500

XML 47 R45.htm IDEA: XBRL DOCUMENT

Accounts Receivables - Related Party - Schedule of Accounts Receivables - Related Party (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2019
Receivables [Abstract]
Accounts receivable - related party	$ 520,786	$ 433,338
Allowance for doubtful accounts
Total accounts receivables - related Party	$ 520,786	$ 433,338

XML 48 R41.htm IDEA: XBRL DOCUMENT

Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018	Oct. 16, 2018	May 17, 2018
Less: Unrealized holding loss	$ 68,391
Investment in marketable securities	66,484	501,000	134,166
Greenpro Capital Corp. [Member]
Cost of investment	134,166	501,000	501,000		$ 1,000	$ 500,000
Less: Impairment in cost of investment			(366,834)
Less: Unrealized holding loss	(68,391)
Exchange rate effect	709
Investment in marketable securities	$ 66,484	$ 501,000	$ 134,166

XML 49 R49.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details Narrative) - shares	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Equity [Abstract]
Preferred stock, shares authorized	200,000,000	200,000,000	200,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares issued	376,275,500	376,275,500	376,275,500
Common stock, shares outstanding	376,275,500	376,275,500	376,275,500

XML 50 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares	Apr. 16, 2018	Mar. 09, 2018
Statement of Stockholders' Equity [Abstract]
Shares issued, price per share	$ 0.0001	$ 1.00

XML 51 R28.htm IDEA: XBRL DOCUMENT

Accounts Receivables - Related Party (Tables)

6 Months Ended

Dec. 31, 2019

Receivables [Abstract]

Schedule of Accounts Receivables - Related Party

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accounts receivable – related party	$	520,786	$	433,338	$	-
Allowance for doubtful accounts		-		-		-
Total accounts receivables – related party	$	520,786	$	433,338	$	-

XML 52 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash and cash equivalents	$ 2,744,457	$ 2,857,587	$ 3,452,917
Accounts receivable - related party	520,786	433,338
Amount due from a related party	2,217	2,210
Prepayments and deposits	269,193	498,335	510,069
Total Current Assets	3,536,653	3,791,470	3,962,986
OTHER ASSETS
Investment in investee company			734,195
Investment in marketable securities	66,484	134,166	501,000
Investment in non-marketable securities	732,137	726,119
Total other assets	798,621	860,285	1,235,195
TOTAL ASSETS	4,335,274	4,651,755	5,198,181
CURRENT LIABILITIES
Accounts payable	2,790
Accounts payable - related party		35,145
Customer deposits			217,743
Income tax payable			12,299
Other payables and accrued liabilities	77,246	32,319	7,884
Amount due to a director	3,952	3,938	3,921
Total Current Liabilities	83,988	71,402	241,847
TOTAL LIABILITIES	83,988	71,402	241,847
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 issued and outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018	37,628	37,628	37,628
Additional paid in capital	5,293,082	5,293,082	5,293,082
Accumulated deficit	(1,089,209)	(750,278)	(373,082)
Accumulated other comprehensive loss	9,785	(79)	(1,294)
TOTAL STOCKHOLDERS' EQUITY	4,251,286	4,580,353	4,956,334
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 4,335,274	$ 4,651,755	$ 5,198,181

XML 53 R20.htm IDEA: XBRL DOCUMENT

Concentrations of Risks

6 Months Ended

Dec. 31, 2019

Risks and Uncertainties [Abstract]

Concentrations of Risks

13. CONCENTRATIONS OF RISKS

(a) Major customers

As of December 31, 2019, and June 30, 2019, one customer accounted for 100% of the total balance of accounts receivable.

(b) Major vendors

As of December 31, 2019 and June 30, 2019, one vendor accounted for 100% of the total balance of accounts payable.

(d) Exchange rate risk

XML 54 R24.htm IDEA: XBRL DOCUMENT

Organization and Business Background (Tables)

6 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of Subsidiaries and Associates

Details of the Company’s subsidiaries:

Subsidiary company

name

Place and

date of

incorporation

Particulars of issued capital

Principal activities

Proportional of ownership

interest and

voting power

held

Agape ATP Corporation

Labuan,
March 6, 2017

100 shares of ordinary share of US$1 each

Investment holding

100

Agape ATP International Holding Limited

Hong Kong,
June 1, 2017

1,000,000 shares of ordinary share of HK$1 each

Health and wellness products and health solution advisory services

100

XML 55 R12.htm IDEA: XBRL DOCUMENT

Cash and Cash Equivalents

6 Months Ended

Dec. 31, 2019

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents

5. CASH AND CASH EQUIVALENTS

XML 56 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

6 Months Ended

Dec. 31, 2019

Equity [Abstract]

Stockholders Equity

9. STOCKHOLDERS’ EQUITY

Preferred stock

As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 200,000,000 preferred shares authorized but none were issued and outstanding.

Common stock

As of December 31, 2019, June 30, 2019 and December 31, 2018, there were 376,275,500 of common stocks issued and outstanding.

There were no stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2019, June 30, 2019 and December 31, 2018.

XML 57 R35.htm IDEA: XBRL DOCUMENT

Organization and Business Background - Schedule of Subsidiaries and Associates (Details)	6 Months Ended
	Dec. 31, 2019
Subsidiary Company [Member]
Subsidiary company name	Agape ATP Corporation
Place and date of incorporation	Labuan, March 6, 2017
Particulars of issued capital	100 shares of ordinary share of US$1 each
Principal activities	Investment holding
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company One [Member]
Subsidiary company name	Agape ATP International Holding Limited
Place and date of incorporation	Hong Kong, June 1, 2017
Particulars of issued capital	1,000,000 shares of ordinary share of HK$1 each
Principal activities	Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held	100.00%

XML 58 R31.htm IDEA: XBRL DOCUMENT

Other Payables and Accrued Liabilities (Tables)

6 Months Ended

Dec. 31, 2019

Other Liabilities Disclosure [Abstract]

Schedule of Other Payables and Accrued Liabilities

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Accrued professional fees	$	58,594	$	20,000	$	7,884
Others		18,652		12,319		-
Total payables and accrued liabilities	$	77,246	$	32,319	$	7,884

XML 59 R39.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
MYR Currency [Member]
Exchange rate	$ 1	$ 1	$ 1	$ 1
HKD Currency [Member]
Exchange rate	1	1	1	1
AUD Currency [Member]
Exchange rate	$ 1	$ 1	$ 1	$ 1

XML 60 R58.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Operating lease, term	2 years
Operating lease, rent expenses	$ 26,828	$ 8,932	$ 35,706	$ 0

XML 61 R50.htm IDEA: XBRL DOCUMENT

Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Accrued professional fees	$ 58,594	$ 20,000	$ 7,884
Others	18,652	12,319
Total payables and accrued liabilities	$ 77,246	$ 32,319	$ 7,884

XML 62 R54.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Effective Income Tax Rate (Details)

6 Months Ended

12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Jun. 30, 2019

Jun. 30, 2018

Income Tax Disclosure [Abstract]

U.S. statutory rate

21.00%

Valuation allowance

(21.00%)

Permanent difference

^[1]

0.00%

(5.10%)

0.00%

(4.30%)

Effective tax rate

0.00%

(5.10%)

0.00%

(4.30%)

[1]	This was related to disallowed expenditure incurred in the ordinary course of business.

XML 63 R60.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Purchase Commitments (Details)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2020	$ 693,900
2021	693,900
2022	693,900
2023	693,900
2024	693,900
Thereafter	2,081,700
Total minimum purchase commitments required	$ 5,551,200

XML 64 R47.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Schedule of Related Parties Relationships (Details)	6 Months Ended
	Dec. 31, 2019
Agape S.E.A. Sdn Bhd [Member]
Related parties relationship, description	Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd
Agape Superior Living Pty Ltd [Member]
Related parties relationship, description	Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd
Agape Superior Living Sdn Bhd [Member]
Related parties relationship, description	Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd
Agape ATP (Asia) Limited [Member]
Related parties relationship, description	Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.
Greenpro Capital Corp [Member]
Related parties relationship, description	Greenpro Capital Corp., through its wholly owned subsidiaries (collectively "Greenpro"), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

XML 65 R43.htm IDEA: XBRL DOCUMENT

Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Apr. 03, 2019	Dec. 31, 2018
Investment in non-marketable securities	$ 732,137	$ 726,119
Phoenix Plus Corporation [Member]
Cost of investment	1,500	1,500	$ 1,500	1,500
Directors of Unreserved Investments [Member]
Cost of investment		832,335		832,335
Less: share of result of investee company		(124,225)		(98,140)
Add: gain on deemed disposal of shares in investee company		16,509
Investment in investee company		724,619		734,195
Reclassify to investment in non-marketable securities		(724,619)
Investment in investee company
Investment in non-marketable securities	$ 730,637	$ 724,619

XML 66 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
REVENUE - RELATED PARTY	$ 429,362	$ 685,288	$ 1,546,057	$ 487,005
COST OF REVENUE	(383,479)	(619,355)	(1,436,705)	(441,409)
GROSS PROFIT	45,883	65,933	109,352	45,596
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(312,270)	(63,068)	(240,522)	(279,682)
INCOME (LOSS) FROM OPERATIONS	(266,387)	2,865	(131,170)	(234,086)
OTHER INCOME/(EXPENSES)
Other Income/(Expenses), Net	(4,153)	(40,206)	86,078	139,301
Loss from equity investment		(98,140)	(124,225)	(30,155)
Unrealized holding loss on marketable securities	(68,391)
Gain on deemed disposal of shares in Investee Company			16,509
Impairment loss in equity investment			(366,834)
TOTAL OTHER INCOME/(EXPENSES), NET	(72,544)	(138,346)	(388,472)	109,146
NET LOSS BEFORE INCOME TAXES	(338,931)	(135,481)	(519,642)	(124,940)
PROVISION FOR INCOME TAXES		(6,965)		(5,334)
NET LOSS	(338,931)	(142,446)	(519,642)	(130,274)
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation adjustment	9,864	(1)	1,214	(1,293)
COMPREHENSIVE LOSS	$ (329,067)	$ (142,447)	$ (518,428)	$ (131,567)
NET LOSS PER SHARE
Basic and diluted	$ (0.00)	$ (0.00)	$ 0.00	$ 0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
Basic and diluted	376,275,500	376,275,500	376,275,500	373,017,955

XML 67 R22.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Dec. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

15. SUBSEQUENT EVENT

XML 68 R8.htm IDEA: XBRL DOCUMENT

Organization and Business Background

6 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Organization and Business Background

1. ORGANIZATION AND BUSINESS BACKGROUND

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

Details of the Company’s subsidiaries:

Subsidiary company

name

Place and

date of

incorporation

Particulars of issued capital

Principal activities

Proportional of ownership

interest and

voting power

held

Agape ATP Corporation

Labuan,
March 6, 2017

100 shares of ordinary share of US$1 each

Investment holding

100

Agape ATP International Holding Limited

Hong Kong,
June 1, 2017

1,000,000 shares of ordinary share of HK$1 each

Health and wellness products and health solution advisory services

100

Business Overview

XML 69 R26.htm IDEA: XBRL DOCUMENT

Investment in Marketable Securities (Tables)

6 Months Ended

Dec. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Schedule of Investment in Marketable Securities

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
								(Unaudited)
Cost of investment	$	134,166		$	501,000		$	501,000
Less: Impairment in cost of investment		-			(366,834	)		-
Less: Unrealized holding loss		(68,391	)		-			-
Exchange rate effect		709			-			-
Investment in marketable securities	$	66,484		$	134,166		$	501,000

XML 70 R37.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Dis-aggregated Information of Revenues (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Total revenues	$ 429,362	$ 685,288	$ 1,546,057	$ 487,005
Survivor Select [Member]
Total revenues		204,138	203,815	104,656
Energized Mineral Concentrate [Member]
Total revenues	100,270	222,789	361,092	66,573
Ionized Cal-Mag [Member]
Total revenues			55,731	43,124
Omega Blend [Member]
Total revenues	68,927	97,170	165,999	68,561
BetaMaxx [Member]
Total revenues	67,789	87,793	211,280	126,191
Iron [Member]
Total revenues		2,813	2,809	20,270
Young Formula [Member]
Total revenues			117,480	57,630
Organic Youth Care Cleansing Bar [Member]
Total revenues	17,206		17,751
Energetique Hyaluronic Acid Serum [Member]
Total revenues	175,170
Trim+ [Member]
Total revenues			198,862
Lipomask [Member]
Total revenues		$ 70,585	$ 211,238

XML 71 R33.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

6 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of Lease Commitments

Twelve months ending December 31,	Minimum lease payment
2020	$	17,973
Thereafter		-
Total minimum payments required	$	17,973

Schedule of Purchase Commitments

Purchase commitments

The total future minimum purchase commitment under a non-cancellable purchase contract as of December 31, 2019 for the next five years and thereafter is as follows:

Twelve months ending December 31,	Minimum purchase
2020	$	693,900
2021		693,900
2022		693,900
2023		693,900
2024		693,900
Thereafter		2,081,700
Total minimum purchase commitments required	$	5,551,200

XML 72 R10.htm IDEA: XBRL DOCUMENT

Investment in Marketable Securities

6 Months Ended

Dec. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investment in Marketable Securities

3. INVESTMENT IN MARKETABLE SECURITIES

	(i)	On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.

	(ii)	On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
								(Unaudited)
Cost of investment	$	134,166		$	501,000		$	501,000
Less: Impairment in cost of investment		-			(366,834	)		-
Less: Unrealized holding loss		(68,391	)		-			-
Exchange rate effect		709			-			-
Investment in marketable securities	$	66,484		$	134,166		$	501,000

XML 73 R14.htm IDEA: XBRL DOCUMENT

Prepayments and Deposits

6 Months Ended

Dec. 31, 2019

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepayments and Deposits

7. PREPAYMENTS AND DEPOSITS

	As of December 31, 2019		As of June 30, 2019		As of December 31, 2018
					(Unaudited)
Prepaid expenses	$	2,641	$	21,081	$	2,702
Deposits to supplier		266,552		477,254		507,367
Total prepaid expenses and deposits	$	269,193	$	498,335	$	510,069

XML 74 R18.htm IDEA: XBRL DOCUMENT

Income Taxes

6 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

11. INCOME TAXES

The United States and foreign components of income (loss) before income taxes were comprised of the following:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
Tax jurisdictions from:
- Local	$	(279,476	)	$	(33,977	)	$	(76,309	)	$	(261,918	)
- Foreign - Labuan		(4,174	)		(45,576	)		(2,777	)		134,806
- Foreign – Hong Kong		(55,281	)		(55,928	)		(440,556	)		2,172
Loss before income tax	$	(338,931	)	$	(135,481	)	$	(519,642	)	$	(124,940	)

The provision for income taxes consisted of the following:

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018
			(Unaudited)
Current:
- Local	$	-	$	-	$	-	$	-
- Foreign		-		6,965		-		5,334

Deferred:
- Local		-		-		-		-
- Foreign		-		-		-		-

Income tax expense	$	-	$	6.965	$	-	$	5,334

United States of America

Labuan

Hong Kong

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
U.S. statutory rate		21.0	%		21.0	%		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%		(21.0	)%		(21.0	)%
Permanent difference ⁽¹⁾		0.0	%		(5.1	)%		0.0	%		(4.3	)%
Effective tax rate		0.0	%		(5.1	)%		0.0	%		(4.3	)%

⁽¹⁾This was related to disallowed expenditure incurred in the ordinary course of business.

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
							(Unaudited)
Deferred tax assets:
Net operating loss carry forwards in U.S.	$	150,759		$	92,069		$	82,970
Less: valuation allowance		(150,759	)		(92,069	)		(82,970	)
Deferred tax asset	$	-		$	-		$	-

XML 75 R52.htm IDEA: XBRL DOCUMENT

Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Local	$ (279,476)	$ (33,977)	$ (76,309)	$ (261,918)
Loss before income tax	(338,931)	(135,481)	(519,642)	(124,940)
Labuan [Member]
Foreign	(4,174)	(45,576)	(2,777)	134,806
Hong Kong [Member]
Foreign	$ (55,281)	$ (55,928)	$ (440,556)	$ 2,172

XML 76 R56.htm IDEA: XBRL DOCUMENT

Amount Due to a Director (Details Narrative) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Related Party Transactions [Abstract]
Amount due to a director	$ 3,952	$ 3,938	$ 3,921

XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 215 299 1 true 51 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://agapeatp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://agapeatp.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agapeatp.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquityParenthetical Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statements of Cash Flows Sheet http://agapeatp.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00000008 - Disclosure - Organization and Business Background Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground Organization and Business Background Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Investment in Marketable Securities Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities Investment in Marketable Securities Notes 10 false false R11.htm 00000011 - Disclosure - Investment In Non-Marketable Securities Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities Investment In Non-Marketable Securities Notes 11 false false R12.htm 00000012 - Disclosure - Cash and Cash Equivalents Sheet http://agapeatp.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 12 false false R13.htm 00000013 - Disclosure - Accounts Receivables - Related Party Sheet http://agapeatp.com/role/AccountsReceivables-RelatedParty Accounts Receivables - Related Party Notes 13 false false R14.htm 00000014 - Disclosure - Prepayments and Deposits Sheet http://agapeatp.com/role/PrepaymentsAndDeposits Prepayments and Deposits Notes 14 false false R15.htm 00000015 - Disclosure - Related Party Transactions Sheet http://agapeatp.com/role/RelatedPartyTransactions Related Party Transactions Notes 15 false false R16.htm 00000016 - Disclosure - Stockholders' Equity Sheet http://agapeatp.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 00000017 - Disclosure - Other Payables and Accrued Liabilities Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities Other Payables and Accrued Liabilities Notes 17 false false R18.htm 00000018 - Disclosure - Income Taxes Sheet http://agapeatp.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 00000019 - Disclosure - Amount Due to a Director Sheet http://agapeatp.com/role/AmountDueToDirector Amount Due to a Director Notes 19 false false R20.htm 00000020 - Disclosure - Concentrations of Risks Sheet http://agapeatp.com/role/ConcentrationsOfRisks Concentrations of Risks Notes 20 false false R21.htm 00000021 - Disclosure - Commitments and Contingencies Sheet http://agapeatp.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://agapeatp.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Organization and Business Background (Tables) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables Organization and Business Background (Tables) Tables http://agapeatp.com/role/OrganizationAndBusinessBackground 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - Investment in Marketable Securities (Tables) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables Investment in Marketable Securities (Tables) Tables http://agapeatp.com/role/InvestmentInMarketableSecurities 26 false false R27.htm 00000027 - Disclosure - Investment In Non-Marketable Securities (Tables) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables Investment In Non-Marketable Securities (Tables) Tables http://agapeatp.com/role/InvestmentInNon-marketableSecurities 27 false false R28.htm 00000028 - Disclosure - Accounts Receivables - Related Party (Tables) Sheet http://agapeatp.com/role/AccountsReceivables-RelatedPartyTables Accounts Receivables - Related Party (Tables) Tables http://agapeatp.com/role/AccountsReceivables-RelatedParty 28 false false R29.htm 00000029 - Disclosure - Prepayments and Deposits (Tables) Sheet http://agapeatp.com/role/PrepaymentsAndDepositsTables Prepayments and Deposits (Tables) Tables http://agapeatp.com/role/PrepaymentsAndDeposits 29 false false R30.htm 00000030 - Disclosure - Related Party Transactions (Tables) Sheet http://agapeatp.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://agapeatp.com/role/RelatedPartyTransactions 30 false false R31.htm 00000031 - Disclosure - Other Payables and Accrued Liabilities (Tables) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables Other Payables and Accrued Liabilities (Tables) Tables http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities 31 false false R32.htm 00000032 - Disclosure - Income Taxes (Tables) Sheet http://agapeatp.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://agapeatp.com/role/IncomeTaxes 32 false false R33.htm 00000033 - Disclosure - Commitments and Contingencies (Tables) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://agapeatp.com/role/CommitmentsAndContingencies 33 false false R34.htm 00000034 - Disclosure - Organization and Business Background (Details Narrative) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative Organization and Business Background (Details Narrative) Details http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables 34 false false R35.htm 00000035 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground-ScheduleOfSubsidiariesAndAssociatesDetails Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Details 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Dis-aggregated Information of Revenues (Details) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDis-aggregatedInformationOfRevenuesDetails Summary of Significant Accounting Policies - Schedule of Dis-aggregated Information of Revenues (Details) Details 37 false false R38.htm 00000038 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetails Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Details 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetailsParenthetical Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Details 39 false false R40.htm 00000040 - Disclosure - Investment in Marketable Securities (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative Investment in Marketable Securities (Details Narrative) Details http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables 40 false false R41.htm 00000041 - Disclosure - Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities-ScheduleOfInvestmentInMarketableSecuritiesDetails Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) Details 41 false false R42.htm 00000042 - Disclosure - Investment in Non-Marketable Securities (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative Investment in Non-Marketable Securities (Details Narrative) Details 42 false false R43.htm 00000043 - Disclosure - Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities-ScheduleOfInvestmentInNonMarketableSecuritiesDetails Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) Details 43 false false R44.htm 00000044 - Disclosure - Cash and Cash Equivalents (Details Narrative) Sheet http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative Cash and Cash Equivalents (Details Narrative) Details http://agapeatp.com/role/CashAndCashEquivalents 44 false false R45.htm 00000045 - Disclosure - Accounts Receivables - Related Party - Schedule of Accounts Receivables - Related Party (Details) Sheet http://agapeatp.com/role/AccountsReceivables-RelatedParty-ScheduleOfAccountsReceivables-RelatedPartyDetails Accounts Receivables - Related Party - Schedule of Accounts Receivables - Related Party (Details) Details 45 false false R46.htm 00000046 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Sheet http://agapeatp.com/role/PrepaymentsAndDeposits-ScheduleOfPrepaidExpensesAndDepositsDetails Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Details 46 false false R47.htm 00000047 - Disclosure - Related Party Transactions - Schedule of Related Parties Relationships (Details) Sheet http://agapeatp.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartiesRelationshipsDetails Related Party Transactions - Schedule of Related Parties Relationships (Details) Details 47 false false R48.htm 00000048 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://agapeatp.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartyTransactionsDetails Related Party Transactions - Schedule of Related Party Transactions (Details) Details 48 false false R49.htm 00000049 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://agapeatp.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://agapeatp.com/role/StockholdersEquity 49 false false R50.htm 00000050 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities-ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Details 50 false false R51.htm 00000051 - Disclosure - Income Taxes (Details Narrative) Sheet http://agapeatp.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://agapeatp.com/role/IncomeTaxesTables 51 false false R52.htm 00000052 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Details 52 false false R53.htm 00000053 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfProvisionForIncomeTaxDetails Income Taxes - Schedule of Provision for Income Tax (Details) Details 53 false false R54.htm 00000054 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails Income Taxes - Schedule of Effective Income Tax Rate (Details) Details 54 false false R55.htm 00000055 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails Income Taxes - Schedule of Deferred Tax Assets (Details) Details 55 false false R56.htm 00000056 - Disclosure - Amount Due to a Director (Details Narrative) Sheet http://agapeatp.com/role/AmountDueToDirectorDetailsNarrative Amount Due to a Director (Details Narrative) Details http://agapeatp.com/role/AmountDueToDirector 56 false false R57.htm 00000057 - Disclosure - Concentrations of Risks (Details Narrative) Sheet http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative Concentrations of Risks (Details Narrative) Details http://agapeatp.com/role/ConcentrationsOfRisks 57 false false R58.htm 00000058 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://agapeatp.com/role/CommitmentsAndContingenciesTables 58 false false R59.htm 00000059 - Disclosure - Commitments and Contingencies - Schedule of Lease Commitments (Details) Sheet http://agapeatp.com/role/CommitmentsAndContingencies-ScheduleOfLeaseCommitmentsDetails Commitments and Contingencies - Schedule of Lease Commitments (Details) Details 59 false false R60.htm 00000060 - Disclosure - Commitments and Contingencies - Schedule of Purchase Commitments (Details) Sheet http://agapeatp.com/role/CommitmentsAndContingencies-ScheduleOfPurchaseCommitmentsDetails Commitments and Contingencies - Schedule of Purchase Commitments (Details) Details 60 false false All Reports Book All Reports aatp-20191231.xml aatp-20191231.xsd aatp-20191231_cal.xml aatp-20191231_def.xml aatp-20191231_lab.xml aatp-20191231_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 true true XML 78 R36.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Income tax examination, likelihood of unfavorable settlement	Greater than 50%
Impairment in cost of investments			$ (366,834)
Accounts receivable - related party	520,786		433,338
Changes in other payables and accrued liabilities	$ (35,086)		35,145
Reclassification [Member]
Changes in other payables and accrued liabilities			78,272
Reclassification [Member] \| Other Payables and Accrued Liabilities [Member]
Accounts receivable - related party			$ 78,272

XML 79 R32.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

6 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Schedule of Components of Income/(Loss) Before Income Tax

The United States and foreign components of income (loss) before income taxes were comprised of the following:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
Tax jurisdictions from:
- Local	$	(279,476	)	$	(33,977	)	$	(76,309	)	$	(261,918	)
- Foreign - Labuan		(4,174	)		(45,576	)		(2,777	)		134,806
- Foreign – Hong Kong		(55,281	)		(55,928	)		(440,556	)		2,172
Loss before income tax	$	(338,931	)	$	(135,481	)	$	(519,642	)	$	(124,940	)

Schedule of Provision for Income Tax

The provision for income taxes consisted of the following:

	For the six months ended				For the years ended
	December 31, 2019		December 31, 2018		June 30, 2019		June 30, 2018
			(Unaudited)
Current:
- Local	$	-	$	-	$	-	$	-
- Foreign		-		6,965		-		5,334

Deferred:
- Local		-		-		-		-
- Foreign		-		-		-		-

Income tax expense	$	-	$	6.965	$	-	$	5,334

Schedule of Effective Income Tax Rate

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

	For the six months ended						For the years ended
	December 31, 2019			December 31, 2018			June 30, 2019			June 30, 2018
				(Unaudited)
U.S. statutory rate		21.0	%		21.0	%		21.0	%		21.0	%
Valuation allowance		(21.0	)%		(21.0	)%		(21.0	)%		(21.0	)%
Permanent difference ⁽¹⁾		0.0	%		(5.1	)%		0.0	%		(4.3	)%
Effective tax rate		0.0	%		(5.1	)%		0.0	%		(4.3	)%

Schedule of Deferred Tax Assets

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

	As of December 31, 2019			As of June 30, 2019			As of December 31, 2018
							(Unaudited)
Deferred tax assets:
Net operating loss carry forwards in U.S.	$	150,759		$	92,069		$	82,970
Less: valuation allowance		(150,759	)		(92,069	)		(82,970	)
Deferred tax asset	$	-		$	-		$	-

XML 80 R19.htm IDEA: XBRL DOCUMENT

Amount Due to a Director

6 Months Ended

Dec. 31, 2019

Amount Due to a Director

12. AMOUNT DUE TO A DIRECTOR

XML 81 R11.htm IDEA: XBRL DOCUMENT

Investment In Non-Marketable Securities

6 Months Ended

Dec. 31, 2019

Investment In Non-marketable Securities

Investment In Non-Marketable Securities

4. INVESTMENT IN NON-MARKETABLE SECURITIES

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

Unreserved Sdn Bhd	As of December 31, 2019		As of June 30, 2019			As of December 31, 2018
							(Unaudited)
Cost of investment	$	-	$	832,335		$	832,335
Less: loss of equity of investee company		-		(124,225	)		(98,140	)
Add: gain on deemed disposal of shares in investee company		-		16,509			-
Investment in investee company	$	-	$	724,619		$	734,195
Reclassify to investment in non-marketable securities		-		(724,619	)		-
Investment in investee company	$	-	$	-		$	-

Investment in non-marketable securities	$	730,637	$	724,619		$	-

Phoenix Plus Corporation
Cost of investment	$	1,500	$	1,500		$	1,500

Total investment in non-marketable securities	$	732,137	$	726,119		$	-

XML 82 R15.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Dec. 31, 2019

Related Party Transactions

8. RELATED PARTY TRANSACTIONS

The Company’s related party list and relationship are as follows:

Related parties		Relationships

Agape S.E.A. Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd

Agape Superior Living Pty Ltd		Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

Agape Superior Living Sdn Bhd		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape Superior Living Sdn Bhd

Agape ATP (Asia) Limited		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

Greenpro Capital Corp.		Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is an approximately 4.7% shareholder in the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. Mr. How Kok Choong, the CEO and director of the Company is also the director of Greenpro Capital Corp. Mr. How Kok Choong ceased to be the director of Greenpro Capital Corp. in November 2018.

Related party transactions as of and for six months ended December 31, 2019 and 2018 are as per table below:

	For the six months ended				As of
	December 31, 2019		December 31, 2018		December 31, 2019		December 31, 2018
			(Unaudited)				(Unaudited)
	Revenue				Accounts Receivable, Trade

Agape S.E.A. Sdn Bhd	$	429,362	$	685,288	$	520,786	$	-

	Professional fee				Accounts Payable, Non-trade

Greenpro Capital Corp.	$	-	$	4,500	$	-	$	-

	Expenses paid on behalf				Amount due from a related party

Agape ATP (Asia) Limited	$	-	$	-	$	2,217	$	-

Related party transactions as of and for years ended June 30, 2019 and 2018 are as per table below:

	Years ended				As of
	June 30, 2019		June 30, 2018		June 30, 2019
	Revenue				Accounts Receivable, Trade
Agape S.E.A. Sdn Bhd	$	1,524,596	$	487,005	$	433,338
Agape Superior Living Pty Ltd		21,461		-		-
Total	$	1,546,057	$	487,005	$	433,338

Professional fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

12,000

214,883

Company Secretarial fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

3,282

292

License fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,509

Incorporation fee

Accounts Payable,

Non-trade

Greenpro Capital Corp.

1,419

Expenses paid on behalf

Amount due from

A related party

Agape Superior Living Sdn Bhd

745

Expenses paid on behalf

Amount due from

A related party

Agape ATP (Asia) limited

2,210

Sundry purchases

Accounts Payable,

Non-trade

Agape Superior Living Pty Ltd

35,145

ZIP 83 0001493152-20-004884-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-004884-xbrl.zip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�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�ZW?13S7UB(VMH;1SYG/4Z3;V7LAWK MNZJ&N%R";_6R4VE7Q.41\)G6[ _TYJ ,=:D0 2)>,MACUS:9YU]RW+>J%H'K M.JJ"L(T6CKL@;*/%9E'"8!)[S/#9)\;_>^5DM[7RGG6M5#E='W1;J_ M6]&H@OUNN+TPW^]F.X8;:DF[W>_V5JG)QON)%0^LJ./4M%Y[< @#*^IMSS2M MW^TN_8)NM]?LMJL@G&][ MW!LOS,>-,6AH>T%HCHZJB01R=%2-ZR_8T<:^/F >\X-M"VAM+Y5(9VTOE8BF M4"\;RN5R-&+#X'IT^3(<&\XCNX40_MK!B3B3(74+I'C6$ )\D4&5_2+U).B4 M'6(*]2>!-OX/SPVG\ ;\C8.P'/!88EJ[3B5NIZ^E7,[^AW083"[L(C4]G6RU M_T$=!IL+.W1=\K@,CW.%V[K6KC.72_5]PSS+->>7$(*B]"CYR*L*_+56:IMH MMT.H'P,++]IUK=]I]B0#-U\(]5OI(PW)OZ(+LEZKVZT- [^ZAN-_=P/FWWN& M&2=SW[(A@SX>;.:C*;5=/_18?"-NNS6HJRL8^N_0#ZS1ZQJ@@9G+C>N>?< / MW0:1>WYQH2D%H]!6#&%T M"_)%%O ZC&6 9+1D]!'7*:@2R=*8#S_]RN)/"!5HB;N0#2;1<%2-!+0 MR:WG7[OQTR)T#W9 MDV&'X(3]&=SIB$=$BN"38L!3@8)7+'W%Y;>AD*XIQ:G$!:?PW&FM;'ASU(7\2--9D*D MJCR$:-6@0<<%OAM/G!-&Q%(;;$_,?E4Q/!;%7" '7)2&/CZ!G0I936"0KME0 M[A;UA^-]A/%YAFW3)5W? EL+31&E%D@8F.1P8_TYJ_80*?YJTJ,=HG-(X,@(U7%#X%-1NH=4H9(BSZZAFI69($$#04.C>9(&LQ"O4\3(= [? YCU(C T&9#/@WL? V>$8),AS#-@5K MB>?0YW3JN: 9,'=X7L /QZ0WX;=%[Z@978#!@"/S27NQ'40!=AUHB[,P4BV' MP9P1-]45D*>8 /!KEKI(!7VN'\ .U!$/&#IU'9-K"4\3P59,D3*"8DD4F&;^ M@V'CCH;? (;C70''C*)WU"BP^@M8D[SN(WNY8&A\\ Y)U@R'?(9;7*I#42*' M9)]ZO:&D3=.\*I+5<9_A:W]L31/# TVAEL'0QJ 0S(OL1:Q3B^=78Y$77>H M9SWE_'5S]+V'GSF3/<8;@*VXO[[XX\OUUT^7MW?QZJWW0;G\?W]5JB7K5Y7U7L=K+@4Q1X1A_W35K_[A$F.RSD" 3_% JKR3)%9 M0($-!85$S!2<* 1,Y/=-RPZQ6$&J[$V:B1A3:1C@94L>JNPH*)"YG#*S2^9R2M'+7$XI=IG+F5,KRFC/ M@29+UIR\'"^* MS!1?O[C O#]<3!>FLU9M,UJQ3L@PM T/)L85)2 M*IA7@J-:LQDEWKDC!>(X MR\&,^#AY^"V;:#]S*FGHLYWSPS?\P?\%U,YH+9 M8IA/EN\BKYGW9 V9OWX8W MJ5EM13VY." G!,A+Q_SVYVT^#]=N:"E\Z9R45#B ?OD!-/!Q<($[1X*Z5SIO4BTO[A,>9,/5<M=M=0;Z[HG*$PC! M;S/4MK9KMF<#2N^+^_R'^_-B[+K.8PYF]EK-;JNW(^HVLCGK2Z-O-B/J;P"S M6QBU,H"S^RM[(.XC!WZ\XQE1U01=O+&YW:Q^"_Y92FV&D/)$%P[#EA#=VAW1 M!>.>900WQ3_U(?I?HO%_<0PZ MO*.QRML\EH**^,OL*+%'YH!Y@VR;%2%R7% M;BNX@_G=UO6.2'1;35!IVK?G)#8DJ7)7<3;H:^UF(6[.:XUXX+/E@-Y8AGT7 M3A&&]]Y-6G "SQ@&(6+1W2+FK0?&E,-:[T)IM&XG?#>6[Y,[L1(]?1V5QN(:56(OJI'5G?> M;UT[DI>OG!WKQ';HJB>_MBG'R$;-;;9F9;5R2K8Z+3V=H[1HVW19^V)L*]L? M#)JPZMJL_4&.]O56?Y!>#R]J'U'I/K&IZR,6_H9\TCO-=JN7&DBZT:(=YF$< M6$J],VA7TV$N3G::G4[Z@N"J#I,+:A@/\9O"'YGA6<[C)W<"?UC#Z-5[-_Z4 MC\I-[@:"DJ46]J6IV_UPBUTF;.J#K0[78U/#,B]?ILSQ&=\\6Q61KM8KK9G. MAE_8]L8$Y)I)O::^K?YS3:QN.^_XR=,DLL(0T[:8MRGKV[V>WFF+<&N^V0UZ MSLN19.C"'?/I+P0,'UM3_Q/SAYXUW>#2)5U8 MO;L\OS.=C^/HFO_OW[R&\L5]5OYP?RI\DU>4:;F\IJMKI@@(HGHLJ<) ,#)> M/<5W;5&UA0.'S[W([\K>-2X;YPT%^E> @#C(SC/477$GG&)BE_?5>@+;=!.\ M?@TJ8932T7Z=8Y"QB$6" (53H )"M!01UY!Z^>^9611(W:I3GCU^BV2\"ZZ M:]VH(Y^R.K6_R3>C6?6L]UM0@A(=U3I&26Z%XU/-9!QGAL^CJF@ MU#/PPGZE0DFFXD=7=W$)]!8Q^AE>KV7PP)NHL3?O5.*JPZM:06P'@X,'VHU> M=N:*^DU"$@TEIN:?X"8A&(JI$CJ)K7(R'EZ5Q:13R:=T/;-4?W0U>\EK>$T; M->@K8Z@]>&T^-+ F!"@ ?>_^Q!_P?X;30,DI52A<^IDEE,UWHPP9E<8+7.6! MY6T&>/W=?>*XV^C;-YO?46!S/AS"\M2\\=P1\WT":_C,F%\V>LQNR:_NI#Q) M>>*;7C^=/K]MBO+$/IU^9J58F"3"W;LQ7G$[(RKJ*1KY:O%B@JNW@U;O,NLM M;9"A+E]_E1*Z1+#KME9*,F>]Z+1^MZ-7P)QK7N32>?SJ^OZ%X7FO(]=[-K " MX*I=/.S,>_W7C[O5ZXA6OZVG,E^6=U:6+.&M\I'5TWJ#IK9]LOK%R&H-.LWT M\GP]661UES\&:T4PYG_"BCZWNT\H!0O:BA9C>;K8 4U1-'(U^N&$ 2CT_R8! M+E [V(#:;"XH!!\QG@9F@^+)C.6$T-1U4@LV)V;'^KV8#"Q5[OZKI7Q!?OTZ MRL^ ]/0UJGV1OB E. _IG;D,X/V2/N\)ZZPO*]8(',HJ_\;K]@9SRX#R(=@' M>ND\^,Q,+-=Z%QA!")'M:^;ARN:SKJV53R'"=C36#2S P8YU Y-Q%&/-;6,. M=*RKPH8O?^3 6.QVMCIL_B.&(TCP(L/VD4&,DO3(_.@ IKAY6I ^H?<&[5XF M WUC>K8\M-76:-'0NMI ZQ_"T%8;GP5#:[4&O=ZAC2S/POZLUVUE\\?V.3)Q M^[S@3=DET<["R5=2BH+ /0QUD0E=,,)VN]GIE#,O.QGCPLO$^<:H:SW]0 =8 M4%^U5KO?/ !A%E^)+-)!9WC[^Z0\,F5%E*-_G('#:R?5O?X06S!?9@KB_ MLR()=X7]QI+F2_K$]=1OME9Q';P=P]?1MY;_,[DNH^5TM#&LP$QZ5N[*9:G= MC%7DE"5]Q5[:M<,NZ!/S_$UJW6V3[!6;1H="]LRI0G&RFXW!8#=DK]A>X$J,W,P5WBPS[ECTQ)V3141QB^F!A],@77[X,[1"+8^)J M!?X?%RY5I'>U]4&KF\I.V(",+8VDZ-E-N]]KIFNSUV@H!RG:GV.WJ_7T?6 M%TV-U#KM;K/3J^-05A9A]IZL)]>[8WB%>Z^JLX+*2X=YCW1GS'(P=SN)L.8# MM(60]WIZN_4@!'/E.CC@"\/^9BQ!B=Z_7*XG[-'X:$,@0=;P?&B9=\Q;@&:V M:- =[>"L\;UG31!WNJZ*^-6:NA/#GT>^WG/L5R3,F $!:6NMVL>%_2K#%%W7 M:^I!5@RY/F'*JGWO(F'*H%=3\[1B@ 7"E'ZO-V@=V/"6ARG9"=37#FUDM0ER M5LV>PD'._FG>)$K9/]6UB#)6W>=9&65D@7J:G?ZA[2!N$*2T^MJAC;)=9Y9),;1NIW!H/:AYLP("P0YNJ;I_=H' M<;-:FC?*:1Z:Y-9'.5GMU'KM@Y->Z:V@7N?03,Z!!%FS*4,K@ZRL4 ;]?CV/ MYU?!6^0/TM!,UG.39<6Y9^$H36NVNYU:;K.N&&6Y**W;[?1JN11>,>*B05J[ MI>GM QMCP?.RSL$E)12(T33"?SJP\>6-T>IZX+QB: 6#M XB01W8$&N[D[7. M$=0SR%I!=2UVLE9A*M7AO*QH99G#S"1=L9]8>)059HOQ,J_#,3-#FRJ]+BV M<(^IP_;?;W-Q,#HCGGO=**!L\K6+;+5[ZS9^46=-91^1>J @; &GU0XJ8_*$C7 MF6%;C_#GOX$'UNB5>KM/ZD[\ES&9?OC/OJ[U/OB*QP>M3&'4KXIM^0&6K"!B MO!0'J"R&X2LC%V^C^N]W2SRV_$ ?B'2MV^3<>UC%1RK3J R9;?M38P@:@.I# M?T\-TXS^SI*KKR?WV3*#,8ZL^>L'Y<'U3.:=8?438^JS]TKTZ4U"#Y+B1?T\ M,5"NH6%'HPS<:?(H*B4];D:/B\Y:K5]C/B"E::K/? B9.:=G> 4?0OQPFQ(Q M*#;Q*XPYE_ 06XO_",SU9&F_KA!95E)YFNMV5[6W^="C25QHX/31*R?%HGRH M@I?%VJALE#FE0]Q?5+=L1C;Y57&K/"LRJKV5?,O!.JG,VU;FQ17F3ENKR];G MVTRQ?R._G_EJ2T%)(HNL5+8:%N$.($3(,BHJ'A6MF*]EO5"- Z*=.Z>-62N] MU):]U'QMS]-V4.5+HTJMWJ=6+RYPN1>=SGP5?;V]S9 5PU]4LC5#V=KRK='^ MD-Z,NXB_TCY45=(U0]/>R[MFJ%E7[O:+2X08[S_/[\_&+K_>>X?C&$-^\";WA&!A%N/+I M9W9XG[[5T=J9O-ABE&YCI+N\2;^06H'W2\2FOO;QP*):,:TZ3MD#\<4XG_LL MJ)=#P_*270,1@E' \%(XP5S7Q;3F(3%@G1KD8< >M'?=(6U-R5YWZEJ&;')@ M5^#5+6\"\=R5<^'ZP?7HRGEB?C!9#5P5$1&Y:^&MT4'GNGW0[6.-B+44E"0U MPZ_G_I!%;P^C_,MO]P(,2^@WC*A4#[RO=#EK>H\YO?O[M_ M^VUM:_/=_M.U0R6[B^A0_"=C&*+,/EH.>@&STSQT3>@;&F5\MX\&R+>PK3T39 MU].E O?OEAKJ1X:")@NEPP<8%7_K=IIZ^VYMJLF!O>7BIZ:T.,;-\=WDL7V_0[^I: MKMYFD&(K]?DS&RAYNJJ*O)(>J3@W-NT.#7RJ.F*%U2_R-9Y/>_7T/=OYAC<= MUV:3/ZH7E!2?K +%]DSO=EO]%+3;@GXV)*4H#.V9WFHWTRZP.E**(EOJ_72U MP.W0D:MDM];2,H@V*T@A1T0F;^8AL151B;:TM4Y+^,85794AJ:C6:*U!JZEM MEZ;"->3;30*'VQ5-.3U_KY^?I$CAOAG>3T;')G=L&'H4CO]P/&;8>.'O'X;E M5&:)NOU6^DY9OIZKH[>"6H6;=UY!K<)J.M_0ZU:J)N7V&?>L1BO."DKO VY% MR2NG+NK_VKDS\)#T+G"'/Z^_L&2GOKR";=QGX2!PRWFFW9Y;=2WLL3U_A"+$YT-K=W=%7.%K46B#>/1&83P'[ M_79Z=[48@7PNX\F2^0F?Z9=*%I#Z0.]TTL5\FXOUW+00V'(<(F M!,PDM<9M6X^-09>M)\95>[,P:"O4WD+89SG,O#0\!YK<\([^$M+N,!/3WXJ. M\Z;G:F_EG;$SE!5A-?_Z,V(.>4_6L")+D]?*S/6^"](WM3J',:A"5JC,)"U/ MZ3Y,2VFJ=V!BMJK8RTQ-D_[):6K6JGA4!3O>[!?QST?FL)%5]5JC1*]%35NG MU4K%\FLZK("^"C:?H#[>GO0%/MU M^?JMB-02YK?"GC=TXUCAU_#'-Y[[9)G,_/CZPT>UY+TB$!C><[1*>/#M$E!8 M3;26T)/B_5=+>?$-RTP@70>RM=Q=7?EB:L@4"S7Z89&*MTI+A(-9\BN1ZGUZ [$G[O?33;0,]NT M:WNMA,R*=6&C?BM0AULV%>XS!B!I$T$S'2]]\KS MV K8:MRG';",()&^XMXN"#W6D:4@6+L#6]UIORG8?&5L^ JAKR) F1.X"(+F M1MEKBHVL(FJ,1X_1V8HRF3."9,>HK\B>C!S-6+C\^HF!V/ B/3^N)# 4Q.?\_8W^ M9K<<^;9H"NV,"X60,7FCBYS"?UY<7%Y^_IP#%KD[R ^+K#?UYJ90QYNB&FOY MR?ME,]KT_@QNLF<]CH/8-E5.7L:(S'+&4Z4O9!B;ZVV0B\ZJ"(&KEX>A*%+W'@XC$Z$#9+,DZO M3K?TAHZZ8+HA1!E;,TWKN]ZYR2K*TQQ(J,<4_Z\VO;<8H#-QKUH$U42+;[VD M@B]8*LS'X B7BYL#RC/$W+_H7;6O]^G+7_KJH*4K;W\X1F@B*-\[%2:,/XV@ MF1O*HFY%"$^]$0G_'3I,:347]M;JJ+UFE_?6S+9>$\[NIZY&/M*B=7$$.[OG MI7$]=P]P91N0]1^%B/2=.(%YKA$I?#%K*([KG WQR!567KCB2SW/"_OA&G7] MJG8$VBSF!*IY$,'VNB>_PIVM-%0L7.P. M6NJ@N0V^;'N)6T#L6L[AY15R4678E7CV.3$+B$.7XJC/W,B[5)3"V,G<:$MQ MR*W1]:TF:V[3#?5Z:>:X9#F'AF2'W@ M3_1,,3D6GL8MU0>&6P\FLXU77K .Z^YQ@AN[9?#>TX4RZ6-$PPFE"F$ZG!+ M6Z0V\%]UMO;=E"KU!"X1,@379%B.8K-'\ %3GFV-0!DJ[E&B/N)_HZ<,WX=/ MH%^HK*%S%O\]M UKXC<4GBSH*P:_AIMI)(@W9 UZ"O2?2/"H7 O,IE=EZOJ^ MA=/*A@_ B&<+)H8X',#Q^.%P#$P((/0! BW'M)XL,S1L>!4I$L4>C<='#X83 MP-"QSB+.51-3H:*"?5@KTK. #CZQ.!]OH ]@(=OH8/+T0@&>.TDB9,B4S)W)F\YD-%>,TKVS$E552/9)KQH M6=IV 2XZ7]_B'QYH_M;+]*1[*4]3995CU@^^BH(Q*P>/9S)X]O/9]3Y!?!>, M0GN^A>+R6)643 M4HO9BORDZEJ[WV]52VLQ[[&2UJJEO+[27'[6M3MYA,QO.&3A8KZ[SKUGF#EF M^89%O!:A]>0@I%J:JY+UQM1L1?,VI*:DXJT%.@L9O[^X%"DIMUZ5J:A;BHR2 M56$7]EV"P,WJB,X2V-L6@5LI="K6<'<(=A08N(+YG!N^IA*;VM+[T7WFA;1L M1NW6G.<@/[%?K2'FLNV8GUHG7G@E!!2@JT+.K2E,-TS>WSZ/2M.R+8W2VO&M MR%DR9BT%7VS&R*CWQ@LN02&D=IVA95OTV@4M3:^<"&<2'N+UW1#ZE)Z(P_/B M%WIO0H_-P8:>-1L9JUPQE7M@PNK+PB?"A-47D4^0"?.K\$-A J_R&*-A;G"3 MGX_4,N%QUPW.FLVSYMS FXW,$G@3PK8UN#P3.CTX;9%4F^U6/4>79Z:F1Z^9-T% +9'/O6)?Z_<;_<^$GO5M M+2VE2,]66+Q0[_;UU![OPGXV)J8H\LRBFHZ5$%(42:8_:.F[H"4?#G.ON:C^ MYRIB%BE85#K\-<(S_80E-UX"GGO^C:>>;[A;KO4&O=9J_<[3?7;-DK,12F,Z MIQL1U6TLY^U\QPR;VQD5Z0#7#[;U2&8,'KIRJA)K=] :9+8_\W67D\H[M+_F MG\PH(KA-Z$LZRDG9_=CR=D%8W$].NCZ[H1>,=T!8TE%>RJS1;@B+^LE%%UF% MTJ3IS;[66TM;MJ_UY&U\,-GI:/IJ:@H5X]L*R-=&G98%[-JHT[+@6Z4[K;[8 MX8P;A6>PV[FGM@OSMF&WA?'"6TVM$YU[Y>BS"AH+PQ(.^EJ[N3\:\]54U]NZ MOBDC^6;&]0@MWZ5CWKBV-7P]>)@UG@1(0\,<2[R#BU5L/B!/ MC^(7]C%C=&3Y0\..>::,,)U0W.3'?+E4++,05F@'!C -ISQ_S$ MIB[0[Q_3I$F-D%AFBC&>VM19Q@?*)QT:_CCZ1LP+&9M\1/_HXU1 U@.?-4K;Z*'1, MRD '^HB&!U)^QT500%A8^T%#^4S ?]#ALN&8#!Z=8'T\S!@'7AF/'#(P&!L! MS[85X\)<7-NF7-H'PA#T,#ML&I"-B88&[D7EZ".";A5'F-":-3W4(#3C/CK6 M_^(X%"/>WS=X"@>+/;L4\9[:JA$26:X8&H, M>/HQM,&Z/1A@E;"#F F*Q1/R$S*0YR;[*^2YQ-"40?N,_LQCSV/F* [#7'S# M>VV ^;(MYZ\P I:(!A,13UKT#.XX8,Z9.P*S^&A8#EC(I$74 5/DXT7,@/=H MLR0E)L2"3,F0I(:DV=9/(&'LNF:49(T "[B5"BP0UQ= X1Y0*,LQ(%,=#2FU M&O=*0&@_,-QR0\A:SY-]MUS;OU0RO&'4457"->Q:7 M&>!YUT%-44&C@IDW4.E08.&=IIL$QB^$&R#P$(2YH^F M,_4G[C'0Q.3X,O\X/[\A X"6S\-(Q3AHH,5A( !E2%ER,$!MU!5YCV>6*7',X$Z-E MMV(/)SC+3O?K&2S=(Y[CYP(0%3W>\]@"'^^'#[!Z '_#[_5 D(#J],"+KB9> MW;/\GSZJ-$1-3L!O\[C/#LR9L34%-9W@A26Z0$0>$=P+O[HWM W?MT86CWFB MWQ@3\W &QKBAG ,! M%8.+?(5Q(E&!#RQ%(@-M4V8D3-2#'C:<7\3U^+BHP( MCU-\F(!XF_3,QM"$1RON$X=;%CQ#QW\BE_OBDV!8V &C%ZYE#=.=1A'Y^=T/ M?*)[UM15)3*B>I-#B<=65=<^*&_OW:DU5/IM72PH&09*C"\LIWBFBU>W23BF M12$T67/3)7LG+D:#W>/^ &_$^?Y[Y:WV#L/"V! C?= $WJ'&F)B]6%26+<84 MHZ"0PF7\!E17%4JC*F_U=T+>D7H-N54>B?!^4;L1!C>,YVWK'5_>.Q;.*<6D M!ES.&\HYO/%O"+&!, 9'@PGVHNT(=::':&["]_-_9%X MQJ<] ^?1CMZ*GR.Z/,;#6<4"\F!0L4\B.I%)T-CYW06*-P5(GM4A<37UK=KMIOM6FN\',(5%RT M ]$B/CKZH&GD,QMT#^+>,&7AB_O,,()?>GU5[^D"GC&[ $6TIQ:QF6S_P$'_ D9R]( MWIHA*]GAIK%>ES&5+*3/4LK$)Y=0-+":C+PJVBB^E$<(!&9&RQJQBL+5 OH% M<7>;DAT7!NQ%C5,F<+\;CID9VNQZ],GRXQO"3O3X-B[XN0&F%1+$>3V(*I=(]?.'3H>B-^)B)Y20/2_-P M=WJX8\.[B1BJ;KN,*I00=*I&14Z9[G- ->=WJ6ZESN]?!I*\'6MPN0("+3T_ M0O]=Z#U93["8N*/CB8(.[ !J"6C=4K4$BI9 JXPC1\A+O=E6M59?IJ:G.PKZHJNQMGMZMVVW&>, MF7= 5ZY#QN4"^OMF/!ZL0G3[ZD#O';WF#7JJ=@)!E];MJ(/!\0==H+6=;GE[69]@ MY",+C&_&R\OAVI'>243[?1CF8%]5^W8W3%W35+U_ O92[ZK:H#:&I'1$.A]IO'[PGT:K;QZA."_ GM/>*-^4EH&]*(R!'NSRMK M/;5] M%'IZ=V6[4Q(>6W0[Q'P[&&"AB28*Q<8*[^A^LD) MU%%OYCUI.UQU/ '# JNWSO%OLY879'VB$CH$9H'U5\B4+Z^&'<(*!VS,^= R M\7I,.#E@J](YB3W)XS];D_QZLS9":=O@CU 9]M=\]_H21VMB, M'/G(*^ZWY!CI5VOJ3@S_9\X!Y^BT@(#672.JO,%=)BG7XN[6(3*ZUU0[_:+I MMI+;98[+"N>+2W;7U(IL.U9=1I=>R.O<$QI)!)51DB5Z=5JC-W24,H*WVFQK M2?3KNRZC86U]H+9RQVC5,E6*9DWJ3T?5^V5MK13-%D2CJ9UV5VUV\J832N'L MTJ3U>VJS638D7,?4!:[S-T)%2KY*_F7G0J,2,(&;PV/-0@@F+>6IKGC04%NK MPQ*$M>106@193&)"4CS! ,9A(6'<$&B\_>$@RH!RAW4M_'<*UK<(":P*WK)(?'^37CE<; MNT:A6HGE=6 KM7WQ;A:XJU;KKCKI]+YAIB1$DH3KJ@O4E-1%"=>UE,PR8CA0 M7)X<.B"1O.I"W@;3H1P.DM[.CS:"565F%E\%K<,^455*XO)HC;SY4DM(SM') MKY*=DIV2G:?.SHJ<0.F$M7\N*"2XI_"@=$K0VP(RS=OFN[PS0K)#LD.R8]OV M;NO)=C?,FQA8_DHQK=&(8?U$1AWX(6W/O]7X\DG\6="#G& V3;.PFRTGP*(1 MS F*Y&VGD?>64C4RR6TF3U@H2*"D?.EEF*IP&%6-E\6.,SR MJ8)5Y/@MSQ?\' :AQ[Y9CC4))[=4=/W&>*6*L9]=;Z:0\4$G#E)OZ;+78P-S M@ +F4;5.K-8Z5RF>J#$>/<:HLBXOK*VXHY$%*W3+4;ZX\.0?\*],0>U,IB!( M:&(%\>L3SFE1:'HJ6*U N,2KP,.7LR7F4S6NY_)CXJQ#!P:L!,^NR&VR_*2H MJ*PINIV:HKM)G[C/5!YG#O(GHP?$Y3VDI>PMH>3;HBFT,RY4M"C*?Y+>'>0_ M^]&;>LD#ILU/TW*0MV%9$;U?KJQ(3QWDAODOPI9]K8^++?#!,7G,&,%4D[LO MZWAU(--5!X;N94?@2!RX>^RNTO-)YU/)F4WF358N+ M396N,*)ER\QMJ4R+-Z$WA$B>7<1Q]F$O4]9X".@RQ _1L%/K"WYA.JP3M6N7 M MM;Y05DKT:D*HG9FN<:D<*77X;BN,[9$/-18*V :Y34\UBC:QC@JFK].FR$ MN]%\(68X)GXO/'!F7>;+A9E[)NMU3WY-II5:DW4'+770W 9? MMKTH*R#V?<&RED_4*B:>?4[, N+8%S[=T8FCBKFQKYH11R>,:N9&^0IV4AQR M,Z]>FWFZVNQK:J]PE%'?Z#/7IEXF+B^XJ[=@4T'N\&UEAZ^C=CJ:JI=6SCJ@ M%Q7;CYO-1;ARAA[N_<'2F?Y[Y9P/AS Q O\6%M/6$[Y\RVQ$TKDQ8#(Q/^^. MGA(Z%G_HQ]VG-XK)AM;$L'W=,\+LC(;&34M1/SO=]?1:?V8?.@R'HPM]'Z_ MN]X=+6UZ[7CNKAJY9'["8GAGBHS:%KD,D8%!Y* ]_Y[(S6&+&!W;]> :G+-G M]=?J*1^%*A4^!6)!51!-:)@)UL G3]FP-G8)1S+,UG/QVIBM%/#9V);P-H-M M^Y]P+>.0#;BJ/+O7XIDG?^"!C;$;I++&V VRUUFQ2_E'#_VC$JS!=9Q)& E0 M<4^77+)TG F!F\VVF8WD2W2WG_U;"# M=XF0J@7:-)9J@59-RD;GGD0\+[^*KAVS9.%'G*<)3^DC%*Q<5:7K)0Q] 4>= M#6<7M8+C@'B>IDN?D-5JUZ/P.MV2!1 _+L:'P9_M"TU<;RUV\=9&A0%E1PF3;2* MN^V2VS+1#XW\,X9Z7+2EB?,ZL>^FC7>Q0-.WYE4AS! B>9+7,54 M"^8L"3'7XL9HM:P-*K$D$&N(PTS@'N7(FF62)53*UI 8NND8(WM!!G>&!)5A M/OY"\0M02P,$% @ TFY[4/GCS:4*$0 K,( !$ !A871P+3(P,3DQ M,C,Q+GAS9.U=W7/;N!%_;F?Z/[":Z33W(,NR$R?QQ=>19?NBB;]J*J7O(R<#N8G=_^%@L0/+#OQX]U[J'E"&" MCSK]G=V.!;%-'(1G1YW/X^Y@/!R-.M:_?OG;7RW^WX>_=[O6&8*NPH4^Y!512X?6FYU]8'6[ M!F*_0.P0^OEFM!([]_W%8:_W\/"P@\D]>"#TCNW8Q$S[O]]_V] M_;[5W_TTL4[.+G<>I]R $^"'E7N[_]@[V=WG_^R]G?3?'NZ_/>P?_&[8D@_\ M@*U:VGU\M[O;W]W=/S-COT#,7C&_/[A8L+>/-^BW&<3O@A. ']A7\&DTOKU^ M_^/-[^^6\&Y^__6X?SOV0&_YSMN[//!FP__\^/+QV]?7DW]?1TU^8/8<>L#B MF&-VU)'\^+"_0^BLM\&CB_"=BKS__OW[7EB;D.8H'V^I MFXC>[XGJ6\#@2C*O11IZA)D/L)VB=_P5@TS\IA=5IDB1DO0@(D4)J0,S= S: M.S-RW^,5/=%!NKO][GX_(0]8=P; 8L4R!>PV%!U7J%DH<2%3\H0U"B9&_3P] M+U23=OWE0M7 JDK!A@G&@:?VO^/3GN#K<:(NIX(4V2N^R0+VD1J'= M8#"Y7C& &5A X"_X./=ZR:#E(LL4"\<')"_[R0?3B0X':A&MNB1]\=E++ M%I4]/K(#H>4 .Z?81_Y2#'/JA2UT+.0<=;04HDVN0=BJ Z<(HU"UW>B_OM6U M$G;Y)\".%EDQDO" 0><*_Q+^7E#(N)B0Z9P7Q(PQ20&3#5P[<*OQ MK%51LL0%B;DBO8?WN%O%7 YC%P\)9L1%#B]QK%B0 M%4G:NO<:4&[7'/J(:ZOP=;I>[_A]<\=;KU*"?VHE$"M?L:OIU4+$8KPUQN<4 M$7]1.(>8H7MX3E@\""K0ZX%ZK0-JW8I%IM:ZG7"&2K5DB:9:C]QP#O ,LA$> M^\2^FQ/7X3'SZ?> S^1YV'3$>LS>F&,6-V(A;,G-_-.*&MHB5@R"8CK5L!'2[2"F6VTO%7= 8P^A'JQ9>AXX A M#!D[!O;=C)( .Q$(Y61Z0-Z).)GOKEW" @KY'[+ <%E*1%IKF:T$9!QX'J#+ MJ^D8S3#?4]F [U%LF_O#1WAVS7NQC6 R-,QH]="\ST(32Q6#0Y)KK05;B>16 M C3"]Y#Y8OX8X0M [Z /;ETXAG9 ><,)-*546E#ZNUE0UO+$.K*6:*U%MAZ- M2X*[GA$BA91Z5/H:5$;8$E*WR"3(B(55;&SX_T2@1&6!34Z;V_E_5^ MN'2'6QKQ0Q+42G_'\S.[@3;DCN ]D'5OH"M"'AY@)CN94BH]!OM9#!)YEB20 M%\$H2.2TTMUR'YY0 M@!FPPY1'Y/#"6KW+WV1=GNK6EBRIE4XO3I=4RXST#W(QZ#;I$>_/_#FDUV 9 M3JQ\LN#S+0V@5C4187(;E M$PM8B9Q6.GI(L,UMB<\"KJ8WB-TE\;BR2NOLO=P6-2U$I ]",2WUM>I&1Z#W>VX3*HF*#W@D8:WT_CBX9?![P,TYO5]O.G.E>C_GMIMK M?BL2T%+?FN0<-\E3FN4K]W);4/-\I?4J^=7.4Y;2+/XDC/4,4_XQL1ZMW*[5 M)/%OO8IDMQ,EL]$B0U6)0X]7;LM;972U&;6RA+^,ER&M'JG M\;/%>M_G<@1R-K?='M8DN&2/EY/I$HD[>P:9FD@]2#?D%*X J#5'N\"Z8S2BA#Q:GH#[R$.,L/_)1O0=X]<6J1"]TC/"6F5 MY*J[S.Y',W&?4;2PTH4L6ZV MR\BS]Q/5 UDOVH2^!SWA>8<->M#VZ2Z#LQ%U2%*92XO[ZTT>J=A&(88(2D/5 M$#8SC#>0J^\%NDMA7Z3?;WE)T<%8^YHTY]8@K+7.;0M%_H9@/.M9T1C!\&4\\!AK1Z='-)QL*'Q;;CW/"\ M71J$9:2I ?X" M08Z^/^32D(7W"-)](&[72AK.W#EH-?A%%PHDV"02O@"&?PF*.5JD\7\>4?HN MD$LU:JXPI#N!3"C6\53CVTY0 ;D4R1-Z@%*.'OYAB;WHEJ]9"6 M;C\596>*"?0H*M)N\D6I[>#- B"-)/'"1H*C%Z!%%-R+[!A."84KCDQ*YA9,Z@QRJ7N2FYW[]%K PQ M:24ZAX!!B32U>#U-A![57$Y'CVIZ<0N;3'&T>VDS ^HZH/;\R7!KI&@1/U"\ M+<@<\:35_W?0Q3_B6TTW<&J%WW@Z%!_J.>HP)#[FU8G+YA1.CSJ ]X%N\AV= M/[AI.X^>FY (T9IO/(7=)NN-N.%$!*!V3DKN&U1<"%G \&"DERB?"/"1+]BO MI68LT0[O;[WG,-D%MU5-YBS0?4%;SX7\9S62][ZJ1F8Z[ N9.ERW\JP&\Z%3 MU>#T:'LA>T]6C63.6M,J2JS=4$V)A&\#);3?@5-IP8J8Q(_NFMM4 M >U7Y0K<$+:O9.Q!UV=)R1.UR7^O;7-U0ED;Z&/PJ3J3KB)S7D:,HJ^\%WVE M?_!$93939&,M4ITOO"]$E\+9;ROU6IDQ^:.[EK*9,@&E/)1:5A]#*<[57T_I MO]GO)QIUW80IZK;BBXI/TV#3(937HV3\Q)]'C'))@\GU'XJ$T@0^^L\Z MH=;*I)-,@UQ7G%L>=7P:B(5)?,+SD"]8B#B3<%UU@BAWT;&B=3;ZRN2AG\@8 M^= 3E-SHX);Q)2T0U+]2$BR..I$XQ$ET9J2OX(1/Q"QS=I01-<&0*D?4X=L" M5D33#&Y)Y@&8X5.)M@',5&?@784DREAD;[.3^INHV^OLH= M &^1GU@?U7D$\[;H\CF@Y,9<3?FZ)NYM +P>;?GRRE!%%,RG",^>8QES>;0G MYFH>.3:%#HO.'1O MH.T"QM!T*5[+DS*5K(L[@Q==T33/RI;3P3UQN'@-+EE- '0!W&MQ9\8_\-@A5B$ M$F9B5D,JNAH7;^=7 TY+4J'?_8\16W4T,5&,_?F%-W9RD%^&%=W;R(TXFSJ: MRD(B9AH[-7H-$"J+=2ZG='Y]-"-MK*7#E0#:0T"P7G 5^0.$%PL@+/,4U\#(' M5.9O@OFYK69)9KD"?7,GV8#YQ(,TGF8RD75A;6-C ,P;X%WM!$;_'^&,"5)X M5TK8V'@/W 8 7T#O5HKDTF6;#B>'> #A9^Q7+*UFOKAV3;] [!":5C-35KN. MOU((\8*2^#1XR'N(B #Q)0$Z:6NJ M,-1NW>H+)9I?85BBO$Q1N_Z9]%Y:]:+*VK6^#MOB6Y6+;S=I ME94U#=%W<,]#^!DLT%E1VQ"]N3<_?CHI\+-O4VJHJ:M=6/NXY3NNKKFJ4QH-BC0?-T3@)20?J2+5!FD91Z4 5 MJC9.RV.5E@WJIPF\:M";HV=XC2&M9+JH=@WE83TL'O'#YF@\<(!W"?T'0N]X M/ O$?6&^.\]L0?0TM=L0Q0-\5 T^*R.%3$U#](WCEP*=%;6UZ\V54<<+JHK: MM;V>$XC1X[4;L'R.H*BR=JU7%UFNII^Q>($$O9=O)Z>M,"6NW:HPB3$^'8P= M?#Q7)3CR=0W1.0B;I.?H7GR>S5^>^TKU=62U6Z)(B,5G^:6)LRQ=[;8HW%W< MJ71DS;"$_Q@P!+29/Q5![=J7/_^K"-3,Z&NW;1S0>W1/Z)C7V)DIMZ"N=IU/ M,:0S](-W$<1_B<&;O-@OD\8T(:S=FA'!0L4A<"_ +)/+5%;5KO&5!V?@V.6A M9J;?Y\MKU_48^N "/#ZF-G1'J!2Y(ZZFLJ5W? MZ)/S-E?.GP\!A4.7;^887QJ/079;;4)9NSWA5 9]]#V 'Y? #7CG0/; 1LX8 MTL!33'OEM+7;-*'($[N2M/:YTMKU/$<++HK=94[>LZ6UZWE!/Y*'3^1N."<$ M9Y:2@KK:=1[QW1SGV: 9\JSME5AJ-/A#+WHS M&O_Y7U!+ P04 " #2;GM0*IYBP[03 "H $ %0 &%A=' M,C Q.3$R M,S%?8V%L+GAM;.T]:W/;.)+?KVK_ ]=;=S7S0;%E3Y))9G);3FRG7.>Q7+9G M]VZ_3-$D).%"@1J ]&-^_0)\2*!(@ V*)."]2Z426T(W^H7N1N/U\U^?5Y'W MB"C#,?ET,'US=. A$L0A)HM/![_>34[OOEQ>'G@L\4GH1S%!GPY(?/#7__S3 MOWG\S\]_GDR\"XRB\*-W%@>32S*/?_*N_17ZZ'U%!%$_B>E/WM_\*!6?Q!D/B M1_\IIM_8FR"&H;N+4QJ@#:[CH^F'Z?')U)L>_=>]=W9Q_>9YSADX\Y/LR^.C M?S\^.SKA_QR_OY^^_WCR_N/TW3^ /25^DK)-3T?//QX=38^.3BYR\)\C3+Y] M%/\\^ QY7"V$?7QF^-.!Q-_3R9N8+@Z/.>3A?_]R=11D^N:9A0>E\#,)TCA"MVCNB?^YE6QZ]1?^&OG)FEO& MZE!\><@5E*X024Y)>$X2G+P(;=%51BQG(,.VI&C^Z<#G<)/2-$27?X' )B]K M/EH8%L9^X!UVI/*S'PF)WBT12E@;68V-!Z#CQJ><^25*<.!'1D0U0O9#H1A@ M2"B%S>:SM? ]7!F,:TCX&XJ6B##\B*YBUBI&4<(SC9LX MP@%&[8(UPM(/Y9?D$;%$:/.2_.+3;RCQ'R)TAX*4X@1 ,Q2^?VJO8S)9[4EQ M&XY^J!:#1'A7_I\8T8]^) 9/&YUZJ'XH*ZR+W:( \1ZX#-CD%D5\?(?4+3V7S+/PP5SAM8QP^URU$/U0YG,\SWU"?.#+*:VT=8&UY>7-P^Q MPT;3&0]G],9_R2R&:X7;$4U1>(7]!QR!1C$<0U^>A_^([OUGB(.I->UIM*[$ M8#M+T7U\ABD*^.2S=8"J07KR;3'/?4E2Y)"S^2UFW]I=FPZH+[I6*YR4HYYW M*$(HG_H#3 L VE?6\,#0[RGOZ/P1$A%4[B&PP^9Z,#IAT&-E M64!':(BG]XP+.N 4 (-G%##ZP A&BH)GW!OAB%W[5"1BCVCO>*A".!(_$[%> M$*81X@&/9THXQ#[%N<$R%@>8CSM6D+@WJQWZ&C,_,%7M?EC'Y$P2_!EF$W^Q MH&@A/*JT0L$G%(@GR"E8W2-T;4E&68B),M+.GX.LQGQK, Z&ZL]-:9@5[\?H M?)QLW-1;=,4W#C>2R(&$[LMO]Q['F[/LHV-3G.-QI9 \;]Z3N@?I>,A5!5,] MFV$99X8J";>M*5"EP_4XY,Q7HBIK@,/SYS4B#,F-@!+HKX=A9]$215(3/H:R MWT2+)5Y#F>ZU$QM\5YH,PK2NAZ%6GXQG)V ,8]5-)%FV-X;..0?MM?>:C'E" MT0K:.XV2P,36IICDFU;R%E',)_2(S]S0!@*<(/35PY ZM7&R;()D\*JS.?7&J ;G0;+=*^0S)#4%#H1>D(_)YTU*@^6 K+;CUW$; M^%&0YDGP%?^] H&>$T1"M-D[*9C><$YCY[R X+I&RR\/WUH3"+0Q0EK/PD,Y3)T;0X,_"7XN/?\BCP):6BN%AV M$/D/*,JZ_:UHM]/LT![!S?6(T^0+=TTOW-RSXR5J1H#@NPQ*IG-* R^F?*KQ MZ6!:]N/3H&(P]0,<18M#)JK" LT$<\LHX>A"O50,+V=6-4;A&_G ME%6MY'$7DA4+@)$ ! Q3W0]656<@!>% M <:(8M%/JY!=RP/@L!TO#<816"+.C:PVIZORMW8F$*ILLWN0LY,\*_AHLCC7 M#$9:<6G-K9K:6L\RBIE)L9:D/4FERD% *&R/&+6B&JW.0"S.V>0.\??4#Q%X MOMT(9-M-@)4'8-UU=76LD^BA;2A8]H. #:J+=:6]OS:A,M*1AU M3B?9&N-L/L3NE(0F^5,[I.V$!,J;.M]UN_K?D;^VV\E4;/Y\N,OE%?]]E#V$S:=[ M*QL*3^ ;"KWO*OB^'W G9(>[8BM<_:#C:HO%GVVX;/2@9?U8,_+?*6\ M_QL:SW71O]+(:LK/N-/^&L=A-JP0?<0!8G=\P.B2?S6,;3?8(/Q:_M_&<8-G MF-C.,[.+(L3^,K&5F_I!\G><+,MZT?ES$*7BGGJQ ,K_AMH\I1,RV^Z_7:][ MR,BY1"7+L@H?1Q9YAE7L3N-)5LL:JP:NS[JLIB]%<58+8=MQP$0N5VL! G#. ML)JVVOQ**/(C_ <*O_(YG!R>8;O"FN!MNPLS;1HRYZAN2P)GY,[/+IL2J>\E MV=PY]3*C>0;\"TJ6<5AN8-3D*%T1VJXW==+^GN(;?B%,$">B6T[%=@\=J]]% MON-X09"V:TWF#MA ("/L\ERM?4Q%]X*L2U(C2J$; )SM.I&Y9L#"<,Z);JM9 M92*)2NN19.&V0<[#2S/0(:J=Y1 MR!@FX)HV-[P4EO<9$:2M^"D!; ]@N(:5W+I7,6M8HBJ7I_AO>27H)J:9D).$ MXH.; _X@22W8U#-1N?:(%>M=EYP9X87)-\A%LCWHIV24+J\ M]33\WS3/>$L1-DHN7Z%I*>N-1X9MAS2.!5K1K4N+CJ9O(U;6ZM["U^H*W!XF MGHS]/_QUS'[R=M?/;;$)6'5]UR_/EE9FZ\\P5IA\;\ DQ^3EJ*QFU8*.[+XY M+I#/+[\R<=A@,STX%5>VM>Q1-L'Q_Q,(\_324$&O,E7@)%)Q<=@9RO^_)-5; M);03@Q9(VP%Y;Q5"A>/>/*).^%[!>.WAC/->2&TO MP Q@#*__?'2=IV[W6YGBL;WF,X Q=+P@RW( <&O'Q' G%/=6^-Z[)RPK^K5M MGWCOKBGTOY7"LFV4=V4;%_U; 6&Z_M%=70-%\PH">]O%FUTR?34NF.(_N*OX M[@)T;WRW3F/VMP0%(F!UYN@UVH%6=J_#(>S<7-)MSJ]" M2]PZ6Y#C+[/[)/ M30T7"G MX#LWL/W6S1IQ]&F/-\7KA/?Q:<"'A=A8MAD6VYN9%48)!79TW4RC(-DPS43D MG'76R&^J+JD-$PCNZ+H:0,5F?(X6*&KT*&YWA@Y-);BC"V==!V>+F-R;,"OX MO\#$)\%^T:,1A]6[RN( H7"SM3G;VX7"UMN8VN ; MFB'"&KYL Z*H>/]3F4"8X7!TQP5 BQV8=734"@'LO%MWRW,HBH,LEF3OVE4_ MD%K>((K%^N'N)+S8)'[^'&3[<,4[O?GKO>JQ/S8=ML._';G7MW::%E^9V0OZ6[D>(;9.F9^])7&Z9I#\-^# M_-@G"K>G/M7>U@7:;$=_)^S#; M@C-#ME?%5<[._"@>HN9,1C%+*>*_R'BRBPI+3)Z,:KAC/\(0ZKJ9_.-=\K,39-D%GN*' M"OQ@!-=W*;&)/&5J)OUDE_02C2?AX1\7F+P"U6!<9.=G\AF?\*SY8J-"[#_L MTBX!9]+?@@]&KRQAZ4BM@N*WNQ17Q.I5$0QX:A)T%G;ZKN8J+1QSS8Y:%'MM MF/Z,187X][68)1!Y):;,/@I<7N-QE0'<8_VEJ K)M3";0W@[+V/U[SE68L1G M;R.5=95F FNQ,X?T.*B7Q)[O;<&'\\LQ"9"X!C4;);/Y+6;?FN5Y7 N/55@1 M\0OH :E=K7!2NK/\!ID%(LKTY+@6"24,Q970%1P#YE@/#/V>\G[/'Y61[[@6 M^;9@7@EG.0W4IH/'M?@'3P>][\J?ACSBWIJRWV?^K)F[6H2$).[>=SG*00_N M@U2G8ZT62DT4-SR#;0F]CK5:W 6D]6/SI,KO=7S50C(PRQ^#M[;L6<=7+6Y# M@WQ5;JUAX*06\]49]A@LM&>O.F9JR0 LAQW'%VR2 M61T'M?Q 3FG'H%.3@.GHKJ4%VC1L%$MJRP/.Q%-5$;OVJ8#WA64-PLA5KR )("SS&*?K,D0^HY M'XF;OC?RLI]"P:RB/M,W2*9&M0T8UY*!<+8F_F)!T4*$@4LRCVF^B"$V%&0O M:^A-I9:T&(BF:C!52CR)E&PF6A#CD.U(4I3NAY-75/2BJ^5%G44G=>^5_7NW MC@TUN+C:[V0[V6.9HH/L1KRRK6UB!')8/W19^1C94[4Q*ID+4";-HM"MG2A% M4341$^%];_%.O";9B+LQVRZI:8.S>CJW%/WLB:#P-!'/>*DY432WO>D*IIC: M(5L-ZV,^;'%)\K?3M@0IMF'J06QOUC)30CL_2D5,K.U?@%2@8 &D86(J^T!- M+P\90TG[S8 @8*O':F3Z#-DQO,]PN,S+0$6UDS(:_H=/OS:K M$?%=NEY'&%%%TM74T':JU4'J*E8@\AXWR5(MNTB>LGKU4?:;:+'$:[VKK!73 M-*LS56=TR,R6I CWO1&C'&S M]*,+!+A)N0W.=J9A?N=U;,1?[XE';^KWJ<$/4J.TBR5[/2C<$$7,85)H:$PII3"!KO'.6YF^%_Q><4V3 $A#<=L!MNWDZ[L*4HU&VH+YXH\Y1@6V^?YS33;14+.JKFPS\X*;H.W?82]FVIA4G$TXY72 MH_SL_.;A4/ZUV"ZDS8]J*V6:_&B#7LZ-1 \6,\)2A?SSO(JKY;:V+*;AML2< M<9GC'H7/AD-]L$E-;3E+=4E/MN*M5CO7\5@=BUE,%PH7YV!7B+@%M+H;*B"S+)"_E?:I\ MZ*EC*AR#Q<0!2N0U-[+[)Q0]HE^X*I>:HEIWC+;G=:8JW\DV]A7E" ]5 "F\ M7R**3N>)+H; M+XT&T/C'/U<+UWJ&Q$?8^WPP?'-T8$'/Q@[R9I\/OCT,1@_GU]<'EA\ SP$N M]N#G P\?_/.___,_+/KG'W\9#*PK!%WGDW6![<&U-\4_6U_! GZR?H$>)"# MY&?K-^"&[!-\A5Q(K'.\6+HP@/2+N.)/UKLW)\ :#"38_@8]!Y-O]]=KMO,@ M6'XZ/'QY>7GCX6?P@LEW_XV-Y=@]X)#8<,WK^&CX<7A\,K2&1[\^6A=77]^L MIE2 "Q!$7QX?_=?QQ=$)_>?X]'%X^NGD]-/P_?])UA2 (/37-1VM/AP=#8^. M3J[BXO]PD??]$_OG"?C0HF;Q_$\K'WT^R,CW2W& ;!%%#K$1D<2G8;X.4;, ^&@R/!R?#-RO?.4CM%"F; M8!?>PZG%_J<-:ETKF($E!,&2-J+%(?ORD-HR7$ O&'G.I1>@X)49EBPBL%2 MB-N#_K7W$&#[^QR[#AU6+_$:5M3@2_!1BMVI9:S"\\6I +^ M_,K%+TK-IU"H&5QW9 8\].^H8=)V>1;ZR(.^?P;L[S."0\^IPBC-H"$]AHL% M(*]WTP*ISB4LT@ M2UJ7?P]M2&N@.O ']]"E_=NAHT[U4"Q;OAFT8P*7X#4:>:AB+N 2^ZA:C^)2 MS2#+ROQ(@.<#.YI3J[!5E6MJE%>?8MN=3>_H=$;&X#5J,=0JM!V1$#HW"#PA M5ZH7RW-H:N2A/$'L)(98 JD#?76!>ML%R%\Q!>(0)NN4RL[*+](0V,;IKZO M%R0^Y-WT'OG?JX =M:<$(7T@F/>DK(08"@N,'Z/K81[7=^ M G%G46O4I=,_4#7M;EQU2I91_ 7R!V V(W#&1M3,#@5=4$#J((?2YM90=4^C7J M6[/L8F-5GOJDXFB>DC=D[E8J;G-70=7.:ESTK% SRJTBE31I>S6VN?+-H(H( MD'.Y6D+/AUDB20TT5T.[J^@,H@P)[4/1;XQBCI:R0C=:21=RYTA:$5I40UN[ M3\JK$VD.NN(F&5U6$\NN.5NMM?&8C+I#45FT<8P9A;&C3=B+#ZW$%"ZF"WI( M5VYP74+:06BJAC8E'A/\C-A)U2M,FI%0AF.;$EU.I]!F#6;]-5M [222%,LV M9;J 4T@(=.CG(]^'TO-Y/6ZM[4.KC@8*+%KOS*IU&3)M M]P8"'V9()3M"(\QURCD.B3UO4=1J_B)I ;%3@< MLB!V^ 0'#EJPP\7L$'E245:C:R[("PXIZ6%"/R<#!2A9:6T=HFX12$;E"[4:;%\YCI MQ\A#;'Z[H;_F<,-5 #T'KH].,X8[WC^A'S,>1_&?H36PTE+9'X'G6#$+*\>C M+>3EUTQR4(\IOO4Y>/HS'8Q]["*'+:NMI+R5,M""LWS_( ?Z1!ZT]5..W]_; M$Z+&992<4&]%0FV86WAJ;=A'32I7@177H$-*F3LK.1'?R8N8\+:09V6Y_PTL ML?^SE522R)A*Z6([)YK+;K1M'RW-#BQ3X#]%HTOH#V8 + ^9EW((W&VL)ZD;C(/ -QR!LU3-%AK[**4.%81@"><8Z/]MXZDV&)#$T9 M*'5>=QT+=[5@)"3/B"?=&I$% '#L9-PFJSJ> 0NDD\9MEU]>="X!\9 W M\ZLL54X_*1O%#3.1 #EW;NJX,]EVN BC#>QH%S2WC(NW12H[EBR+2=D0;I@% MU83ASE7=&I6_%"YSUK=I)^^[,9/"DJH4LIFSU<,<$.C?A4&40(D."@)3;).: M;XE2Q-RAKE-#?(5!W'^ST:^B$7)DQAN@B)8[)'4_(EW[?@B=BY"P(]V0(.Q$ MF;"^PI?H&V%$0:*X\<:2EX)GQ+!.I;<:O\OIJQ3 R>'=^9:,>H'<8? M7V'R ,DSLNMVR@*;?;6J0!J><=^;:-RX=>YN70Z??36O2!R>?4\[M2]O5<(< M "H!1#/O/"0$>G;V,/+(VE1;%Z[ M^I#9,#W<4@B%^[W;S52)'?'WS>ZL=K-K7LS!EY/Q5$%&RLE*6+6%7#XS7TZ* M#^Q "/+91F-((/TERR?:SD\Y65E6K>E?+55?3I2/VZ(DS)@%,NRL#3]KP[ M M@:3S^&5%&1YMB[)APSK*AI&5Y:1#ALK,?CDYA@(YKCV+,=,L2T7VOQSZXVWT M43^.CKBP'W+EV$KG0DPA_QD&WG*QLKPH1\GG*R$55M"5*0*S$%_NPT]4SC2 M_:9X6W KLP?F +_;!IQ3JI5GT-Z$77D:?B^,$9R3S.U-U/)IQC,83\M3%6, MD95RBAI'PLO*,6MO7+0+"0ESB N3:US"2HJT-F8(DA/F\!5FS+BD18M: ;: MM2G>VG@L3%F817M)D.,RA M+N8$Z#@%62=6 TP!4Z7"';!&1"Z7CJ:4>TTCSFY:OH!"7-KS?WO_765 M_KK*GEQ7\4F0L1#];=LZ]*-)-OX>W6ID>4/+;Z=0%S7O?;R>]^^]^U[W[[W[8WU)7O?WBQ[]+Y]4[[]>GJ.;AD"[U7H MR7.HC??;!;B;'JYD]7SG\:^GED)>%]#N5>^N[CQV[I"TRQ3AIP+ZT'XSP\^' M#D3QD$1_V!Z-Z$>3&S@#;B3+*V=JIE0%(D-GY#*H7#7KU'(,B#O*4Y(\A>9Y M5J WS$'8RH3:LEZ-G"^5=:]U8OP*%G3=',QA,H1QANEMLLD[4T,>7+0288TF M%#IV@0W9@0 *-,Z,3I:8Y-) ;NE64,)L-5>HFR+/1$K@CEDD^=S!X6\]%2L,5S ','8S_/"%N8^U6 M2Q*>0=]V$^+>\3W*7#"[>)5 X=AF?QRE#UG_V"'K>SHR)(CYD>H"D:'+X3*H MYL2E,]!$X<\2,OU1:)X:2Q5M8,RYKJZ-7#'7LX?&W*3*(\TZSP W%KHE\U:! M+F*A_ 9?/OJ406XE!+K[])Q]2>"&5<-T*,R8S2]AZ-10B;N-L&D[EJE*QRPJ MTTW&[$JM5QO)$S9S=K)R%FH:5MJ#>M67XX1[LK)%N_JY)M$C\$UI>%VN&X' MQO6MH,L56*#X3.8-^@Y=-,?8N9M^\Z;@&9/XMF 0Q*V;WQ=KL3,^"%1?*DV; M ]>+)4 D$@7[_K471ZTV\2I.=ZPJ9JYAI-%K6;8J][KBO=7\ ]IQAC%!/Y-D M8*X!:\AAIF=)QP;"7L6\@/'_UUXJ4S(SY 42#ITJC(PW;1UY)#9$S(N?9Q\. M1OX S&8$SIADF5?VV&/QS] +*TZ,%Z[:*P39\^?&\TBR#_Y%B5,2,/T1\CX> M_V/&X\<$.Z$=W*697?E!^7)*0\,O7+SFA.<3?&Q!E&;5%86.!>3ZP_5"W19, MP!?1B-A]4X8P,HK2@+$T'Q2G53^S1-,NM/GA^OCX;Y&T@R/BU8T<5V-N>ECB M:/?2@V2&_@V=6SJ-$>!N4L6)3XE7EM/^/)BJXN4DX)JA83M<8X]A.0?N+9@) M-5]"V<5FE)*N>9@;WXWB!5\7U)L_<^D*1AQDW2+3_OJ6JEY+ 7,'YH:5>D87 M0+=@M1*J-$\T>6NX0DO@\M3YMND1@&!/W/'7!-HC&,K]/0^5I$W#:OP=[JT MGUW1Y7KH J$JBX3:7U=052D',D^U[YL>0:,+^#9%$VT512' MM! \@WQHV""/!"W&;BC>P,T333X:KN02N#QU?FQ8G3=H26'Y_#>C&56>B+KJ MANNS#"\_$MCUX\-1C/N*"LMR/Q)@!_^#Z- 7^@%>0'*YLMV0)1X:^3ZD?QWA M8T@UF$W>ZNX=JC'=VD+Q3-Y1)A_E;9K,4TU4R.A%HOO*;#Z%?,&U]V8RU5MI M_=9]G]*GWX_9R_T892O]!@B*-H"I".+CL45*0_=EN'BU[,OL9(&JXY5EM-T< M?^5JEV\$PX^[[F8'(S=F=K65UEV9^"W02\^Y_?U>Z*@7"77OR%0W;EP%5]-F M3%SYZ!D2,(-RBMTFUAYAK:'=4LRZPJQK W_Y]4*NX:X)M4=&ZK75TNTT\&79T>+U&X]T"S1T@FM[)BD'0-=[HFXR*LX2384-B"4TT>A^BA4&U8:O0#B/-):Q"&H+3*SXT^E M,ID6?'J8TS'F#-!6P-+H4;'CNZ^$L!&)2>B?O6YHQO%#=I%D&_$\9^P"C^7C MJPJ;M%-;-P&PP# /L2 .@?K)!]L$+KLR"7_8,5!NC5R%6EV0]6_$(@])8$)YGOSS%9 M"IU<+KWN=2&OP6))K&8&"?.YUIUU8C;JK MSZ/!+:;\&J9XPIP*\A*?:O:5& MP3GVA1GB2LCWS389U&9VG[C5Q&]YC FRX1B2Z+.*Z&99$>.-(T;.G;_-7-]E M=H\EEX+E*\!AG15@?L=89]4TZ[%Q4Q5^%2R,WL"65KA&\>@IAB;+Y M74.NO+FF4Q=#8FW82*Z3S-9CLAWI;5I4@I+[W*5D:7/MHBH$=R(WKG=]Q9Y= ME:I=7,YS"CZRG M,,?(0<_("8'+S[#-(34T8,('K,7KJZ=\EKD^!RLW>)7[$%6& ,BFKF.C/ MQRTVA,!@\+S A'J &-^RDE*E*?I(/]WW3Z%!2(T M/8+RSO23+_CE5_S]?(ZQ)\Y#74;:17[?';4M%(7KGW?\"-:?]P)>W?A"?VNJ MOX#77\#K+^#IT(FN[;3Z%_!TO\W1^0T\X5,>CD3M3WL0\*U.+?<' 4W0 MJY%SGMD' <=S##VT8@^,5!X"+*75_@*6Q E /E">6FN_?]7P%O'E'R&5C*W) ML,=68>*P8D4Q0P=Q.?!<2W6;>"*/M2K8PR'O)O GIW L(X"AD;PFK&/D'-*T M!36NKI2-2*$NL/<08)O_[E1"6R#5_G:@5#?!$J!YQGC?[39+(P?3N\J31GRXGO HY"* M0]A1;ZG!;[N0\4:KPL[U+\PR4WQ=6\%$<8'],T\&MY8=AMU-DX6H7>7S?IKYOTUTWZZR;]=9,F;&ED7'C?KIMP-B'32Q;^ MW91=8:98(YP4U*J[/Y=/5$2K8U1MC]H(GO09)>@5'_0I)UYI3]H\N,= M--%]Y*_V09/6#O\9LI\W[.AIU1TW](:BQU4;;NU1Z.AN>@]]VI73" R$;(<8 M>*^<9B\N9+#:9<&;N?NV:2T)V"OD <]&P'T(ETM,73F\D<8+"+ #ZLZYK_?P MCY!Z:,YHP5XME>E$N_ WV/PMR&GF!N!&0JFM"G^?;.:+%5]W>X\S/MY#VP6^ MCZ:OV14-)SC-&2Z5>!ALBIJR-+V]QTN:6+UYP+&/1$G#K2(M0=,;>/5M(WV]MRC(L%/"?^(<.O MS^76;Z[]Z)MK?Y*+W/HWSOJ+W/U%[AWT;MQ%[OZF<:OJ5;TGWT&>,I5[\@;G M'BOW'4?!.?7Q7I$W^PVXHU84:^5.PTE(T'?EMSHAB&^V%"80:[K:; M/-+9[@(NL8]$4;LLE?$:+X U,URZN7O#]@,"2.AB_0P"0KOE!5[07Y"=2O&( MUS])F6MGUL;;N!D))<*Y.L,=(]MF,7[_'MJ0CM5T%>0/HC,Q+,<8"5XSAY:K M2(4GEM]MAT92;E:&'?TX86A%'+>.*TL5V9Q5WNBS89V-"5S&^==\.M&EULUH M*B) SN6*Y7>*ACMYOZRA3411%2KELZ26ISDKKR]-J4$BV%3P2X/G CLY4 M9522(4'0SYZZ$NOD=%LG>6MG:]O22I:0'6+/U=D?:>^C;GL7=5.V$J]?GKUF MOQ%G-%'A86@QF(2,#B^U94>MI MQQ'S6AXN1P^.=S9WA(<=RTAUGU>O;OJX&G#3HYA0M2$=KA$F-^B9+HC&P>M- M(*-E;JFN\C"K:%P,GJO]]M4OWY=#2=EBV(WO?G"/! K6[+Y-T#+(..6%LX R MA+9>*Z'6MFIJ+!W24H6W7>( H/=N'_0@] M&MW:I=!SAYM6FGOST<=]LT 1/=EXEZ MI:>>F;N6#8:MLSLF193#ZK*,#39QDP+R&L5IIXWB(O;3\WX1#P[?^SF@$'TRLD/V M 8(LH[^!)?9_MF)^I2E26KO"(9P0LY\@6O3TA(#?TF(<8M);0FIPAXA:8A2AZ MH4! KC_-3K6"L0QP;GQ-?R:8IJQAY-F-IBS67OJ>0HKV*#Y(7IGA3M-?F-U. M,W9+/IY\>R@Q4O+EMX<.GGNH;O*X!&330Q,O' >>0B ^DI$EF;PS6'^E8+E1 MN49?P%!IH%]^Y3?0+[]J/XA>HX4F*+G1N0ZFSW1 >["A!PC"$CY,GG0/_)[M:.,,6";O(?5?=Q'$E9.XF8K?IIN[H< P"Y,UNL.]'^=^FF+P MX@AB*/PRQK]86P&=9Z2&FS\?Q>5JB0C\'0)>AY I:JX5E"30$H)0W\V"4TA( M=**,'2X+?)8L,=J;';DN?F&/5 OVMJH+FVL\11FT>&'*YKN<3J'- M;KB/@] ME9N=(41>2!METCJQ)QC_Y'D8;TQ%4;C^@8$VO8?4?[+I/!RWS> *4JC 9:H) M*9#7'+&JL968[VDK4)>1Z^-TLP&:V?3*[ RR@U[88PG[6(Y(1N'2B>@,TEEH M([]P<_!8N#>6WP+.C4N;MIC6TZ]-%-*KVKD]K[S*TN>NCVWFNM^O3RHW:IA[@9/XEJ,O.5!-:' A<=)!0*O MV6>%935T)W%A9T H;.&Y$8&P*>=(R)BW#C'CQ]4O0OB(+Q"AZL9$[O1\X9F0 MF)-%65D!MH"5LM-[@X(./>QYG&30N9O>(_^[Y'V PB,?>5Y1^DC&K;\:T PH#-,#J,H4B8@UQ^W%&@6RR V M* E!E,#5CN9BJMD(9 MD%_"[)FO2E+C#O&6X'VDE5:-EE7ENIGM*K5?;:RB\,;-<>W8S.3YK5&[[L.L MEB0ODIW25#Z;%27@6>C4L$7=F$X@] ,P@T,%YS)3:C+4G<- M=:>@&CW/6!T]\G:.%PL4,-%8$K)XZW]&O2LDFX>K\)I;AF.44"S'4_=V(E>X MS*[P#00^S) *-X4+N>?$XN9WB:.:%_',J>D@K$ZDB MZ03LGR=*2C_Y?U!+ P04 " #2;GM0M?#?^^!- "'200 %0 &%A=' M M,C Q.3$R,S%?;&%B+GAM;.5]^W,C1W+F[Q=Q_T.=SA>6XLAY2+;WI+7/ 9+@ M#$X<@B8XL]9M.!1-=('LG48WMA\W;;]^^O4G2I^!;FGW-WZQ3N^)6:9FM<5/6C^_>__S^QY_>H_?O M?KU#%Y?7;YXWI (70<$^_/'=__CQXMU/Y%\__N'N_1]^^>D/O[S_I_]K^4U% M4)1Y\TWOGO_7NW?OW[W[Z9*K_W,<)5]_H?^Z#W*,B%F2_)?G//J7[SKU^_;3 MFS1[>/LCT7S[[Y^N5NM'O U.HX2:9XV_J[5H*3*]]S___/-;]FDM*D@^WV=Q M_1T_O:WA-"633R.-? =)'OV2,WA7Z3HH&+N,7X.4$O2WTUKLE/[I]/V/IS^] M?_.\SP1@XFSK*W5/]M@A^( MQ4/Z13_3+WK_3_2+_GOUYZO@'L??(2I)>*BLU\^]LBJEMZ[!WN L2L-YLA_J MH;8G^*3O9,4!%>CJ.Z_"75H$\5[@NYK.85_C_5J\U7/?TF0ZP?NU=$=S$MB% M"'ET\\K;-:9_O"(_]2#BYX),E#BL0=(B-",P^P8V,51E-Z6GZUZY,1W-TTQ: M=U;D)LCO6;EY5KRET^E;'!V4_G;Z[GTU;/]W\J??Z:2(MS@I/N#T(0MV MC]$ZB&?/45Y_ :L=:7&][-LA:JHURVKH0;8VU+^2>+M.R>RU*TYCWM)L^X$+/HA J/';OWJWM !E:-;/242&/K8PQ3E*-VBV);/E.D!__H2W M]S@[V,A!4.Q.ZR4UL]YL=G?S.QG&RB#AWS' +/GHK_XR'.ZK/[>#S_RO952\T,T@V58F12X9]BUU7%!D M%'Q*&RL%[U0:@W)(+RZ*6MDCS@V'\XS VJ;)JDC77Z5#C4;.)9^4,+L<$H3 M\$:%;,@5+H>8(+ !:1:&$3V@".*;( H7R7FPB\B^2TL:@XY+ EG![Y))JP"& M6#8HAR1K=1!5.ETDJ%(#1KE;7 11@L-YD"51\I!KN:82=DDR/> NN^228&BE MA2?P:;TNMV5,#PC0!=Y$ZZ@X*I&$#5"((TXB\L.0.^1/OU_AAR">)P69=B6K M):F$"Y9HH%%J2#[VS@Q+_J089SLLK0:L\[3;*?>)&F$ MG>V8C(";[9-2TCL1K. )!R*5?#.]4(TWP":9+T$6!?.V12S@8--<1FM!!%O)M'SYR)*'LHH?Z0WN,O-!;XO-+.Y6MSEQ&X"W9WC5;+>*6,)4+@Y M[XE3UQNJ .KZ?+9FW2&_"5[HV97^-E0NZW29J(/;6R[*!,'P2(=.?2$ M%\DZW1H' 5M]QP/#N&H-!@L[94@#R"C$NBMO5@#JE8!X$>C[JS3/?W!SK(63 M*35EW)\G"6#.#C*ZHIX9XL>E^8LDX@Z/SV41%6:.+FG&'O1.NWZU>CYV%Q4Q7FX621@] M16&I?#JFD'/U;$P+LWXR)A7RSA83LB%9F"P]T&BEI[WHYL.WT M+6:;J)L@*U[NLB#)@S4=-/.SE^XGFE/:,06X=04?6[&^>[BMMG?2[@UY2-Y* M##&Y:4?#V4.PPZOY;!4F9X^A9LDLE7.W:M; ;!?.$B'OI# A$Y;/5!2MWLS? MS-X@(H^(PN2;)@:OW-'=6G9%9N'DX:9XN2J,?-"H.*:&$?R )4IY2(0Q@51P MIU)#7 \1140TIR:1Q"6^6O>/>I,PT/'Y-$$*7_="H:< @TB6**W>*QQ[&V<_ M&MG-3AH5GZ.1Q9REE(=!(CN0=J.1RRF-_##+H^ JVM*X%0;ZR(7=$D<'N$\9 MF20@LFC@R6E"%-#W5.4'5"D!."TZ)XOV-(Y"NAAG[_DB+ LZH1=U=69D EL? M&ZGDO+/' IP8)* 51[6\@PT3^6&1%#A+ GY3_S&-:0!,ZX'&0MGYP&-=(6$@ M,FIZI]9><-4#5:\$5!5Q]'%+09]'811D+.9*D&CNN92BSLAE -M022$' M@SAZ<$.:M-*H$G?.B&4B][PQ2OOCA0!938U&%"@[AO@L"$)4 "QW;G%>!W52 MK'($"5>+&P6T>DTS^-@[,=28Q*/>1FI*;][1]@__4FKNPXS2/GBA@"SCR$ 4 M'%_D^$3NK.,@SZ--M'9POS[Z0NLLB&EH[]4CQD4=TUMS?:46=WE990+=O9I2 MR7JGDR7 (9\J<<3D4:TP[7:*N8Q6_NCY+ EGZW56XO J"NZCF&WGU"L9>UUG MZYJQU6E6.;:*WKFU#]HAT;B?<*V/ NHGRDM G2( K(ANLC0LU\4R6^'L*5K+ M7CRKQ5S-@3J0]>0GD_%.)0,PP:V,BS*Z5-+3CDVKDGS)4TJ@Q7BM<0R2RSG< M2ZEA=G91HI!W IB0B3LG+HJX[-3[ZGF"LX?H/W'X*:*9:>)S:HBDR,@J34T& M"R5GS+"N0$,3HP8,SMC"%)Y1UGJH4D0=S:GIM$@3^M7G0?PI>% 32"KFC#(: MD U))#(P:*$&-B1")8F(Z"F1G=KTRRU^",YBG&CN!D09=ZM6!;QV=3H0@&%N M!2IAM4G%$).;VLYGN @^!<_/:BL/)9S96 ZML7#_8QCVE6(2-JV5T.2C=Z9S M9.I^ZFZL%B"U0W0&RPU)P",,R-GTCD6_I67R<)EF]+FJVI0R*6-YD.'S& =)'B4/9T&FF8LMM-S-SM95 M:.=KHPH,SECC%.9TKHB8)J*JJ-%%1-G)UA 7T5]+_/$EB$LR>D7KV3H*5S@K MMX;=H5'/[0;1LAK]/:)!"0:]1B"5[A2Y*FIU$55&3'MJAMUET98^H%1S:2CA MC#5R: T_^A_#8((4D_ 4D0C]S\ESF46[=!OD\A1#4@EW^)(9S&3:+^ (25AVB$&X$B***\8'E&/^$@+S,8KC2?@N=HJU@(2CYW974I MK-KRO0]!6%^&2(B4RV4 ]/!/4:*W>?]S9S:7P6ILWOT0ALTEB 2;/:9IH;FSD[6U")M@]>X.(,"+2B(O["F&I M>ENI:'UUNB@P02LM<5H]% 4P&#?I:5=KG 19E)IRQ/?EG.>'E\$4[:1@FQO;X11+R;6X]+N,ZA07=J M20##P:?@+VEV7N9%NL69Z@VG3,C=REP%L%V>#R6\@[=JB.JA1@UDIH1;O,;1DW6R!%'< M1[X$%6A9RH2A+!B&&0 J$R>T\I-?_WU+O^ D5-P4R$7<70#*P;4W@/W/O9M= M TJX _R6(BXVN6=*@DT6%D1?DYEJ7?>4$= M[4DRN(4XXBL-\L-P@4'^]#N'<8L?(@H]*:Z#+1Y46RWF@E,FD)1"*AGOC#$ M$[V(&"=:642%/?+BG"V0XT42XN=?\8NR=H*<6V8H8/:I,1 "Q TY,@4Y*F'$ MI!$1]T*/>BB[(^5*ZM7_V!499*!J#G0_ V%Z"2#E?$%EO)JY24M^$10Z>P_D M7!M>"G/(@)X0*"K(D"DYP87),B)$5-P+/68$24C17,;!@Z1B@\]=T4$*JZ9! M[T,0YI4!MC]M:5" M& 2+;! JUII4Z?0KU4*U&N)Z'OGT)8W+I BRE\LHQMGP_D4CYY8_"IA]W@R$ M /%%CDS!DT88,6F?&U8^!M[B79K1%-C4XZ14M9JY&"7$MCT1B,7MI(IXG3.;/H$*HK+5*W"V1]*#[1)++ B*2%J""2!T= MNNP):F9Y)!(;$<_)$NPAS=0': ,IM[210NRSI2<"B"0R7 IN,%%4RWIDQ&H; MQ/%9F4<)SM53TT#*+2.D$/N,Z(D 8H0,EX(13!35LOYVUAS.?$N#324/'[+T M6_%8A7I65E,A[98F6LA]NDA% =%&AT]!GUH%<9TZ.K=/"CVS_($1O4WDYX/J M^DI$'9-'"7; '$$.$FU4X%2<>4:M0G6&ZW,J>B0[?--0TQ=R/!%) [FH8X$ M(&)(8*EF(2H)8/"X*>_C:'T9IX%ZF].3<SN_OD.06',>Y(^S)*3_F?^UC)Z"F-0CGQ7G09:] MD%7^ER NA\Y:(W6=/ED=4YW>NU4;13"L&X-68"%18NEMUO0'W*K#(*3X:O(6 MQS3U\DV0T81-\COUT=I^7[5JJZ1_Y"I5!4/,<7B53V"S]@GL*?F%E8!VI(BC M''4>3M*+$E\2$X]AIE[%)1UMP'G2ST(-# OML8IYYXCF"]UY\E2% M(=[1/2>42=F";QZ99>20/[84:1'$5[8;"%6\@)0%O:O\';D&#&)T^&W8\H1Y_NA%PG_&6.X48!9W%Q;/ M#+J-CZ>6]PSO91L'44V[;%('RI@P' Q2!.8I7^Q3@91"SKIAT M6#-J>^?>WI#U/$S2Y'02+AY]665>"GA;1AF63[#6V2(P^2H[96GC T!K;"T/ M?%! ;7V(AM?;?'DWNP)U(7,5!?=1S,:B61(R[ZO'- YQEM.3_N+%L,VR5W?) MF+&5ZG+*5M?[5+4G8"&1U&)VMKA:W"WF*S2[OD"KN^7YKQ^75Q?SV]7?H_F_ M?5[<_0:.JG;7SCH%3W2TN(!62T.DW+BKZ [98'"JO@*Z"5[HRNPN"T)L=^4G MU?!QS:>!+KO:DXB#X949H_(*;\=50+)JGQMEO:I'GHV^2];I067>7K?(%06/ M?86L.&ZH(]%?\)L;.:NTDLX.$/10FY,"N9AWBIBQ*;-" +M56Z^S$H>+9$W MW07/6+G)DP@Z'G$40 ?CRT#*.U6,T,13(BJ!BN 9U@3&3R_Z8R+97%3UZBS_ MM*E/@N76XV MT9IL?)=9=QML=)0R*CIVE[*LR,!IRJ %AI764#4.5$6* A16B9!A$%#<$UMO MGGV?1MB=0L Z9E7BTSNS7$$;M\QSJ;?9TC ?^IKQQE!#>PP/[C!J].D[E//V M<2?LK^!,??0I.MQ3\QM2%B:#'[\9T+VOD4HZ]MA501UXZ [%P!!'C4WB@MQH"4=X[=5&@] ^[!+$W*8=E(/LIQGLRX#AFP*8F$:P&URC85C- MN3^B]S7/Y%P[03_]X9].?OS#/Y[\(_E83CD4Y/05\P5>LP14Z*?W)XCRX@3] MGY+P]*=W_%>F-A3Z7S#X.@M#]NXZB&^"*%PD5?YOU2F/2MKI69D>X%+C#9_$:J M19V-HDN&V5>D2S:S%AC>64.5W/S4@BCDDC"XUP'&SO"HEW:&'W&21T^8GSE? MI7E^C8OEYBYX5I]BCRO%\1W!/E4<7"",*0(,7_?#K2,O=T)<=\M!,2D"!IO% MS9CUKLWW-MAN^POK^$2)3WZ* G?G:W*,,Q\?*=0@N3(:3N:D.K#X9HG6>(8' MW'NQ?S)P$V3TZH..OFS?=H,S%O+0ZEA!K>SOM,94(?4!CDH3S'P["J[QF*?9 M?$.D)0^[.6OV_58M(BKYHZ&J FKZ#36 TDX!TT@WX2@'+NU8TJXQE*L5?-.M M#]Q$-2X-FF8]B+84XZ>"<.FECA%MK>6;:(HHT98JH"EGCA.MXAWD6X^1RSPK M34]W(V,6>!9J8,AHCU5QJ0)S72<$8C5"KD\NH*LX MH5K:)9Q2VBNYU(LWA2A<4FF7;5)"05JSC4CJ8:?BE5:&I1KH=!XC0%JQ#-P* MC5^2-,'7#5YV2FF7!#- [G)+(0J&5GI\BBSN_D%NIG=0KFM.$_S8KGYD*8ANY3!V5.TQODJC=6+.[6"VXG8 M!+P_#:NDW1#N9TZX!#_03:?NELR(5)B)EZL[M+Q$%+NY@T&"%XYBFL<4)SH*8/DD, MMU$2T6F=9D6OXAFK_!,LE9UZ?HRJ4,\;Q$H3VF@T"K7P5F)^=;6X_G""/LRO MY[5ASG*':<62A]:[2M$P4DFG M3YS54'N/F44Q,$LL-39A;W!]OOPT1]]?D0'N!W1YN_R$EC=S2J'E-13J4-"2A"$5K7XX0=?X8.]P!4WH"$DWI-Q? MKHT\F[?Q:F5ULU)S1IL1E6CH8Z$#@T;V0(7PC$23YXO!3+>*HDZ584QPLNC( MGY,,!S&]I_H01(EFN62K[#N>NKI"IKCJHJ9W1NX%=\C+5A!1;UWZ_H^^&$#I M1$'7CW3^4%5JF:R"&"\W[&YCD:S*^SP*HR![66:\BW["Q6,:UED.5%OO?4MS M>JYQ6)5[9R#[%06&\(?A%XY52&F4[B'&6_H +,IW:4XC>F^:V]4$U66@\^/D MO%#E'B"%1QF=%&C]%HDPS\@F)0LE=SD&;"O0YA4P:7BGW2B8PM:VT>/C*N$2 MT 6 9HE,EKRZS9=&R?D.UU@!88>KU(!U/FR%5?ZX1K'9)5N9.9"#Y/:$J+Z0 MBY*25+.J;YKD9WB39K@3B7'^3/;W:496+&3 7Q1XRW)YT*N\E)UI+I("$T/H MG0$F^D;W#@63-IWHE##)U\'J;]-7=-A926]$] 04G-O?+K\L5HOE-2*< D@I,G<9 M+V,&,B[I(X77)4U/ -8()H.F&G-@D,$F#,)-FM'1=U84671?LN.)N_0FL$@C MW\X]D 4UOMWOWEK"[T"59JD0/ M"8^?NGZYRX(D)Y6E;9&$[+>8K6IFX5]*OBNU:+*1AI@( X3N.&GSVG3:20" M[]I3UGHX %3?A=;5EZ&B+1\%S1? & 8D;577G/S&75NE33!J$WWT;W'\U&.* M)AJ\#CGF5\!:7DY3.=']M3OAPEFJUD'FZK>E9T$>K?P36=L\4NH_X2QXP-N[W%1/!X>O!A7#VT$E.;NC/*RJS<7E M?L5XI^/AV(<4_=-\\>$C??IN=GVQN/X 8\!4- -K@$[][<;1?0MS.;P>5N'NJ+M?24[93Y#=ISG6K6$/ MJL7D0_6QPJY6+V[OZ/);T1!#(;?A5F4 ^Z%6NQ+>AU M+.&53/O@F8D!>>W< MP+J*$LSN*DV5[ AZ88< 5,J01@H>2X;0-$RAHHC):NDR:;/O&0/Y1Z<-O\-9 ME(:DY;)"-\YK<(JC./EU#23ZDVT %<]14ZQ"I?B-CV)+%,OX*!5+ZM HGCKI MR-MIMUU3-R;*<0GG++B %KZ>AV:Z*#-ZN,DHQ2+,7>-O[!/U)&JEZSS(O6UU MA#'?I B&:6/0"KZ[-TN63"'&++E"@CZ12CRBGWFJ(Q04Z._>OWGW#I&QA8\# MH(G*A[8]F2HH Z"JHD(67!UH0B>K'.[!;+69O+RSEG54_N?+-*OCI>S1V25E M ."POGJVPZY0 '1&:U$+^Z)NC$.:,GH6!EOV#O=;FGU%[WDFNH#&J^OQ?[;+ MHAB]_Z=.!ZA3,[ZB ?M [BL+ 4!^0P6M!_)71W\];(?\AS4%Z!SX]O?TV<-; M\) O@^"-=IP&L_45W?^;H%T'3%K+"?S)()[__>3A6&>>Z*-FD#>=]^MUO=RAV%1'>JVB4P2TVK)'J[Y\23>H MJ_WWB.N#BU?<743>9&3]:$A*HI%W?U>@@2V.=1)A.)PS(-0NYD_0CJK VX\V M_>@\R!\OX_2;*=*=7L736*<$KQCB!'DX+#.#U YH5 DQ+7##&%DE4W0W6?H4 MA3@\>_FR%+ D'AOZ,*;@-GJ M([J\6OYIU8L5>OT!S<[O%E]8%ME?8+"[W0WF=^DMIC2)8MR[_KQ+C\/_:;[* M:2[X"1NKES!^@N\!T\LFK)R0>K[]*GHLF=5?AI+JXI[^E?Z\IM//]R7Y&A0E M/Y!%#_]F=/^"TOI;4=!\K;;O3N45/E7<2D>;@ F;!:(=SR+Q:"Q7!,\)5='08=",5(;-[*(BB,V) JT+RSD8CSS'9 ML5"OB3@*[J/8O.GP2=[9>IV69!(@>SDH'.6\IF%):8GSD$KX/*-QDF2_)0G_K.K.:7KO)* MZ G:UX%/22E>(7HJ%7KA)YSL83> F^!%\]C;0@_&2F!0#;N) MOU*"YEMH"U@YK>^XV"NAWH%K5$4IH&AYR.I46L2KH^RX=6E%X&,O2E6I5 3P M=6[O"SZ(2T_BS$KN4JG85J ]]S1I0"'8*+3"GKZ2>@V3<59VSM7P/M.RJ@3O M(Z&^:L914*X.^.3)A%DXFF>"]'@4@Y^[V;N'P=A.DT'S*E^UAV3VYW3V)7H^ M01U;=<.1JFUQ4(;BXU5%GD"U8C[?/@5S;!M7I\#!G0UBA MB4?CED4>84Y+E<^2U$T)-'7Y[?$1_&>U!0&@LD5%+2BM*07,FF1OZ";_V<7U ME_GJV/ZSBFW9376<=I?.UG\M(YH_JW%SJ.LB)&H=I>EL@S:N*LTNS4[-.^O& M8Q57P+7L%!E4CS-Z"A64.=@I^J.EKLLQT( M>)TF%JP;J>MO%#141ST.*A2AL&X?T'K6)6ER"CC)NOUZX^ %"]25Y&$KR%>Q M*5+C-FZ*HEKUM6R*+J,D2-9'V!1I"P) 98N*6E!:4XKWY>G!T$V;HLO%]>SZ M'.2C0E+9-<9ADYB8Y5;"8>42J5HL&92<+E.M*M!;GVHUP+#1"J;DIH =N=(A ME3V](*,LDX?'-AKG@$9K:5*%T$XV[?M4K-VYC]&&/GA!#76G<]@.YU5LVM6XE9MV>?B%35T0N"W\?+,AW6JYF3^OV2.N M6])!EPEM#/I_^D3VB2Q6V#,9LJ^+UFR9G3_.DK#_AXYDDY;VHGKL_"%+RQW+ MZY73C+114N*PNB1.$U4'@0#,:4I. /45.[1_5& 65F":8CCVS"\OY^=W- _D M_-_//\ZN/\S1[>QNCI;7B)VVS*XO^ _S?_N\^#*[FE_? SJ&H33Y.M>&KB7F]TI EBK"B]U'XX.WU_,SV_GL]7\![2XYC^1 M'_ZF1X;C+$#^=I<:OA<5?[/+!\OL=P#6#,KN?X+N\4.4T!3J](22U\A3?*K_ MKW@*,+J\E_J/8"I.0CN..HSI7.YV,8L'',1U".%%LDFS+<]:80CO;*OM--+S MN"KU@C[;J8+9XHW#*X2"_GQS^[%]>7R]M/L;K&\AD'2WN.J M*+S&FN@?@J#C=T0*H(/G00,I,(120C,\8XN #&>+I,"D30H33092;CDBA=@G M2$\$$#MDN$1J<"E M+@F9B'#8^O3EH3-43E+IVYR][+7=WKW,;9:O:L/6V4P M]!N+6#O?72^O3]FNB6Z1^84A2Q'&8R8R'XW&$[A]1U&]C+A+ MNQ^2QMA:>H=/]$7.;J4G;:CF]GJ2;_'>=R:OFN(:O&B_C+L013T7]ZA^];/F MWTBOS*/7Y 1?/8"FJ3O3.%I;I&'0*#A-IF $WDN)H)3VSFQKB(K ,_3 J-8 ME_WFK,RC!.?Y!<[76;2KTDF>!7F4+SQVMMRGX)H=.%EI@B'K*+C"\KOJ1L^QR@ZCV8VL4">JG:6F=QKN!5?_1+@MH4,_!YQ3/&M6 M#(3CU;WPSK)24N89=.%QSPZPAGV+!%WW]^80&&@]\)GU(7'0;O@S*;\:%HX8 M!"L:3C(0'L\EC"PU!FX&AC6C29MBTQ1ZA[Y^.FFJ9F2E1!DY2-6)KOL(@:9O%QC0D2B5= M$D\#M4LQB1@8,JFQ#6G3D00WL%VE09)?IP59*&1!2*/.LF"R'9;GD MW4'5[3)SKX+ )[F15X%"J$)>JO\-'4K MS%C2NK8!#&/IP:7Z2*YY8!/(DF_N6228/G&<>BB3=[)B3U"GX!-4%7W"UA0\ MB# 4K\)V "EIY[VP< =*40>L"5-*. M;MP'YC9#7\&GB7FE:E)SNVRUJT1_#:O7\4ZYD4#%U6UGHD==17"+754-[9>X MHTJ P$S+Y>P(=?!\M5^ZJJD+@Z_\-M0P0@Z%G :LD +L!8_H28#ACA26$%2! M7T9#&\58C+G'- YQEG.(="=G/X:-T'?J\3.V6CVG'UME, PGH5VX3 M,.C)]C&=G$76&VD;19>$M*](EXEF+3 4M(8JSS?5T9QFOSHU'TT#I94F#$9J M!T<+M5? 2:.S+B/E33<)6I5 KV&0XTX&,Z9,2J> MZA(5R".?I%ZF(4^OXIEGVD%.)P^9:6;_G)IJD_F"\?=E%R6^2^N(K-K37[V\ MXS>,>MB#IXAR8>_TL$6H>!AX4.?4JDG!PPE1T", %9RQNJHY?0+%: J%B=MM5-0W>.U/+^R25_FY-)0R65N9G\P->P2!3%:%B$ ;@A?_;&)7$4MEI)))1%>I%'['2 M!$/ 47"';&3*=/_2#4TRT5'?.0L8O]S\AH-LGH1Z:EEI.#ONLX/>'/CIQ;TS MQQZCL-!B2I0O+T2-!D"&,7J1!5].*A R^MJ-67H5QX%]$V*)0YU89"+DDD!]BE35\"#%&DL(;4($*4&(T8#%+( MGW1:#C]VNOX?Y-H,2#:*4!)$[@/ZE;W%[;VKJY_(M2_D>!T5S6*IZY*7HZK3 MY:65(C1>C@&M? Z9-?+HU%$*7=FK(8LEOJ6BYS==I@6_E184IHU&;'KL%8)Z M[-4&E;&;B37R?J+X6Q1E4@:Q@$DT4ZTLZI.@67%#,# M[W),+0UF[V"$J*=7)^89YL]MCA>67#%/*@)E2>ECH^!L7K0"WLR'6FGO]+&& MJ*?/9&'SCO7@] DG)29+Q_0AB>P/QBSTW#XNM:Q&_TFI0/\05B4-AEI&B*(;15XP7S;.+1A\6N&8 ME/GP 2U M.*=\/W,T1\I=AA\)MPGG.;PQCA[VZHZ=)T=5:N V::4+9E0<"5CB*MFJDUT, M(^CW<9KG/\!@Z#S(:/+O_ 9GJ\<@PW;$-&HYC4QB5X5>J!*]"ACVV>$4@IE4 M6A71:,9LE%-U&)2[3#,8O_2P(^,!Y;FDZ<'5[A)X M[\+ 4/O0&@Q)7Y6'UKQ ^L*B: MAZ\VB_8Z)SAL[<:HBTR;)1L'9>:,5\.:\ M42OMG6'6$'4QPL"<*UX&4?8EB$N\W%3I>H-XD9!]5+EM/2A4?S(;_"@?&0QTK#V0!F![T9P?3B MWFEDCU$(C=.E>REE1]9 MAG>F'@AQ98"A\Y[ )73NZ<*@[VK]B,,R)FL3^CHN"J,@>UENKJ)M M1%:_=0"UE\H):)E5']!5<8*S_#':=2INO *:YKN_H\XLVB7V(:4Y6WX?7N5F:;Y_4=ZI?AS\.C*3(D_;,E>(XG 9!5 M4ML0U=G<_'G-'C32>!'T87^^*D@MZ$S:V27?4-]FVL5U'6.:K_ SJ1RO<>1S MR>'E>^]7$U9*U]DZA]"H_B9T"^=!W)A,OI8ZOOVCM9R&G:5W#$H=Z_RE*M\G M.32@A-"CDT"_CL3/>R9[5E.*%#@-K8Z];.AD&?Q35#PNMKN2+:0*3!JXL%\; M6)?C9P$PLIKR6=ZR$.^4/A2YCN8NTE,:MWQ5HK_:H[&;U&W$5L^^% ];O+%5 ME&SM;(OPSM?#<.O86A75^+X>-9&?D:;]^W'V&_6U>(QVHW@ZHA@/1!U=20E3 MKLU0_0_E!32 ?V?Y3HIZOL775Y-QE=', NLF\=]%O3]"G*Z;4'Z0J >\)\L\'KHGF811#2VQGZ M1C]9D_DNV.,><9\B_?2%_2LO[PSCRP/8&_:NA*X[-(5VN@*[!X36'R[P!F<9 M#@F^69YC%FO,=D-Q<&E^>L%>599W@%%% >3^/OBUOB95>8SNO$1HA+\LBS+# MGZ(DVI;;6QI0/;ZI0N61I>' @7ZL1\DA97MR)3F\.10^)/L7#+"C'%X;7;=A M:JB3(V?RHZ1>?6Y(FST2!!T 8PZ2QI;EX1AIO^I*#I'&%>2=R,= KUWU5V4< MD[M'"E+ P@5^PL5C&K:^#,MOE6/P#<[HJY'@ 2NZ_@A]IX$+QE:K%\+ 5MD[ M;_=%+#QMJR5I0(-*="I/J&!+>ECQB"MW=*E?CB#CSM-) :_U;!H(>.> #I4L M91-_'H#67! E1'.J4-IQL*8!P"_(?HZ?H&2[E&<:E=5!*^XN;+89=!LL6RT+ M@Q9F@$)$;*K!8V$3'3IW15VMJ9A"+[_791QD]*@MSTL[B*P>I;722+OC MB1%R2Q.E*!"6F/ ))&D5&$.8"EISG.ABT9,R:A.!W5B1]*+TV8- M&%4.HFP:>$K96_%=^@UGZ!''0/*D=>YC@FV4L,GI*OJ*X^@Q30E#N4UUI?,HQ!7D?GXZ!7A'2L@B>$6Y+.T%Q4Q[M M%65;(LJ;(B>:XQ9D21YE] OH??DBX9V\[=ZR4=NLXVSVLX7?3(4F!>^\&X-2 MX%>C1E^&K*N(U%&CYFO&)+S/Z#GJ!>;_722UF@#-2C\$'8Q_I9+;U-[SRW M?:]H'6MMCX$]3572A/%4J8(9F<;A587HK-7[CZI/NN^M89"5.WXL-]UZ+A.: MA5*UX=$H.+U9, +O[3"5TF"(9X0HQ$"NJ96!\=/I[X##LX 7F,6UUF5XEBO MXB=?GAJ\/&6>* ^&518@]3FIV@1F)SS"-I!9=E"Q64%SS=@U0BWKD5Q]N!I6 M<4&H=.JAT_ HV-*UO:>U-R<[/T^_R:(UKD/-2QV"5,+PUM%FJ,)18^7^$*(= ME6^CYOO; Q_4*\"91 ]3E1VK/8N8_#QKD? <7K9G63)Y#^=8:MB2,RQ1V U- M?N8T27C@,AE-;($.B7)%]L&_(--!EJ<^+(O<\CG)V MT_S])Q_FN\.9OJN/!"\W::N 'M,X9#&MB=9$PT!W9U'M-I*6>U4UY->YUJK. M!H>1E6G&"4L][RNN/.HOZ#'CV-% @M8Z M>[1=VNC7?Y_O:&ROS6@:U,<#%_H<3_O=7-W;^7%.:$CJZ9PFJR)=?^4;AEE) M:I?1.4=F.HTXO.6V#5C!Q38CTRQUO.0;'Q0T*E ,Q'=T5L;AHJ_ , .@)J-P M3S8H!EF615X$"5V>65FE(_\*3"-#:[)/VNK .#DX[+ 6G)< I.Y=PVN^:0 M)R1+".HRQG(\O.[#-V#K!#-0J7$ZMAD$5]^B(NS2T#US5[]W,PYI> M$ASIB0A9&!\G-/^14M V5R=TK\SO4\YP0,^TZOBH36:"M/G)3)XCE.LT2>VQ MFJ&7M?;00L%P^U@U$7SEFG)Y_-SJ/H]=I=.0H06\#E,_H6ISPWS(TCP_[U^R M#]K/I.22ZG85Z/)8KP%E338*K7!T4:?\R1HM=$I^X6']=\?(^',D^L5Q^HW> M4URFV45:WA>;,A9K;&#CN#*3C4,X.4OP<-Q"$S[XR91\F2=J0U;B_9 MEIYM"EFG:U$=W-[Z4B8(AE@Z=&)X%I[##%;:['-;1V+4C/6O-*U)/G1)^DLR1DV6]XD&KKGB=5@^8\.P:R M?,#?#3HI#YPW;:)!3?*Y"YROLVBG"K!HJ^GP8F9,53HW,C9J,$: 45C%.YAV MLT5S V8=]1/"LT;__[_H(L ME;0%L) ;(9#P"#=9NB&T8Z'^+K$R)((HYG:-+P?97V3T9;R/\09@DIB+C1C: MX*G<+PZ6&/43FD5%HGB.B=%L<84Q2D MJ;S?5C0R6A%D$2.RK#X*06<4T0)MF"&5@D$('33QK3X/T]X1GG#@N(K6=!^C M,'SW4V?6%B$U)FX_@F%7 8_@4\T%)C1@+\2[PHRBC$,?*#F\CL-37P"&816H M9!%E&[%C&/DXJS]%2N_JV".G>Y9N>FZZ;^FJ*'<\!Y;JYW;0/ I9E^35PNU24BH(;:^M M RDL@MG3"A269,HD.BB Z'Z@Z$!US*M\4-N1XZFF& #J+&2%B.FL@SH0Z0) MN)A\*0FSER87'!SW@XR])NT?8!@=$+1*CET0+"HP.*?4:("AG15,R;D!"SV^ M&YPTP6%;]RRDN7/CJ#LI=0TGM1;Z/MQ@K*LE.S8W*D-BYBC$0E@'*NTKPE - M=5 #.UM9*T.[ZQX/7''C?4"> W?#3)MHF+JY!EGVLDFS;T$6JL85G8++@<0, MO,=&I328H<((43CP++5^PBC!!4IK_2D#%*I!DGULE.'?<"!UB[+39.N\0;?1"U&&,7A=X@\D:CSH)<&>D+T%< MLD/%QJ%9M;FVT71Z=F%?E=Y)AEG-.R?'8QVRLA%$02T)@X \Y"<9@IM\:S00 M*'5LB9*2]**J.Z6):CH=4X#[Y!UC*B8F\[#1!D/.T9"%55_P?,2U5PC2_9/Z+V:PLST4<4"[P+[U$4XT*N% M68[L*I[3I1Y4=3%IZE[% M@>D&A]=!\&8@U#TXV[\TT[U=!D5G/7[+6 ML=69/Q=9D%:!U9L M9[4 8_2L;I3H";-QG>789CX<9SC!FTAU$VBIZS0RTICJ]$(GV2B"8?$8 MM.(A*],]08#F\ I3-=Z.Y)]:RP/S3%60<$ZE HUM!IQ*GEG,HN[/5WM=IQGL MK6@WK@@?)ZYC*B<[>K71!\/./4"++[!Y$:#&Q!I4U7WVXZA)V0<[[2HDXZ5> M$QPCK>"JN0AA]V%E'E4%@;E!F&#*7/JK@[WJC;^OO%AP#WK!/><]9J6&A/C\ M9O4&Y-K]XKOQ?O M5Y\[VH5_*?5I$_8K"EIO455V;)<8E@-F&7< >$E@UVV0T #G841*)?MB/:W_ M%MP@7LG20(M=>-I6%P'LNE<8;T<[P8XJP:L7V3@WV1'J8 :>\9B'/+T6O&>Y MWR.J]3P-/A.Z!#H:;OH9VW7#S1C0\@1L3U#70D+5"-]L6X&)>AU .F"U)"-R M<(>$%ISJ (E-40$5AD&:[?JRX>M"I.;WG4G@RI^<=03!,$F'SD@> M>E-]M'#;TXUA]5O-EYO@A9TW7)3X&C\7=]]P_(0_D1[SJ-K@[5^<[_%N3*5- MHZ!-66 8?6 %AJ3_\=V/[Z:*'6>)].X19WBV*>21YOAEMX4$0% BKPNH;8 _LGS"'TD"$3UL7^2-3RX ;;*(FVY98&.6#R9$G MJV2]SE[+%()S]Z#YMG=8Y3M0;..&@"6"96P(%FC M YUC0Z 2BOT(FF*7I)6*Q_$2GR&XXU*#:W3[38J[(\ZICI7G3T$.TQ^8*^H$U:1(/Z8 MQC1CVE5$(.+P$][>2XY3K35_#].U,\.1[RIIJ\IZP%ZPA2B_5!^1 E"O!%05 M@:HRT)]Y*?_AQ:@L>#L]$DXO"+'69,BYP\_%&1E^OHIVU @#,YT9J2*,/=&A MZ5T#5.NA/U--Q%2U)CHDJU.5@7#6[T#=&@DB[C(YR<&U.9SZG\,B@AR<^ *: M2Z&956<\@J7-AO9F9X.9(5O9SLB.3)R;;9Q[,W)NL'(.VP\53M_R#!. M=EEZ'NPBLJH[3[.=HL65DK#:W@1S:(5:'E4*B&J\F;KO+9(GG!<85PGYU#U0 M(>@PQYH&:"?1FD0*%B]T$,5WVD^XR#%&=;Y$GSV4 Z=U6R2?@NPK+FC(_!5> MEQF+D:]>!EMK0K24/6R9];@^BA+4EH#:(JS7RI/Y_@3W99 H>E/W0UBFD2 3 M'IHPD:G'3_9*4CUJ]CYV%S%?!-4&QF\_@V52$9@TOXK7(? &9U$:SIYP%CS@ MC[]>*-I8+@:KN;48)8]\B?!IP*41$8=CAD^_W=J8H1$#;(8A1H,9B#@ ,\R3 MT-03NB(0FU^"3]'T. F!L)]@-C&_*P*TV2T93YO=.]LS7#M0SI+P N_2/"HT MBUZ#/#"#6($5K--JL<19M9[W56T_#>M-&D?K%[6EM-*P[&0#=6BE2@=52NC/ M7 U-?TK?S1ZJ.:F7BCE;+&M RACR O+47@U0Q0:6:GCZX_LNL#,["IQYI<"9 M!07.H%/@; 0%SKS.JJOU(P[+&"\W;'=7I7#,I3D<[^A'ZF%\_Z)@&?+@>@@) M7:H"Z9MVOH>^Z::[K'/K=HHE$S@[J/(\C;VM46Q)85L$5#*, MQ*\C0544JLL:+MY V+Z\SZ,P"K(7_8F_0@Z8%;4@Q8SJM32(K%TQ>R[TUU/BX# 6<+)BFPA@6]3V$97@9-B-/)9*9?&O/O MT2R*!P*.K:M:"/<^A6A=_>*WLJ[=JO=@ZYJ,Z\FV6M/"M:R-8:'=Z4\\:'815UX@=I@B&UTK ,9P-U M3T.-/6?TV"GM/%=,RK LNP=RC:$7"2*%G )U8AEMUM=ERCW-U]WQ]_LL*5!I MR3%[_R.="Y_;G0N?>ST7/KEU*??;GF6M;7JX$>0 M@-7L*GC#1J?7VK6@UQ;_^.N%H<4%"5@MKH(W;''JOS&JQ0\8YF9AL+W&Q;VB@BH=Q)40TT)W23'AB;9*%90@S4,'CAVJPZZ*0Z%#K1%TM/Z:A?BWK,@ZRG%0B MSTL<5D]H1,LH18$9QH13L$NKP(S"5-":Z_BQ2D:8$>V">$:SRK#=A6@.40:8 M'90 15>X2A(%C:B?=F<>DS@)9Y_U3KE=$6"MKL*G\0XEH@"<)0NS*./GC.=I7M!U1'W6 M)!ZG:H1AV<$"J7!+KHUK-SW3PF.(D>KZ)RUSSI%HJ!&P)97",E9:L"PU!K*0X:G6I5VG MU>Z<7^=^?:$>@XQLE6YQ7L;-F("5^W"]."RS66$5[ABH$LN5Q-3: 0\W>W8O MP]XM7L=!GD>;ER[U%!H"Z#!G:* -_+6UQR[G.E"\ND M]H#U-_4@.F;CLYRNRMTNCF13GB "RQY*?&*ZPLJCFO2BO!+UTN@LKMYJ/EN% MR=FC-N;@0 A6PVL0RB,)KM[,W\S>("*/B(+?C2G#7N[H=CF[BIZBY.&F>+DJ M]-90RD,TC FLPD:5&N)ZB"@BH@DM%E6U@[ /2=53@&4N2[16 :H@[*PD]+,8 MZ93RL(QE!]:N;X$9",D/LSP*[(+@"I( #:2!J0YR^SU5^0%$5-O^NW+V&\V" M^QCM\@NFRDLS?/S(,M> M-FGV++5N@Q8QMV_ CH/V&$4C%YI0-Z\=G?ZIJ-%C2PL"2C<.5<<%W2!>]R0X:#;9JPNX1\619Y M$20TW\/L/B^R8"T:<;]B8)GVH#H,#5X7AJK24,**H_/>FA6(Z?R1 "2[=WH(,T]"4_1-O3@L4UEA%=*K,"6Z%J/G2HAZ*P-Y&B^/^FHR MF)46++N-@6P*C-B>A>(@-P>[U8O#,IL55LT!+]."TMG: M8\V+* \>'C+\0%>)BV239EO6!'3E^(23FW]>8*SA^@_<4A&#[(DB,^I?$+VR84J?*E1 Y9=;.$.C=3HH4H1=33] M/B9+$XKK/(@_!0\*(TED8)E%#5#8O'-)1$1/B:S7IE]NR4+I+":[4]4D,Q" MU>@*=,*D0<40D_/:VF>X"#X%S\^*MNY_#*NEI=B&[5P+^1U-,J7#;OL1K,85 M< E#1N;9V?:WM$P>+LE6JHP#1>.*(K :68EOV-A,$%62?D?G["%(HC4!5#R> M!QD^CW&0Y%'R6_@JVJ7;(/^J:.'^Q[!:6(I-R$-<"?D=AI[7[!;JENSP MYIL-V9HOD_;JL+ICEMS56^K!,LLXT,)X5&DCMAO&3!^E2?>VW//=^*?L8_KM MU_3K^6.:)JIMLDP(EIDT"(4@J=D;1(01D49'C=9K<94&( MSQ6!_?7BL(QBA55P0:F4ZM/8$Q8LO*"*?CP0N/<#Z>D9V8=F41!?2GQ%I%*P MK*&#*+@95(X]'6&TP7X,XK-7;CV UM8!+G,>9@+]UN* &2'(B;7MO3@ M8YQWWNL]@EXJ=UM+TI\]X@S/-L4LF.'T47 LM?>^(5E M#ROH!*5]M[H3%->EG:#:/_*$OV.@1:* E@GR3: D))A) Y9M;>&^FF>!M!KT MA810$Q,YOT<%>VT.,2C@"9U$D5D[SPU,C,)Y1#D35QYV- M#2Q#)7=VY4)>":QF+J 6-32FUV;L^"9K!@-1"E#S:L")AZ:-J.^QH0/%T.(P MF]JFC3TU[:I(UU\?TSC$66O(T*4R)&:560U3/DVT^9&3+?9.EFT@Z.W<^!M3Z,E1B M#%]ZEL"%?$T6."9_??B V=,3^NXKW$9)1$,1%=&3+*K:.$U %AD)6)AHN/H) MJ@K@;]QZ1:"J#)_[+7D$N6LL[3IZ#4"VLP0JWZBU;]"Y(OJ^4OWAA":3]60M MCN4N>*[ G!%:*48XA>CO/X&QCPFAS+& &((HU'T&?5_I_.!M!;#=9?B18"$] MF>,CY%AN"$;R6US2*&TW:4;/R;K+R[OTFI2=)@7YGIAQL\"D=:5V//)7 .J? M4]5,YE;5?$_3G>F1/._+=/%"OO,$-=^*JJ\5]@3];T;U5WMBGR( (4\#U88) M/ OR:$V#ID1Q2:1E)-NO)$!<.K "QFB,UTTT1A[8$74*/4&L6#:W5P7[6I@- M@TY*UV!#(4!3@AJ;-&U9?M*U@\\5E&0L8[>%:4:8E-1I/EDX.9I=F(QH21_\F0+UXX@K*5WK:Z:'ZUC91:^=[68?O?#-JO[H[ MK_A;*@[NX&H?[UN\QM$3G=+ZT=D5J\B1I0"BTP'@E3>3W]>%_4#O)ANW^;; MDV&<>C#VOR@QCW/:K;'F!F-<":#M;@7XHP;E"LET&9381T[Y%;Z?RL.//X7X2.!JNRE MU 33Q;B[1I^&TNAE=IW/NCC0W7)\+2P[;.7X,NBVJFAOGDA"ENOG0?YXDZ5/ M48C#LY?/.8UBV9P"S\B*_TG)"7MM0!38 _30XG230\M =2'H_@5]3\LAAO^A MEN7)OD*$;E.BBE&*@*PZ#J\0*;D.DURDJ-)';0&H+0%$0/FCYQL!,@>/ MQJLRHZD 6(,M=ZC?=["5: /JEGN 'CG8-D7Y&VR=YY*!TE_W BU&J1]1"JR> M>QDE0;+>M^=*M.'W7!WHD3VW*9-&ZH.%0\T>R M(^C_H2-Y0S-5A^+.HKI4%6/Z2*^[G2( Q#-/%1]'>A&JBT!#']AJYW]3H(LIW:1[$'[*TW+&;YIQZ#$0) MV>=6^Z$TD8Z.+K\?P,SIM=J3L;YE=HT(,4B5GJ6O* GV1JO;.\MJK28Y39E(K14 F'8=7&>RL MU0!@Q,GS>?D?\_< J\GEI=;V=M-0/^JW&$65PH"ZF1FC.IDAP.&Q<3BV,H]< M%I1U#!#5#M2 C#.(A[)(^!,DJP3PHC"40CG-094&8]J2 @H^GQ#6VE\EOT M9 5^UM>X>)-%"3T")#PBJE$WC7)9/8[ M\E< LOQ4-1,BZ=??@]JU(S^J[7\7Z=+\&)?ZQU;?QV3Y-Z+F*]M1@9T0KSU& M6+ ,KR@CEJTN(,:,AJR*(MDZ]5SQ*))7;13)FR:*)"G)EZ=/E1UV>1]'#XQS M! M929 -SMTW'#_A3VE2/,I]?>Q4 5EU+&+A-*5.I=L6P&Q'^S$M!/%2$"\& MDD59P-/+:%,\_H:#S-J:?37HEE2@M;8BB^"*6 &(E@#&@';V FV>,=:0M'OW M3U?D)_+G^D_D7_=$G_SE_P%02P,$% @ TFY[4$?YXM=5- N( # !4 M !A871P+3(P,3DQ,C,Q7W!R92YX;6SM?6USW#:R[O=;=?[#7)^ZIW8_*+;L M)(ZSN_>47AU59,V4)&=/[I<4Q<',8,T!)B I2_OK+\"7&7)( T.,0#EV'7_WYM4(D9!.,9G_X]7GNZ.3N[.K MJU>C. G(-(@H0?]X1>BK__Z___&_1OQ_?__?1T>C2XRBZ<^C79$9_=OH M)EBBGT;U]<_SA M^.V[X]'QFU_O1^>7-]\]S;@ YT&2_?+MF__S]OS-._ZOM^_OC]___.[]S\<_ M_C_@EY(@2>/UE]X\_?3FS?&;-^\N<_*_1YA\^5G\ZR&(T8C#0N*?GV+\CU<5 M^;Z^^XZR^>NWG/+U_WRZO@L7:!D<82+@"=&KDDIP::,[_O#AP^OLMV731LNG M!Q:5WWCWNNS.FC/_+5:TK_0DQC_'6?>N:1@DV>C2?F8D;2'^=E0V.Q(_.CI^ M>_3N^+NG>/JJ5'ZF048C=(MF(_%?/DK67PWFP0H%R8J/C.5K\5YQ:XFQ&.RO1J\[ M]O(TB(1&[Q8();&N6ZV-+?1C$C N_ (E. PBHTZU4O;30V%@2( 2CV?CE9A[ M.!@Q1TC,-PPM$(GQ([JFL5:-YISZE^!L$9 YBJ_(74+#+PL:3?E<>?%GRL>: M2?(RHE^-AD^#J)]^C=D\(/C?V<#DX_(TC3%!<7P: MA%_FC*9DJNLCF$%/>DR7RX ]CV=W>$[PC /%Y\XPY!]*N*CZJ:;JIV?%Z(IO48CX%[@.XJ-;%''[GO)91S\50^G[Z>V$ MH57PG,T\7#'G:$5CK->CFJJ?GE5EOFK'4IC.T\1??T M'#,4\LVGUD#E)#W-;93[OB0I?,CQ[!;'7_13FXJHKWXMES@IK9Y_4"RA?.L/ M&%H TKZ\AH<8_9GR#UT\0E8$6?M]^C#]^C)V?!JM\W>?S1H[^Y!U-OM$ 29 M%U[[\2IA_3?CLC\/T[SW,$[[\>E@O3?C8M._@_470FO7UX/U$T:]+R\+.!$: M\NG=XX(:G(3 NDT<[KH8SAGN0Y$N<%TS1" M?,'CGA*>XH#A?,#&,0TQM[NXZ.+.HG;XUC[] U-H=^.Z3\DJBC_'\5$PGS,T M%S-JY82";R@0=Y!3,-Q[^+0C'65+3)1U[>(IS&+,MP9V8.M[?FK#+'B_CX_O MQQLWG2VZ\MN/-!65 SNZJ[S=O[B_/7#-D\53'$V MX[*?'6I%N;JF0$CM?='FSK?2JZP!GEX\K1")4;414 /]?<'N+KK2HTH3;D/9 MWT2+!5Y!A>[U(R[DKC6Q(K3J"[9.GXQW)V .^XJ;5'2I;PS=Q\K"A.I393D22MYBXCR#3WB.S>TI@ ["'U]P:;$$T8?L4@_O:2L'PDA M'&U*=#&;H5 ,F/6OQ09J)Y% +&W*=(YFB#$TY3\_B6,$7L^[<;-V#FTZ&QBP ML'A.;>PLFS"Q'G4V[[TQ*^LR5,;N-0IB5&D*-(1>F.]3SDG*PH5%4?7\5=*N M&(HY23;"K_D/:B3H*4%DBM;)DT+J'3/0^8\%CS?Y_XY'1Z.2JOK'@$Q'.8M1 ME4?1\[+O$0UKW8U$:CX@1^;D?O*'JJ\G#S&W^3 I&47! XHR]G\(6ACIZRZ= M%:J-N6ZSVP(Q"K^;T\?74X1?"P'$'S))CMX<%W<%_I/_Z(^\$[=HCL6W22+N M9[1TG3=M;[G=T^J0.&'AB#+NB'/(2IX!"VL#H7F]H6CQ>I7%.(_"!8[68VC& MZ-)4EX7>J$:0JGIY%_:/P5FV6$17W&:>?D7/*A :38$H'/L'@T1J)SB4@MQS MONWJK[< :OVM3UIOD]&ILB>(8\.U/1 MIM X?@9"9\QE>[.67*W=U60_#>SC\L6D5V M",'=,HBB,C]3!<%60R@$'NZO6T5V",'%$K$YGS,_,OHU68ACL( HK4%" (7$ MJ\TW0 4NH7G*CO>Q$"+?GRIQ:6D-!<6K+;E.>)?SU8+[XP ;J;>#HN#5!ETN ML$/]3]*'"(>7$0V43E2M&53[7FW,I>*ZW&G0Y9+F%4[N%ESP>)PF6>DM/G4J M]QM*.B@\'F[.(0IQ&LK-XSKY['G)?R9QL13-H>AXM577BN\!*"+8!H:DTA@* MB%>[=(WH+7#\_75#NFO^ VN'W>VUR6JGVV]'1Z-U\23^YS-*8AKAJ5YBBZYT(;XJ:F<'?5W TBOQ](U6]/\1DCNZ!1 MDU4.&(C867) !]P,M.$'?$"@ND'2?]RAR_RG43[O>WYUX#J76MK#K'L)38(H M:^D4MLJPTON.K8V=Y1%T@% A[:Y6)$F*KEYMSO^,D#QV+4B4%,[2 P *I$ 9 M?)JUVJZ:WU 2ZJ8Q'9VS3 $X3D!)]F8=DHO_2C2VQQJ A[O$@>XF!%:-'T95 MD1"TEKA,)3"VEQ;AANX#Z* R15(&&M>)89G M!B,*XK2\Q=!J'HVV[K(D=C &B<1^()+O/>H6JWRX0[;M K& XF"HA=(B0]Q$3>^A@3&4H49%(.M*S#FD2IUL90E*S% M/8Q-3R&S'Z!4TNMUJ6N-EE XK 4SC.&02>L'%B?3:6;OW/(#S'(.[-8L?I M:*&P60MR&,,&UX@?"%;ZEVTF:\]YYW$!\:CW#>+K\'WPI R(F#&"8FLM6F)N MDMUTY0?0\N=9(8XA'"YKP1%CN'0/T@[7V==M?[H?BAHD:'N#,U0;O:+N]*I8 M^[L_M7MC[^#WQD9_J?'[Z^$>V7XV?%SK(M(G$,E\[PEBV85>Z!Y03C_<>V=F M&O)C9:WW.;^3?9(F"\KPOS?VK4.S2>?ZAEIO,,I4XB]\6;T[0^A*&M=7U7J& MK:X*?R%3EX50"-BE+H2/44^@4OQ L!)W,E\&0<2N[ZSM@*2!U#XPRK[@;O#F@=%U M?_7;>"F!TX..[(5N<;-@V*C5.0SNKR9<:-^<3TD=)I%E-$[!&'*+ZCD7)YE-.XWLN;P:>7WCR6^B&? M% F:B_G+?0S](^/3XH31F>J,LM;(]<;>#,,6^89^['&'HD@4S$6$KW:1R'.= M+C')GF\2=;Z+TA&*^#"0WG40P QH,ZT,WW +7X?,-R>NQ1^;G[6O"EB$&_*%D@@ %&ZWJ:;0V&@$#_FK[9*$Y\)0T$D8G8? M TS4:PR4WHM2-F H#87S"="R5V-R%XC7;;-(T16Y2Q]B/,4!>QZS?'!^0LF" M3LMZ/8IM0%>&7E3%,85\1_79JIRS7 68B8E$].V*-*87R2P+H/.C0H[1) O6 MAA\6J5B>;Y#.1530^5%&Q]3 8-H8^FY]LUTIPX"8I%S>3:SZ%,TH0Y7+QQ=/ M7&T<,TSX+'/%W>ZLXI,((-)LCYL]ZL5'N"YV;.FCSLL!F>U(]@# RQBC7/3" M_$X100VA+F-#*OCPHT1\(H7$A[::.:\C9(9BJY!#MTG(U8J)>'&3 M0Y(D##^DV?;DGN99S,"X4Q\?<%Z[J$.$JC_%>N19M@AUR1*HRII]S[AYP7I+([)BT!,_35NKSG6B:FG@8Q#KDUGN,HY8Z@?C4&,W!> M7%;D M06ZG0"IL3G#KRLQY42V@_>TBHT^V*)$AZWVE\V 3[)J.O+9(B!S%%\1Q6WI6B[R#_!BAZ>"_\3X D13N=G3>,P,HD;P1/H^!#7:+JN9T/@' +1EE0 M'0!*I:UGP-2&E0R!2O>K?H$/*.1#26SG*!%SULD3A@#23C9$;-HEJ62@N]R MU/MV3IVF[J^ M$%#JG$ M?FP1)#7B=.!HR%S?<^@"%$@3/3OP'M3;TR$M:^_ZAD,7B-6R>V*0^@IQ6N.$ MLW!]CZ&3H9IJR ]@]U0]S_[BU]B#V"^:MT(,TRGO 4O[7YJWOS1J M803^RO>CKT='D]KB?"O$;&>/Z7F O M9BE5C]?(5HL3[0*ME(_KBX;]F*OGX*I2E+HGMYFG)>[Z/==7&<&#Q:["AQ]0 MVFU?^\=;]U<<=]C9BN[WLBNZ(![<>-AE9VL I+U;D-TWMQ:!]#1+ U !_L=^ M4S;\K!+_0E,X*K[,A'$W1E\35T'B3S5X\XP.G2(\*_-X%L2+RXA^E51T?&]@ MDIS3*&?EA:&M)3.RKQ8JMU%#T:$)HX^8XWOZ_#D6;Q^O;V*?<.?O,7]'1"MD M%U[^&*(4S68@LJ/&_-AOV;T%:@NH';0^F#CR9E,5W]-;%%(2X@C5.GQ/>[-6 M.U]S?1K4VSBQ"<:++KME[:C(*B([%^L::$T SPI]63N]VL?@,53)2QE"@RLM M9NUX;8^#K+^"9'L?==X6,[-V1K>OE:M+!;2!3CKG1:^-JQ5I"5T?^NUQ$@$J MT8_=$>\D7T-C=([R_U8$+C*;0<]H@'FX/L_;XS@P5ZVO0^(D#&G*-<;UA?"C M\,%N4998.PF89/\CU8&>E^MSO@ZXZ8"'*G#X*TA3]O/\=9:ZP/E1N-&U/$SZ\CSZ&S2RT$5#DO)5MW.T$N\WRD(7 M>CH?JJ]VA!DHH7M4+4X%+*WLKE'']4'&Q(=:JQ:F +7.?-UY9EFU6Q.8>'@L ME^<:!P\XDAW!R=4)9^J\_*F%P6"LT^'/(O#SZS[R<#RH4+K',)>Y;H=>B50B M<7XBT$]VEY*7\_JD_>5W 71F*:V#3WR%>9R$?Z98/$ZQ/M I^]5ZG"JHH<3. M:Y'NH'9J+JY/OD2CSVT)!'*[!)([+U6Z.\!F KN/-D'M^882(.2M0UQ*[JY* MJ5V;UNAK^ %&N-[Z6*[A V7?69OF)2< ]Z5Y(JT/!JB$%(JIM2"A%4R5>O(/UENT*IR8\:QRJO%\CAX4TS&< Q1D:\$_ M*R!#M&9KSPWI!G=%0\Y0ZJB;\8!B:"T2MSN&':1^X7';%N7UX7[!1XNUR%IO M%F^NN:&[[!>S&1_^X]G%4Y@5&;CEAC$F0@GB_R)I^S&(4):$QS6'P\QQB1^0<>V_?HI\"V% M#WKSR?O92?*\>E7S/+#01U7'N=[EXWG?_0!?DO1H[+K!:NBSN!_SM9+2U2K*M!U$I;:OR(RR90ZX MOK(/E %T7/D4*#?4CA^N9RUW$$_Y_E*9 MJ-L82VI=*=)!L^_BC6,V#PC^=U!4?3Y-8TQ0')\&X9)_J?(9!60Z*CF-*JRBOL_L#L\) MGN$P($E3 ^TV^F';1@MFHKIJA=UHPV^T9GBPU#ZVFRK, -8)I1^:19KIQ0,K MK"[IRF34JOT=O]FVOPT;46A\PVA4X>1RJ[9.GART^JJ9-MMO@NVT;+-F,*GSXCPM.HYR5N[%;Z97>!EL;.S2\:QJ0^(8F?.IF MP504(\AJ%%2Z:62$'=DY-D@%@EM6N).Z/+#(K()9GL$LSL/SDC62M?#[;3NL M$&=+XIK&*+\<=2Z"?[8.&F0/:+HT *AKR/Z] QB0__"O3*R M+0,6CBT+]AZBJ48\L*)LI2X*FL7JBF8UJWK?.&,7C$8EI\S-+'B-JLSL M@Y6NF#B5$%K7#Y>W=@]@A"!BQ^8'QZ[MA7&89CPPQDK"9+O5-3);1479L:S6QQ_:5]; MWC8R0NJT(C$KIW9H(.+[W$G]S#O&D@ 36.*'ALSEZ5E5Q:*;9@=G(&K7Q@7! M;/O(S$ M7AC9(1NG M!@GH*<@TS?BX/MCN@G/#:+NHS@/S%2^5HC]3SN[B49I@\K:18+(A&Q5T+N^. MUD6 7!:543B] EOO%"2$*"=Q;%,Z3!H77#6R>V$ID(1_9>+_VT:2"#SQ?_27 M\D]_/=P!Z.6V3G[/9*MWS_F_(3=T@/1#NP-@IA=+MRO/LFHUX]GO*& 79*H' M15#IB)QEL1I# 9&F'_WWMI6+>?^FF2K!%J2F E?*=XX62!R?X/H<\W%U$2=X M&22J2HC;[6C $@.' 76*G88CP(CM7CX%&5[2A_,C0'2 C&U5KO#S)LQ4LCPS7ISZ0@\ MH2M(@%#;>QS.U'RUX@\?X;9[9+K96D4#Q-A:(6ECC/4*L+0WE%SBDRI?$&EH M@,JW5NG8;"X%*< /)_<6/2*2(O&@Y)Q@H]TA@!2\H7>/&UPHG^ 3EQS&LSON M@QML3!0T4, \",$ I/$)J3L4<9[SCX@@%D0BEW6ZQ 3'V3GR([IX6B$2&Z#8 ME1\487_"-KMIS@_TUPEK!MZFC **H#]1'IWTPW%H! MYP#%WZ.0D:%V_+#9BX 1+J.HW'^WX'H!0ZDEA"+H3[@'J L_@+ND#.$Y.4OY M/$+">M(DF69_C?*T03"D.["$@NU!'&AW8:WN*RN9L!CB*0DB#0T4' \B-P!I MO#+" +/?@BA%XUE1,C:(K@@7+5UNS@L4!@U@[R^@3UA.& M*XEJ?8**(#*2(^^DO.\I"?V$]$+UR@:1KQA5QDQ^(ISI)/K_$2)YLKZL]% M"6+S J\JXA 3\['QN:-F/5K7NP;0 RV)6S0V-JCXF.G+*YW?L5S^RRZ1 M/Z"R^+KBW"H;:A20@I3H]F&5&W2M[HVW5>G9/W&RN%JNTLQ'S]_C-/);P:Q< M%P !U^CNK"8/C%)2P%AABHV*5+(JW3Z8W[=1KGLS (O/EYEOVY#"@PYP1B^O MJ'=W=7I@T+*B8 J3?MGVT%CO@4!E79HZ##!.+D.YG6LXMY591[,M?HBU*I9MU%-#5:*VH<9V,N: MU-I9& @7?#(V9SBX>M2["NR-K59J5*N,LE$NK5JIV@?3>U$EJSS&0J3]4TA+L4M=QC%C5P2\O4GZ':0WH6K MZPI7NPR'[EKT;3R4L1\N0A[?X;.;B3?74(TA0]=%M789!9UTYX$?IRC7J_+K M&N4[E:6K?7#TOKD:UI7M^QD=,J=V8?\" M*E[WJFA+%Y$D?9RD+%SPSE348+AG-V7GVO';"?#=1/=FSM=>B#A'28"C^"9@ M>>6']C6@X]6(@OEHS?V;SX'NZR'&(E,S&W>*B7NKG3[A-_[RYO/40$% *4%E"/8#@G"X#W'9Y4B)#V=XQ#$H-@\ H!=EX ML+T^OB96]2S?,4&,9%H)HE]H-!7^97X5ZQ-:/B F\> ,Z)VY;!K%-GTS8Z7X M$8')$[T_H61!IYO\U?'7XA[=!#'Q#%8P5RSJ!BQXF5KZ<'XNOO[UVSP].^<$I M/SCE!Z?\X)0?G/*#4PZ-LJX+)11E$90NN+3UW[A/_KC&LV#*.O]LV1FYZT: MC88PH;?UNY*)L#\5YQV03MJ\2;V%8^6VZ:VAV7J/[F8D0QQB;1^.-2G0120$-TM$$JN:5&LNWW&*4CD%$.8?K1"]!&\ MLP.+=()2R.3);*75.A@DN\% _65KY1D"G-QU.$ _OFK/?R2QXI"ROXI?P+:&8-.3FU9&=]V'BW<2S&G.[6JX"S++> MTSB^(GF88Q/@D)BAGFP8@66H^'Z86[/69+V@4/Z"F3X4H6?@?Z3:5"*?<.03 M 1.7S\Y1_M\K4HI1K !U&903IADCUXNBR5S9144>))_" J>5#-1S'!]I7@A0 MYJ(V*C$;1%?K&:GUGHPJ71&_+3MS2$X]!&(/@=A#(+:OL-6$T6D:)F-VA]@C M#I$\&MO><@B:EW;>75RVZ(_8;!8]4N:C*IJ[C].JAE 3@C89;&6B\J_P+=T= MBE H#\7F:85M35WFH&H'2#TK4BZII:WK!4%L+HHB?^+3& NB,TK$$3SC=JC4 M-(#.V?;'5.U@'=@*'U BOGX61)^"N5+KK2U=GC$8Z5DAIR7-CI?<"S^-^,Y# M'0]M-'.646.J4YF$EA1ZRCA[NM1[ M9EI2(!0?G$-AH@E+8-PSO)Q$J?I,=;L1>-/A7,/MXEG2Y35>\8[$7Y2ZW&X$ MU:7['5R[>'X05/?1,)ZY=PE>XPC?X&E?&_W5EOXH_%D7^?#ELKG1^7W1[>'ZA^' M Y;# XYRP0Q3*<79/KI]UNE>][6T'6FFGQ,U.Z-2D6T=1LW^^ )=^Z".8+IM=G8 M6?RT@VYEHEK5+P?TEU_/86.VTM!9#*3;F&V(N(\Q"]-KLS%T/K"6)-=AT.Y7 MP7Q;=O(9HMQZ0ZAB^X]==U!LFXS[&+4PQ38;0X^LO5C&9++Z$6TJGA++4X?# MYVIPH+)I/Y9[;F &0XDJ&6IDB%FXFFC0)-/G B6G,U M_HI\"M@7OAO-RA6$*7>D(3%U-J"'#>AA WK8@!XVH(<-Z&$# M>MB >N1([W5KX]Q_ANYL^O"=^RV[?$5$5ZMNK\111IXJ(=+3LG*;Q5QY($<[N)"C+?H2YA&Z:*R$^V#)MP\"'",*RXC[&*#U$? MOT(1>\_-!Q5LOA>SD_"8I_@13],@DA?*EC0=@N[EO7=7*KO1(5%2*7N @BM. MO/Y[3S5!HS:I=$S(X9=U6IO!XD;[3=QF4-[HXCKX)- MN\26DJ\_L5_HUU_IE[,%I41=#[J]J#>/6Z, M@FV%EEUUYNY^"I[P4E%TF[?9:N+R18X6_"L:;97%W13P"1.M:NM-7#[,H5%M MFRQ]J/:0W@));_G^D-XR@/26R8(B@I]$N7EM:HNDK;.G4 !I+4KQ_-B[K@TL MSY\47BW3O*Q]8GE"SHM-Y= M)D*_$\3$NXK!7'$*;<#"_VP]Q,Y*F!YLHF MD?,P'11K@.@N,VDMX9O?N3/ MB3P/T]/)\&+Q72<)G$2$/'.D0&P-:K!I/1! MA!\^Q ZOT]NKP&;I/OU (79R\[O_4(L_-[_;/"H?LW$E=[\E69/*Z]_ONJ;L MJJZ J\'T=3K0WKO(;WWD-[K37JO9&$L,UGC\4Q<'HP1 M>T25H)3R0 Y(.^!47P,I^XN['L[W(>?[.R6?'L[W7]SY?O]!HY=QOG\X%/.Y M9$46E!C/;E&<1NO"#0B)X]B /$L,14?D_T$81 H_C:CHWB4F 0EQ$-VEJQ7E M?@;=])]D.U3N:T3/M^C/E+L/TY.E>$(*8G6[\1_,L5B_"O5MD("BYX.H2M'6 M:V\GTUL41D$>H@E-3.]GV@))[#.2%3\1^1F_081"BKJPHIZ/+]]NF0 MX#(*R#3_0X6?9V_-M NM+^^KH_/AG&%89S] Q1Y.?/P*SOEYXO,-W")U<)IS MN$7:MT8/5QWMJ=;6!5TK%5)\N:#;EP.5G''O[AF3^6]!E"J<$"#Y4"+/1MKP M!T U/D.()=>ZZY-Z[_$2G:,5C;$J(%AO-9@ ;IMP?JA]*\FRNJ;*3-D?MF,A);=1A1W_<<%PE''<2I,%D?CP5%*E?_J@26MC MEQ7;&C!_9#2.SW1%JW5TCKT5!2;;%=U "AC^!8B3**)?Q=S,VKKTF@W'013]^+/3-;MZ@I(,%5ZE<^U^[&'!3>@^6W@E#J[Q(7O$DBMVA:B/E4OOC]E);^5!V^E!RV5I>B\^-RN_5V_JPKIX7 M\ZS(7(J+]Y#$=>&BYUQ!XV2!V$D<(ZZCM0KT:_#.C%TZ];51HC5R27/'JW-/ MR&X[ZBK56#K$WWC^(ETGPO(4\9:&KA?'GF&0B>G34ED?(W4)#8U)0NQZX=R' M;2GUUOU&J0?ONU1WN/ 6MO MZGK'(!\QU4V 2DQ+^[#\D^D*,4S9-7[$9#Y)GJ\3B)(55*Z=>1-]:X7?G^K! MXUM!Y?I\L+/J]SWJ12]B'%SC)>;]U2N]O;WK^QL&ZE8);$G1^W]\WMJ]#)BB M39ZA]^4VAG)C'H<,K\3?)8A!B;W/PC(1QIO#$;.P2ZV),N;R4R\QEZV&AX#+ M(>!R"+@< BZ'@,LAX'((N!P"+M]DP*5E@T!9IA;3C=$6V6#W1ZWBOYB-_PQO3>U^.S2,B*;KDHI95BD1]R;,T3N@2L8NG M,$K%DP$B883_,[T/GE2>3P=FWL=E=A%NQY";)X_?-!-UZW&J#AG+$@:NO3;P M:#!4R?!O(4P8G?%QS7$(HDND>EVCV=+U81S\QIA$2%OK9#&()L%SEOU."=^5 M316YP=GRHB%R??P&"W3#1+>D]Z)@WQT*&4H"AC.P)>J6M'5]Z@;3LE)02\J] MQJ'(-)5KM-K ]9X1IL:F2-8JRX6;_:A<@\UF0RDNUBZ>+ZYP:W2LO&8C'+]J MT&Q=AKT@,8[BPAD#T;7VP*J!C]R+"OT8#^>YLU_WZ^0H2YH#L?O).79*<8?O MOTJ&YB1EX2(HQN9.YJS@Y#I2MZO]:I7D02)"]M+A@D9\4_JT@>UV;N]PY5.'X3NZ.CK'(:1V))KWL "R^['R MM?55]QZNBL9U5*RMY'H('W(VI:1S M[%S"$6N>4 'TX<>Z92>W^FZ"K@$+ MUUYL9W2-U33H>AWB+&")[H.G]1*M#M3\<-Q\PUUP&&4L/(O-K(4S65^51#Y< M)QCDU0X %(=;'9[=#_#L/8YU=SXB.F?!:H%#U2OLBN9#P$ M@;OW.^[0?+M+ MJG?7%3/"0!NH[%O4FSG(Z3+37['9_.X^=QN8OO\K' MIOB=LYR*#F-S(XN[%VG64]9=B$C , 4L@/6F0UO\ZKVO;!OWK?FB'Y])O$(A MGF$T52Y\\N8>+7QMHZ@*@EP(._<-KV:?29K@K."FRU<\SI5KM7P.06XR(&+7<51XXB)<%7Y@ M=S&;H5"$*->QJ5LNJKA4ADG*!V$Q&BE1S'HF/%SG#H"1-%>,SX#>HI"2D"^V MN:*32\35'$1"&RGOR'.ML2G2ALQ=)RCL. 0ZJ=*#7(;*(4?UH+G!#H%+_E<\5]1'W(6G_^'$'H0<^ "X>.+[ M PX$)@'?F0L=W?#-NRB91"/>OWGY%'>O(P3^T<'$-?>@>F]#)!-&'[%(6N=& M 0N)O#,(B:RYC[C^#M$/B\(4MPVR,7]"IM?\2Q'O95$0XA01-,,*L8#DCMT" M\R")D5K\6 B*+A>+E#F&8.=.3H M677>/N03)4%S42[7O?/6$/8& :*"]=;#<[Y44GMP^GFR%*D_YRFZI^>8<1>" M,E@UG!^WU\ZZLATB\ZY5)-I[=XO@+L#35^VUCK//*7B47W'RS1=&G$S+] MS#O+>+^(*"X&,$0UF0])_H.\:P&"XW#;PI=,?T7W'=ZV^!3\B[+R3<)8?LVB MK=T0M"[INKN+%3?!$HUGM3ZI+E8HFKN_6"$?/!7U*R2PJCXV%^U]LW;Q]))KR"14[A^ !0Z%K7//_LX+UX\ MB8.)%,<+,76(X[F'1#T?RBG\,"S0/"@7HG)P[!DL]_RCNME/1^<'1+I!!P"K M*I17,UY1E1\ZW6TU=_T4*&S'W7%M)U9DCDKYJ-0S]^[R M49"B&S[<[K^BZ!%]XM(L%)O%[AQ?Z/QMHDY;KTP NW6_0%S$62(O4M6!T:!G M]ZY"^[1(0_N_NTV[SP7 >N MO8,2B?%#A.?9<./#_HK G0$P@Q>P]ALJ:_@7_R0"WXD[;%/)&Q%J755)!^TV MP,7TR5&0=/=^@5DW/"N4+\$Q@.K':S0O:&XH7=>%L0GGMGX\1C/;/78%=)O8?1:%)4S;M?02'2J3$>#P;5"K@.]YFUW\ M1OSK@?>#_^3_ U!+ 0(4 Q0 ( -)N>U "^0V3SMD &Z]"P 1 M " 0 !A871P+3(P,3DQ,C,Q+GAM;%!+ 0(4 Q0 ( -)N>U#Y MX\VE"A$ *S" 1 " ?W9 !A871P+3(P,3DQ,C,Q+GAS M9%!+ 0(4 Q0 ( -)N>U JGF+#M!, *@ 0 5 " 3;K M !A871P+3(P,3DQ,C,Q7V-A;"YX;6Q02P$"% ,4 " #2;GM0P4(.A5\> M 7Y $ %0 @ $=_P 86%T<"TR,#$Y,3(S,5]D968N>&UL M4$L! A0#% @ TFY[4+7PW_O@30 ATD$ !4 ( !KQT! M &%A=' M,C Q.3$R,S%?;&%B+GAM;%!+ 0(4 Q0 ( -)N>U!'^>+7530 M +B P 5 " <)K 0!A871P+3(P,3DQ,C,Q7W!R92YX;6Q0 52P4& 8 !@"* 0 2J ! end XML 84 R53.htm IDEA: XBRL DOCUMENT v3.20.1

Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)
6 Months Ended 12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Jun. 30, 2019

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Current, Local

Current, Foreign 6,965 5,334

Deferred, Local

Deferred, Foreign

Income tax expense $ 6,965 $ 5,334

XML 85 R57.htm IDEA: XBRL DOCUMENT v3.20.1

Concentrations of Risks (Details Narrative)
6 Months Ended 12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Jun. 30, 2019

Jun. 30, 2018

Accounts Payable [Member]

Concentrations of risk percentage 41.00% 26.00%

One Customer [Member]

Concentrations of risk percentage 100.00% 100.00% 99.00% 100.00%

One Customer [Member] | Accounts Receivable [Member]

Concentrations of risk percentage 100.00% 100.00%

Two Vendor [Member]

Concentrations of risk percentage 59.00% 71.00%

One Vendor [Member]

Concentrations of risk percentage 100.00%

One Vendor [Member] | Accounts Payable [Member]

Concentrations of risk percentage 100.00% 89.00% 100.00%

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ExtinguishmentOfDebtAxis=us-gaap_AccountsPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=AATP_OneCustomersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=AATP_TwoVendorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=AATP_OneVendorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R46.htm IDEA: XBRL DOCUMENT v3.20.1

Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) - USD ($)

Dec. 31, 2019

Jun. 30, 2019

Dec. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid expenses $ 2,641 $ 21,081 $ 2,702

Deposits to supplier 266,552 477,254 507,367

Total prepaid expenses and deposits $ 269,193 $ 498,335 $ 510,069

X

- Definition
Deposits to supplier.
+ References
No definition available.
+ Details

Name: AATP_DepositsToSupplier

Namespace Prefix: AATP_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 87 R42.htm IDEA: XBRL DOCUMENT v3.20.1

Investment in Non-Marketable Securities (Details Narrative)

Dec. 31, 2019

USD ($)

shares

Dec. 31, 2019

MYR (RM)

shares

Jun. 30, 2019

USD ($)

shares

Apr. 03, 2019

USD ($)

$ / shares

shares

Dec. 31, 2018

USD ($)

shares

Apr. 16, 2018

$ / shares

Mar. 09, 2018

$ / shares

Ordinary shares authorized 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000

Ordinary shares issued 376,275,500 376,275,500 376,275,500 376,275,500

Ordinary shares outstanding 376,275,500 376,275,500 376,275,500 376,275,500

Share purchased price per share | $ / shares $ 0.0001 $ 1.00

Phoenix Plus Corporation [Member]

Investment amount | $ $ 1,500 $ 1,500 $ 1,500 $ 1,500

Equity interest percentage 5.00%

Shares purchased during period 300,000,000

Share purchased price per share | $ / shares $ 0.0001

Phoenix Plus Corporation [Member] | Common Stock [Member]

Shares purchased during period 15,000,000

Maximum [Member]

Equity interest percentage 20.00% 20.00%

Minimum [Member]

Equity interest percentage 17.86% 17.86%

Director [Member]

Investment amount | $ $ 863,592

Equity interest percentage 20.00% 20.00%

Ordinary shares authorized 2,500,000 2,500,000

Ordinary shares issued 2,500,000 2,500,000

Ordinary shares outstanding 2,500,000 2,500,000

Director [Member] | MYR Currency [Member]

Investment amount | RM RM 3,500,000

Mr. How Kok Choong [Member]

Investment amount | $ $ 730,637

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Cost of the investment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841
+ Details

Name: us-gaap_InvestmentOwnedAtCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Balance held at close of period in number of shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 50
-Paragraph 6
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-12C.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12.Column B)
-URI http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010
+ Details

Name: us-gaap_InvestmentOwnedBalanceShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Per share or per unit amount of equity securities issued.
+ References
No definition available.
+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=AATP_PhoenixPlusCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=srt_DirectorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=AATP_MYRCurrencyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=AATP_MrHowKokChoongMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 89 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies (Policies)
6 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation

Basis of presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

Change of year end

Change of year end

As of December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements consist of a six-month transition period ended December 31, 2019 and 2018 (unaudited), and the fiscal years ended June 30, 2019 and 2018.

Basis of Consolidation

Basis of consolidation

The consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

Use of Estimates

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for deferred tax assets and uncertain tax position, and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

Accounts receivable - related party

Accounts receivable – related party

Accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2019, June 30, 2019 and December 31, 2018, all of the Company’s accounts receivable balance are due from a related party, as a result, no valuation allowance was made.

Prepayments and deposits

Prepayments and deposits

Prepayments and deposits are cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.

Investment in Investee Company

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Entities in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the Board of Directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Dividends received from the equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence.

Investment in marketable equity securities

Investment in marketable equity securities

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

Investment in Non-marketable Securities

Investment in non-marketable equity securities

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

Revenue Recognition

Revenue recognition

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

The core principle underlying the revenue recognition of this ASU allows the Company to recognize- revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

Sales of Health and Wellness products

- Performance obligations satisfied at a point in time

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019. Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Historically, there were no sales return as the Company’s products sold are not refundable, returnable or exchangeable.

Disaggregated information of revenues by products are as follows:

For the six months ended For the years ended

December 31, 2019 December 31, 2018 June 30, 2019 June 30, 2018

(Unaudited)

Survivor Select $ - $ 204,138 $ 203,815 $ 104,656

Energized Mineral Concentrate 100,270 222,789 361,092 66,573

Ionized Cal-Mag - - 55,731 43,124

Omega Blend 68,927 97,170 165,999 68,561

BetaMaxx 67,789 87,793 211,280 126,191

Iron - 2,813 2,809 20,270

Young Formula - - 117,480 57,630

Organic Youth Care Cleansing Bar 17,206 - 17,751 -

Energetique Hyaluronic Acid Serum 175,170 - - -

Trim+ - - 198,862 -

Lipomask - 70,585 211,238 -

Total revenues $ 429,362 $ 685,288 $ 1,546,057 $ 487,005

Cost of Revenue

Cost of revenue

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers

Selling, General, Administrative and Operating Expenses

Selling, general and administrative expenses

Selling, general and administrative expenses are primarily comprised of rental of office premises, travelling, licensing and professional fees.

Income Taxes

Income taxes

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax.

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Comprehensive income (loss)

Comprehensive income (loss)

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

Earnings (loss) per share

Earnings (loss) per share

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average common share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

Foreign currencies translation and transaction

Foreign currencies translation and transaction

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

As of and for the six months ended

December 31,
As of and for the year ended
June 30,

2019 2018 2019 2018

Period-end MYR : US$1 exchange rate 4.09 4.14 4.13 4.03

Period-average MYR : US$1 exchange rate 4.16 4.13 4.13 4.21

Period-end HKD : US$1 exchange rate 7.79 7.83 7.81 -

Period-average HKD : US$1 exchange rate 7.83 7.84 7.84 -

Period-end AUD : US$1 exchange rate 1.43 - 1.42 -

Period-average AUD : US$1 exchange rate 1.46 - 1.42 -

Related Parties

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Fair Value of Financial Instruments

Fair value of financial instruments

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

Operating leases

Operating leases

A lease for which substantially all the benefits and risks incidental to ownership remain with the lessor is classified by the lessee as an operating lease. All leases of the Company are currently classified as operating leases. The Company records the total expenses on a straight-line basis over the lease term.

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. The Company adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019

Recent Accounting Pronouncements

Recent accounting pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

In July 2017, the FASB Issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815). The amendments in Part I of the Update change the reclassification analysis of certain equity-lined financial instruments (or embedded features) with down round features. The amendments in Part II of this Update re-characterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020.

Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement – Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact of ASU 2018-13 will have on its consolidated financial statements.

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.



In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.

Reclassification

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation, such as reclassifying $366,834 impairment in cost of investments from selling, general and administrative expenses to other income (expenses) for the year ended June 30, 2019, reclassifying accounts receivable – related party of $78,272 as of June 30, 2019 to be net against other payables and accrued liabilities, and reclassifying cash inflows of $78,272 from changes in other payables and accrued liabilities to accounts receivable – related party for the year ended June 30, 2019. These reclassifications have no effect on the reported revenues, net loss or total assets.

X

- Definition
Change of year end [Policy Text Block]
+ References
No definition available.
+ Details

Name: AATP_ChangeOfYearEndPolicyTextBlock

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Investment in non-marketable securities [Policy Text Block]
+ References
No definition available.
+ Details

Name: AATP_NonMarketableSecuritiesPolicy

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating leases [Policy Text Block]
+ References
No definition available.
+ Details

Name: AATP_OperatingLeasesPolicyTextBlock

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Prepayments and deposits [Policy text block]
+ References
No definition available.
+ Details

Name: AATP_PrepaymentsAndDepositsPolicyTextBlock

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Related Parties [Policy Text Block]
+ References
No definition available.
+ Details

Name: AATP_RelatedPartiesPolicyTextBlock

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for comprehensive income.
+ References
No definition available.
+ Details

Name: us-gaap_ComprehensiveIncomePolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cost of product sold and service rendered.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 705
-URI http://asc.fasb.org/topic&trid=2122478
+ Details

Name: us-gaap_CostOfSalesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13279-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investment in financial asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_InvestmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investment classified as marketable security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=75019621&loc=d3e62652-112803
+ Details

Name: us-gaap_MarketableSecuritiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 35
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for accounts receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e4975-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5212-111524

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5093-111524

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534
+ Details

Name: us-gaap_TradeAndOtherAccountsReceivablePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 90 R9.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies
6 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

Basis of presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

Change of year end

As of December 31, 2019, the Company changed its fiscal year end from June 30 to December 31. The consolidated financial statements consist of a six-month transition period ended December 31, 2019 and 2018 (unaudited), and the fiscal years ended June 30, 2019 and 2018.

Basis of consolidation

The consolidated financial statements include the financial statements of the Company and its subsidiaries. All transactions and balances among the Company and its subsidiaries have been eliminated upon consolidation.

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for deferred tax assets and uncertain tax position, and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

Cash and cash equivalents

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

Accounts receivable – related party

Accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2019, June 30, 2019 and December 31, 2018, all of the Company’s accounts receivable balance are due from a related party, as a result, no valuation allowance was made.

Prepayments and deposits

Prepayments and deposits are cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary.

Investment in investee company

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Entities in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the Board of Directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Dividends received from the equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence.



Investment in marketable equity securities

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

Investment in non-marketable equity securities

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.



Revenue recognition

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

The core principle underlying the revenue recognition of this ASU allows the Company to recognize- revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

Sales of Health and Wellness products

- Performance obligations satisfied at a point in time

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019. Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Historically, there were no sales return as the Company’s products sold are not refundable, returnable or exchangeable.

Disaggregated information of revenues by products are as follows:

For the six months ended For the years ended

December 31, 2019 December 31, 2018 June 30, 2019 June 30, 2018

(Unaudited)

Survivor Select $ - $ 204,138 $ 203,815 $ 104,656

Energized Mineral Concentrate 100,270 222,789 361,092 66,573

Ionized Cal-Mag - - 55,731 43,124

Omega Blend 68,927 97,170 165,999 68,561

BetaMaxx 67,789 87,793 211,280 126,191

Iron - 2,813 2,809 20,270

Young Formula - - 117,480 57,630

Organic Youth Care Cleansing Bar 17,206 - 17,751 -

Energetique Hyaluronic Acid Serum 175,170 - - -

Trim+ - - 198,862 -

Lipomask - 70,585 211,238 -

Total revenues $ 429,362 $ 685,288 $ 1,546,057 $ 487,005

Cost of revenue

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers

Selling, general and administrative expenses

Selling, general and administrative expenses are primarily comprised of rental of office premises, travelling, licensing and professional fees.



Income taxes

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax.

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Comprehensive income (loss)

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

Earnings (loss) per share

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average common share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.



Foreign currencies translation and transaction

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency.

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

As of and for the six months ended

December 31,
As of and for the year ended
June 30,

2019 2018 2019 2018

Period-end MYR : US$1 exchange rate 4.09 4.14 4.13 4.03

Period-average MYR : US$1 exchange rate 4.16 4.13 4.13 4.21

Period-end HKD : US$1 exchange rate 7.79 7.83 7.81 -

Period-average HKD : US$1 exchange rate 7.83 7.84 7.84 -

Period-end AUD : US$1 exchange rate 1.43 - 1.42 -

Period-average AUD : US$1 exchange rate 1.46 - 1.42 -

Related parties

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.



Fair value of financial instruments

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

Operating leases

A lease for which substantially all the benefits and risks incidental to ownership remain with the lessor is classified by the lessee as an operating lease. All leases of the Company are currently classified as operating leases. The Company records the total expenses on a straight-line basis over the lease term.

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that do not require us to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. The Company adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019

Recent accounting pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

In July 2017, the FASB Issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815). The amendments in Part I of the Update change the reclassification analysis of certain equity-lined financial instruments (or embedded features) with down round features. The amendments in Part II of this Update re-characterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020.

Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement – Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption of the amendments in this Update is permitted, including adoption in any interim period, (1) for public business entities for reporting periods for which financial statements have not yet been issued and (2) for all other entities for reporting periods for which financial statements have not yet been made available for issuance. The amendments in this Update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The adoption of this ASU did not have a material effect on the Company’s consolidated financial statements.

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact of ASU 2018-13 will have on its consolidated financial statements.

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 due the Company is qualified as an emerging growth company. The Company is currently evaluating the impact of ASU 2019-05 will have on its consolidated financial statements.



In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its consolidated financial statements.

Reclassification

Certain prior year amounts have been reclassified to conform to the current year presentation, such as reclassifying $366,834 impairment in cost of investments from selling, general and administrative expenses to other income (expenses) for the year ended June 30, 2019, reclassifying accounts receivable – related party of $78,272 as of June 30, 2019 to be net against other payables and accrued liabilities, and reclassifying cash inflows of $78,272 from changes in other payables and accrued liabilities to accounts receivable – related party for the year ended June 30, 2019. These reclassifications have no effect on the reported revenues, net loss or total assets.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 91 R27.htm IDEA: XBRL DOCUMENT v3.20.1

Investment In Non-Marketable Securities (Tables)
6 Months Ended

Dec. 31, 2019

Investment In Non-marketable Securities

Schedule of Investment in Non Marketable Securities

Unreserved Sdn Bhd
As of

December 31, 2019

As of

June 30, 2019

As of

December 31, 2018

(Unaudited)

Cost of investment $ - $ 832,335 $ 832,335

Less: loss of equity of investee company - (124,225 ) (98,140 )

Add: gain on deemed disposal of shares in investee company - 16,509 -

Investment in investee company $ - $ 724,619 $ 734,195

Reclassify to investment in non-marketable securities - (724,619 ) -

Investment in investee company $ - $ - $ -

Investment in non-marketable securities $ 730,637 $ 724,619 $ -

Phoenix Plus Corporation

Cost of investment $ 1,500 $ 1,500 $ 1,500

Total investment in non-marketable securities $ 732,137 $ 726,119 $ -

X

- References
No definition available.
+ Details

Name: AATP_InvestmentInNonMarketableSecuritiesAbstract

Namespace Prefix: AATP_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of Investment in Non Marketable Securities [Table Text Block]
+ References
No definition available.
+ Details

Name: AATP_NonMarketableSecuritiesTextBlock

Namespace Prefix: AATP_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 92 R5.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Statements of Changes in Stockholders' Equity - USD ($)

Common Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Total

Balance at Jun. 30, 2017 $ 37,135 $ 2,367,875 $ (100,362) $ 2,304,648

Balance, shares at Jun. 30, 2017 371,350,000

Net loss (130,274) (130,274)

IPO completed on March 9, 2018 at $1.00 per share $ 293 2,925,207 2,925,500

IPO completed on March 9, 2018 at $1.00 per share, shares 2,925,500

Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share $ 200 200

Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share, shares 2,000,000

Foreign currency translation adjustment (1,293) (1,293)

Balance at Jun. 30, 2018 $ 37,628 5,293,082 (230,636) (1,293) 5,098,781

Balance, shares at Jun. 30, 2018 376,275,500

Net loss (142,446) (142,446)

Foreign currency translation adjustment (1) (1)

Balance at Dec. 31, 2018 $ 37,628 5,293,082 (373,082) (1,294) 4,956,334

Balance, shares at Dec. 31, 2018 376,275,500

Balance at Jun. 30, 2018 $ 37,628 5,293,082 (230,636) (1,293) 5,098,781

Balance, shares at Jun. 30, 2018 376,275,500

Net loss (519,642)

Balance at Jun. 30, 2019 $ 37,628 5,293,082 (750,278) (79) 4,580,353

Balance, shares at Jun. 30, 2019 376,275,500

Balance at Dec. 31, 2018 $ 37,628 5,293,082 (373,082) (1,294) 4,956,334

Balance, shares at Dec. 31, 2018 376,275,500

Net loss (377,196) (377,196)

Foreign currency translation adjustment 1,215 1,215

Balance at Jun. 30, 2019 $ 37,628 5,293,082 (750,278) (79) 4,580,353

Balance, shares at Jun. 30, 2019 376,275,500

Net loss (338,931) (338,931)

Foreign currency translation adjustment 9,864 9,864

Balance at Dec. 31, 2019 $ 37,628 $ 5,293,082 $ (1,089,209) $ 9,785 $ 4,251,286

Balance, shares at Dec. 31, 2019 376,275,500

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (b,c)
-URI http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 93 R1.htm IDEA: XBRL DOCUMENT v3.20.1

Document and Entity Information - USD ($)
6 Months Ended

Dec. 31, 2019

Mar. 25, 2020

Jun. 28, 2019

Document And Entity Information

Entity Registrant Name Agape ATP Corp

Entity Central Index Key 0001713210

Document Type 10-K

Document Period End Date Dec. 31, 2019

Amendment Flag false

Current Fiscal Year End Date --12-31

Entity Well-known Seasoned Issuer No

Entity Voluntary Filer No

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Accelerated Filer

Entity Small Business Flag true

Entity Emerging Growth Company true

Entity Ex Transition Period false

Entity Shell Company false

Entity Public Float $ 804,186,900

Entity Common Stock, Shares Outstanding 376,275,500

Document Fiscal Period Focus FY

Document Fiscal Year Focus 2019

X

- References
No definition available.
+ Details

Name: AATP_DocumentAndEntityInformationAbstract

Namespace Prefix: AATP_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details

Name: dei_EntityExTransitionPeriod

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

EXCEL 94 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
&UL4$L! A0#% @ TFY[4/0OA@!3 @ ?@L T ( ! M$Q(! 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ MTFY[4)08Y'(4 @ 620 !H ( !C1D! 'AL+U]R96QS+W=O M

Concentrations of Risks (Details Narrative)	6 Months Ended		12 Months Ended
Concentrations of Risks (Details Narrative)	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Accounts Payable [Member]
Concentrations of risk percentage	41.00%		26.00%
One Customer [Member]
Concentrations of risk percentage	100.00%	100.00%	99.00%	100.00%
One Customer [Member] \| Accounts Receivable [Member]
Concentrations of risk percentage	100.00%		100.00%
Two Vendor [Member]
Concentrations of risk percentage	59.00%		71.00%
One Vendor [Member]
Concentrations of risk percentage				100.00%
One Vendor [Member] \| Accounts Payable [Member]
Concentrations of risk percentage	100.00%	89.00%	100.00%

Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 2,641	$ 21,081	$ 2,702
Deposits to supplier	266,552	477,254	507,367
Total prepaid expenses and deposits	$ 269,193	$ 498,335	$ 510,069

Investment in Non-Marketable Securities (Details Narrative)	Dec. 31, 2019 USD ($) shares	Dec. 31, 2019 MYR (RM) shares	Jun. 30, 2019 USD ($) shares	Apr. 03, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($) shares	Apr. 16, 2018 $ / shares	Mar. 09, 2018 $ / shares
Ordinary shares authorized	1,000,000,000	1,000,000,000	1,000,000,000		1,000,000,000
Ordinary shares issued	376,275,500	376,275,500	376,275,500		376,275,500
Ordinary shares outstanding	376,275,500	376,275,500	376,275,500		376,275,500
Share purchased price per share \| $ / shares						$ 0.0001	$ 1.00
Phoenix Plus Corporation [Member]
Investment amount \| $	$ 1,500		$ 1,500	$ 1,500	$ 1,500
Equity interest percentage				5.00%
Shares purchased during period				300,000,000
Share purchased price per share \| $ / shares				$ 0.0001
Phoenix Plus Corporation [Member] \| Common Stock [Member]
Shares purchased during period				15,000,000
Maximum [Member]
Equity interest percentage	20.00%	20.00%
Minimum [Member]
Equity interest percentage	17.86%	17.86%
Director [Member]
Investment amount \| $	$ 863,592
Equity interest percentage	20.00%	20.00%
Ordinary shares authorized	2,500,000	2,500,000
Ordinary shares issued	2,500,000	2,500,000
Ordinary shares outstanding	2,500,000	2,500,000
Director [Member] \| MYR Currency [Member]
Investment amount \| RM		RM 3,500,000
Mr. How Kok Choong [Member]
Investment amount \| $	$ 730,637

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Balance at Jun. 30, 2017	$ 37,135	$ 2,367,875	$ (100,362)		$ 2,304,648
Balance, shares at Jun. 30, 2017	371,350,000
Net loss			(130,274)		(130,274)
IPO completed on March 9, 2018 at $1.00 per share	$ 293	2,925,207			2,925,500
IPO completed on March 9, 2018 at $1.00 per share, shares	2,925,500
Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share	$ 200				200
Shares issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share, shares	2,000,000
Foreign currency translation adjustment				(1,293)	(1,293)
Balance at Jun. 30, 2018	$ 37,628	5,293,082	(230,636)	(1,293)	5,098,781
Balance, shares at Jun. 30, 2018	376,275,500
Net loss			(142,446)		(142,446)
Foreign currency translation adjustment				(1)	(1)
Balance at Dec. 31, 2018	$ 37,628	5,293,082	(373,082)	(1,294)	4,956,334
Balance, shares at Dec. 31, 2018	376,275,500
Balance at Jun. 30, 2018	$ 37,628	5,293,082	(230,636)	(1,293)	5,098,781
Balance, shares at Jun. 30, 2018	376,275,500
Net loss					(519,642)
Balance at Jun. 30, 2019	$ 37,628	5,293,082	(750,278)	(79)	4,580,353
Balance, shares at Jun. 30, 2019	376,275,500
Balance at Dec. 31, 2018	$ 37,628	5,293,082	(373,082)	(1,294)	4,956,334
Balance, shares at Dec. 31, 2018	376,275,500
Net loss			(377,196)		(377,196)
Foreign currency translation adjustment				1,215	1,215
Balance at Jun. 30, 2019	$ 37,628	5,293,082	(750,278)	(79)	4,580,353
Balance, shares at Jun. 30, 2019	376,275,500
Net loss			(338,931)		(338,931)
Foreign currency translation adjustment				9,864	9,864
Balance at Dec. 31, 2019	$ 37,628	$ 5,293,082	$ (1,089,209)	$ 9,785	$ 4,251,286
Balance, shares at Dec. 31, 2019	376,275,500

Document and Entity Information - USD ($)	6 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2019	Mar. 25, 2020	Jun. 28, 2019
Document And Entity Information
Entity Registrant Name	Agape ATP Corp
Entity Central Index Key	0001713210
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 804,186,900
Entity Common Stock, Shares Outstanding		376,275,500
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019